Scatterplot of Two main Principal Components
Click on legend to highlight trace
Scatterplot of Three main Principal Components
Box Plot
Bar Plot
The Breast Cancer Now Biobank (BCNB) holds tissue, blood and cell samples, with linked clinical data, from donors across the UK. Use the BCNB Cohort Browser to identify donors with clinical characteristics similar to those selected in your analysis and explore the samples and data available for them.
Where matching filters exist, your current clinical selection criteria will automatically be carried over to the Cohort Browser (age, sex, survival status, menopausal status, family history, grade, diagnosis, ethnicity and ER/PR/HER2 status). Filters without a corresponding match will not be applied. You can further refine your selection within the Cohort Browser.
Filters carried over:
No matching filters selected: all BCNB donors will be shown.
To request samples and/or data, submit an Expression of Interest (EOI) form through the BCNB Request System.
For specific queries, visit Need Help? to contact the relevant BCNB team.
- The Clinical Summary counts donors. The donor table has one row per sample: a donor can have a primary tumour, a metastasis and/or a normal tissue sample.
- Genomics results (variant summary, oncoplot, lollipop) count tumour samples with mutation data, so they can differ from the number of donors: normal tissue samples have no somatic mutations, some tumour samples have no mutation data, and a donor's primary tumour and metastasis count as two samples.
| Donor ID | Age at Diagnosis | Sex Assigned at Birth | Race | Definition | Menopausal Status | Cancer Type | ER | PR | HER2 | Event | Event Site | Survival Status | Survival Time (years) | Genetic Ancestry | hidden | hidden |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TCGA-A7-A13G | 79 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | new primary | skin | alive | 1.97 | European | TCGA.A7.A13G.01A.11R.A13Q.07 | TCGA-A7-A13G-01 |
| TCGA-A7-A13G | 79 | female | White | Solid Tissue Normal | postmenopausal | IDC | positive | positive | negative | new primary | skin | alive | 1.97 | European | TCGA.A7.A13G.11A.51R.A13Q.07 | TCGA-A7-A13G-11 |
| TCGA-E2-A10B | 67 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | equivocal | new primary | lung | alive | 2.05 | European | TCGA.E2.A10B.01A.11R.A10J.07 | TCGA-E2-A10B-01 |
| TCGA-E2-A14R | 62 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | new primary | endometrial | alive | 2.31 | European | TCGA.E2.A14R.01A.11R.A115.07 | TCGA-E2-A14R-01 |
| TCGA-A7-A13H | 61 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | equivocal | new primary | skin | alive | 2.46 | European | TCGA.A7.A13H.01A.11R.A22K.07 | TCGA-A7-A13H-01 |
| TCGA-AR-A5QM | 62 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | equivocal | new primary | melanoma | alive | 6.11 | European | TCGA.AR.A5QM.01A.11R.A27Q.07 | TCGA-AR-A5QM-01 |
| TCGA-B6-A2IU | 62 | female | White | Primary solid Tumor | indeterminate | ILC | positive | positive | not evaluated | new primary | lung | alive | 14.17 | European | TCGA.B6.A2IU.01A.32R.A18M.07 | TCGA-B6-A2IU-01 |
| TCGA-B6-A0WZ | 50 | female | Black or African American | Primary solid Tumor | indeterminate | IDC | positive | positive | not evaluated | new primary | bone | alive | 17.23 | African_admix | TCGA.B6.A0WZ.01A.11R.A109.07 | TCGA-B6-A0WZ-01 |
| TCGA-BH-A18V | 48 | female | White | Primary solid Tumor | not available | IDC | negative | negative | negative | metastasis | intramammary node | dead | 4.26 | European | TCGA.BH.A18V.01A.11R.A12D.07 | TCGA-BH-A18V-01 |
| TCGA-BH-A18V | 48 | female | White | Solid Tissue Normal | not available | IDC | negative | negative | negative | metastasis | intramammary node | dead | 4.26 | European | TCGA.BH.A18V.11A.52R.A12D.07 | TCGA-BH-A18V-11 |
| TCGA-E9-A1NI | 51 | female | White | Primary solid Tumor | postmenopausal | IDC/ILC | positive | positive | negative | NA | NA | alive | NA | European | TCGA.E9.A1NI.01A.11R.A14D.07 | TCGA-E9-A1NI-01 |
| TCGA-PL-A8LV | 54 | female | Black or African American | Primary solid Tumor | unknown | medullary carcinoma | not evaluated | not evaluated | not evaluated | NA | NA | alive | NA | African | TCGA.PL.A8LV.01A.21R.A41B.07 | TCGA-PL-A8LV-01 |
| TCGA-A2-A25D | 90 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | negative | negative | NA | NA | alive | NA | European | TCGA.A2.A25D.01A.12R.A16F.07 | TCGA-A2-A25D-01 |
| TCGA-A8-A06N | 66 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | negative | negative | NA | NA | alive | NA | European | TCGA.A8.A06N.01A.11R.A00Z.07 | TCGA-A8-A06N-01 |
| TCGA-A8-A081 | 80 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | NA | European | TCGA.A8.A081.01A.11R.A00Z.07 | TCGA-A8-A081-01 |
| TCGA-A8-A083 | 67 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | NA | European | TCGA.A8.A083.01A.21R.A00Z.07 | TCGA-A8-A083-01 |
| TCGA-A8-A08H | 66 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | NA | European | TCGA.A8.A08H.01A.21R.A00Z.07 | TCGA-A8-A08H-01 |
| TCGA-A8-A090 | 74 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | NA | European | TCGA.A8.A090.01A.11R.A00Z.07 | TCGA-A8-A090-01 |
| TCGA-A8-A094 | 75 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | negative | negative | NA | NA | alive | NA | European | TCGA.A8.A094.01A.11R.A00Z.07 | TCGA-A8-A094-01 |
| TCGA-A8-A096 | 73 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | NA | European | TCGA.A8.A096.01A.11R.A00Z.07 | TCGA-A8-A096-01 |
| TCGA-A8-A09G | 79 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | negative | positive | NA | NA | alive | NA | European | TCGA.A8.A09G.01A.21R.A00Z.07 | TCGA-A8-A09G-01 |
| TCGA-A8-A09Z | 83 | female | not available | Primary solid Tumor | postmenopausal | ILC | positive | negative | negative | NA | NA | alive | NA | European | TCGA.A8.A09Z.01A.11R.A00Z.07 | TCGA-A8-A09Z-01 |
| TCGA-AC-A3W6 | 90 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | NA | European | TCGA.AC.A3W6.01A.12R.A22K.07 | TCGA-AC-A3W6-01 |
| TCGA-C8-A12K | 80 | female | Asian | Primary solid Tumor | postmenopausal | IDC | not evaluated | not evaluated | not evaluated | NA | NA | alive | NA | East Asian | TCGA.C8.A12K.01A.21R.A115.07 | TCGA-C8-A12K-01 |
| TCGA-C8-A12T | 43 | female | Asian | Primary solid Tumor | premenopausal | IDC | positive | positive | positive | NA | NA | alive | NA | East Asian | TCGA.C8.A12T.01A.11R.A115.07 | TCGA-C8-A12T-01 |
| TCGA-C8-A133 | 65 | female | White | Primary solid Tumor | postmenopausal | ductal/mucinous | positive | positive | not evaluated | NA | NA | alive | NA | South Asian_admix | TCGA.C8.A133.01A.32R.A12D.07 | TCGA-C8-A133-01 |
| TCGA-C8-A26Y | 90 | female | Asian | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | NA | East Asian | TCGA.C8.A26Y.01A.11R.A16F.07 | TCGA-C8-A26Y-01 |
| TCGA-D8-A1JK | 90 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | positive | negative | NA | NA | alive | NA | European | TCGA.D8.A1JK.01A.11R.A13Q.07 | TCGA-D8-A1JK-01 |
| TCGA-LL-A6FP | 90 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | equivocal | NA | NA | alive | NA | European | TCGA.LL.A6FP.01A.11R.A31O.07 | TCGA-LL-A6FP-01 |
| TCGA-AC-A7VC | 56 | female | White | Primary solid Tumor | postmenopausal | metaplastic carcinoma | negative | negative | negative | NA | NA | alive | NA | European | TCGA.AC.A7VC.01A.11R.A352.07 | TCGA-AC-A7VC-01 |
| TCGA-C8-A275 | 56 | female | Asian | Primary solid Tumor | postmenopausal | IDC | not evaluated | not evaluated | not evaluated | NA | NA | alive | NA | East Asian | TCGA.C8.A275.01A.21R.A16F.07 | TCGA-C8-A275-01 |
| TCGA-AN-A0AM | 56 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | negative | negative | NA | NA | alive | 0.01 | European | TCGA.AN.A0AM.01A.11R.A034.07 | TCGA-AN-A0AM-01 |
| TCGA-C8-A1HJ | 53 | female | Asian | Primary solid Tumor | perimenopausal | IDC | negative | negative | negative | NA | NA | alive | 0.01 | East Asian | TCGA.C8.A1HJ.01A.11R.A13Q.07 | TCGA-C8-A1HJ-01 |
| TCGA-E9-A1N4 | 41 | female | White | Primary solid Tumor | premenopausal | IDC/ILC | positive | positive | positive | NA | NA | alive | 0.01 | European | TCGA.E9.A1N4.01A.11R.A14M.07 | TCGA-E9-A1N4-01 |
| TCGA-E9-A1N4 | 41 | female | White | Solid Tissue Normal | premenopausal | IDC/ILC | positive | positive | positive | NA | NA | alive | 0.01 | European | TCGA.E9.A1N4.11A.33R.A14M.07 | TCGA-E9-A1N4-11 |
| TCGA-PL-A8LX | 35 | female | Black or African American | Primary solid Tumor | premenopausal | IDC | not evaluated | not evaluated | not evaluated | metastasis | bone|liver | alive | 0.01 | African | TCGA.PL.A8LX.01A.11R.A41B.07 | TCGA-PL-A8LX-01 |
| TCGA-C8-A273 | 29 | female | Asian | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.02 | East Asian | TCGA.C8.A273.01A.11R.A16F.07 | TCGA-C8-A273-01 |
| TCGA-AN-A041 | 29 | female | White | Primary solid Tumor | premenopausal | IDC | positive | negative | positive | NA | NA | alive | 0.02 | European_admix | TCGA.AN.A041.01A.11R.A034.07 | TCGA-AN-A041-01 |
| TCGA-C8-A12W | 49 | female | Asian | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.02 | East Asian | TCGA.C8.A12W.01A.11R.A115.07 | TCGA-C8-A12W-01 |
| TCGA-C8-A138 | 54 | female | Asian | Primary solid Tumor | postmenopausal | IDC | positive | negative | equivocal | NA | NA | alive | 0.02 | East Asian | TCGA.C8.A138.01A.11R.A115.07 | TCGA-C8-A138-01 |
| TCGA-C8-A1HK | 53 | female | Asian | Primary solid Tumor | perimenopausal | IDC | negative | negative | positive | NA | NA | alive | 0.02 | East Asian | TCGA.C8.A1HK.01A.21R.A13Q.07 | TCGA-C8-A1HK-01 |
| TCGA-C8-A26W | 58 | female | Asian | Primary solid Tumor | postmenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 0.02 | East Asian | TCGA.C8.A26W.01A.11R.A16F.07 | TCGA-C8-A26W-01 |
| TCGA-C8-A3M8 | 68 | female | Asian | Primary solid Tumor | postmenopausal | ILC | positive | positive | positive | NA | NA | alive | 0.02 | East Asian | TCGA.C8.A3M8.01A.11R.A213.07 | TCGA-C8-A3M8-01 |
| TCGA-AR-A0U0 | 73 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | not evaluated | NA | NA | alive | 0.02 | European | TCGA.AR.A0U0.01A.11R.A109.07 | TCGA-AR-A0U0-01 |
| TCGA-C8-A8HP | 59 | female | Asian | Primary solid Tumor | postmenopausal | metaplastic carcinoma | negative | negative | positive | NA | NA | alive | 0.02 | East Asian | TCGA.C8.A8HP.01A.11R.A36F.07 | TCGA-C8-A8HP-01 |
| TCGA-E9-A5FL | 65 | female | White | Primary solid Tumor | postmenopausal | metaplastic carcinoma | negative | negative | negative | NA | NA | alive | 0.02 | European | TCGA.E9.A5FL.01A.11R.A27Q.07 | TCGA-E9-A5FL-01 |
| TCGA-PL-A8LY | 30 | female | Black or African American | Primary solid Tumor | premenopausal | IDC | not evaluated | not evaluated | not evaluated | NA | NA | alive | 0.02 | African | TCGA.PL.A8LY.01A.11R.A41B.07 | TCGA-PL-A8LY-01 |
| TCGA-AC-A5XU | 74 | female | Black or African American | Primary solid Tumor | not available | IDC | positive | positive | negative | NA | NA | alive | 0.02 | African | TCGA.AC.A5XU.01A.11R.A28M.07 | TCGA-AC-A5XU-01 |
| TCGA-AN-A0XP | 69 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 0.02 | European | TCGA.AN.A0XP.01A.11R.A109.07 | TCGA-AN-A0XP-01 |
| TCGA-C8-A26V | 47 | female | Asian | Primary solid Tumor | perimenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.02 | East Asian | TCGA.C8.A26V.01A.11R.A16F.07 | TCGA-C8-A26V-01 |
| TCGA-C8-A278 | 61 | female | Asian | Primary solid Tumor | postmenopausal | IDC | negative | negative | positive | NA | NA | alive | 0.02 | East Asian | TCGA.C8.A278.01A.11R.A169.07 | TCGA-C8-A278-01 |
| TCGA-C8-A8HQ | 53 | female | Asian | Primary solid Tumor | postmenopausal | mucinous carcinoma | positive | positive | negative | NA | NA | alive | 0.02 | East Asian | TCGA.C8.A8HQ.01A.11R.A36F.07 | TCGA-C8-A8HQ-01 |
| TCGA-AN-A03X | 74 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 0.03 | European | TCGA.AN.A03X.01A.21R.A00Z.07 | TCGA-AN-A03X-01 |
| TCGA-AN-A03Y | 66 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.03 | European | TCGA.AN.A03Y.01A.21R.A00Z.07 | TCGA-AN-A03Y-01 |
| TCGA-AN-A046 | 68 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.03 | European | TCGA.AN.A046.01A.21R.A034.07 | TCGA-AN-A046-01 |
| TCGA-AN-A0AR | 55 | female | White | Primary solid Tumor | premenopausal | IDC | negative | negative | negative | NA | NA | alive | 0.03 | European | TCGA.AN.A0AR.01A.11R.A00Z.07 | TCGA-AN-A0AR-01 |
| TCGA-AN-A0AS | 70 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | negative | negative | NA | NA | alive | 0.03 | European | TCGA.AN.A0AS.01A.11R.A00Z.07 | TCGA-AN-A0AS-01 |
| TCGA-AN-A0AT | 62 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 0.03 | European | TCGA.AN.A0AT.01A.11R.A034.07 | TCGA-AN-A0AT-01 |
| TCGA-AN-A0FV | 58 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | positive | NA | NA | alive | 0.03 | European | TCGA.AN.A0FV.01A.11R.A00Z.07 | TCGA-AN-A0FV-01 |
| TCGA-AN-A0FX | 52 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | positive | NA | NA | alive | 0.03 | European | TCGA.AN.A0FX.01A.11R.A034.07 | TCGA-AN-A0FX-01 |
| TCGA-AN-A0FY | 55 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.03 | European | TCGA.AN.A0FY.01A.11R.A034.07 | TCGA-AN-A0FY-01 |
| TCGA-AN-A0FZ | 45 | female | White | Primary solid Tumor | premenopausal | IDC | positive | negative | positive | NA | NA | alive | 0.03 | European | TCGA.AN.A0FZ.01A.11R.A034.07 | TCGA-AN-A0FZ-01 |
| TCGA-AN-A0XN | 68 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | positive | negative | NA | NA | alive | 0.03 | European | TCGA.AN.A0XN.01A.21R.A109.07 | TCGA-AN-A0XN-01 |
| TCGA-AN-A0XR | 55 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | negative | negative | NA | NA | alive | 0.03 | European | TCGA.AN.A0XR.01A.11R.A109.07 | TCGA-AN-A0XR-01 |
| TCGA-AN-A0XS | 63 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | positive | negative | NA | NA | alive | 0.03 | European | TCGA.AN.A0XS.01A.22R.A109.07 | TCGA-AN-A0XS-01 |
| TCGA-AN-A0XT | 54 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | negative | negative | NA | NA | alive | 0.03 | European | TCGA.AN.A0XT.01A.11R.A109.07 | TCGA-AN-A0XT-01 |
| TCGA-AN-A0XU | 54 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 0.03 | European | TCGA.AN.A0XU.01A.11R.A109.07 | TCGA-AN-A0XU-01 |
| TCGA-AN-A0FW | 67 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | Indeterminate | negative | NA | NA | alive | 0.03 | European | TCGA.AN.A0FW.01A.11R.A034.07 | TCGA-AN-A0FW-01 |
| TCGA-E2-A1IL | 78 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 0.04 | European | TCGA.E2.A1IL.01A.11R.A14D.07 | TCGA-E2-A1IL-01 |
| TCGA-AN-A0G0 | 56 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 0.04 | European | TCGA.AN.A0G0.01A.11R.A034.07 | TCGA-AN-A0G0-01 |
| TCGA-AN-A049 | 62 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.05 | European | TCGA.AN.A049.01A.21R.A00Z.07 | TCGA-AN-A049-01 |
| TCGA-E9-A1R2 | 51 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | negative | equivocal | NA | NA | alive | 0.05 | European | TCGA.E9.A1R2.01A.11R.A14D.07 | TCGA-E9-A1R2-01 |
| TCGA-E9-A1RD | 67 | female | White | Primary solid Tumor | postmenopausal | IDC | not evaluated | not evaluated | not evaluated | NA | NA | alive | 0.05 | European | TCGA.E9.A1RD.01A.11R.A157.07 | TCGA-E9-A1RD-01 |
| TCGA-E9-A1RD | 67 | female | White | Solid Tissue Normal | postmenopausal | IDC | not evaluated | not evaluated | not evaluated | NA | NA | alive | 0.05 | European | TCGA.E9.A1RD.11A.33R.A157.07 | TCGA-E9-A1RD-11 |
| TCGA-E9-A244 | 54 | female | White | Primary solid Tumor | postmenopausal | IDC | not evaluated | not evaluated | not evaluated | NA | NA | alive | 0.06 | European | TCGA.E9.A244.01A.11R.A169.07 | TCGA-E9-A244-01 |
| TCGA-E9-A227 | 42 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.07 | European | TCGA.E9.A227.01A.11R.A157.07 | TCGA-E9-A227-01 |
| TCGA-D8-A27R | 41 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 0.08 | European | TCGA.D8.A27R.01A.11R.A16F.07 | TCGA-D8-A27R-01 |
| TCGA-E9-A1R4 | 66 | female | White | Primary solid Tumor | postmenopausal | IDC | not evaluated | not evaluated | not evaluated | NA | NA | alive | 0.08 | European | TCGA.E9.A1R4.01A.21R.A14D.07 | TCGA-E9-A1R4-01 |
| TCGA-E9-A249 | 45 | female | White | Primary solid Tumor | premenopausal | IDC | not evaluated | not evaluated | not evaluated | NA | NA | alive | 0.08 | European | TCGA.E9.A249.01A.11R.A169.07 | TCGA-E9-A249-01 |
| TCGA-A8-A08A | 89 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.08 | European | TCGA.A8.A08A.01A.11R.A32Y.07 | TCGA-A8-A08A-01 |
| TCGA-A8-A09W | 70 | female | not available | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 0.08 | European | TCGA.A8.A09W.01A.11R.A00Z.07 | TCGA-A8-A09W-01 |
| TCGA-A8-A0A7 | 57 | female | not available | Primary solid Tumor | postmenopausal | ILC | negative | negative | positive | NA | NA | alive | 0.08 | European | TCGA.A8.A0A7.01A.11R.A00Z.07 | TCGA-A8-A0A7-01 |
| TCGA-A8-A06Q | 63 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.08 | European | TCGA.A8.A06Q.01A.11R.A034.07 | TCGA-A8-A06Q-01 |
| TCGA-A8-A06Z | 84 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.08 | European | TCGA.A8.A06Z.01A.11R.A00Z.07 | TCGA-A8-A06Z-01 |
| TCGA-A8-A09C | 69 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.08 | European | TCGA.A8.A09C.01A.11R.A00Z.07 | TCGA-A8-A09C-01 |
| TCGA-A8-A09N | 57 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 0.08 | European | TCGA.A8.A09N.01A.11R.A00Z.07 | TCGA-A8-A09N-01 |
| TCGA-AC-A2QH | 58 | female | White | Primary solid Tumor | postmenopausal | metaplastic carcinoma | negative | negative | negative | NA | NA | alive | 0.08 | European | TCGA.AC.A2QH.01A.11R.A18M.07 | TCGA-AC-A2QH-01 |
| TCGA-AC-A8OQ | 72 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | negative | negative | Indeterminate | NA | NA | alive | 0.09 | African_admix | TCGA.AC.A8OQ.01A.11R.A41B.07 | TCGA-AC-A8OQ-01 |
| TCGA-E2-A15K | 58 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 0.09 | European | TCGA.E2.A15K.01A.11R.A12P.07 | TCGA-E2-A15K-01 |
| TCGA-E2-A15K | 58 | female | White | Solid Tissue Normal | postmenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 0.09 | European | TCGA.E2.A15K.11A.13R.A12P.07 | TCGA-E2-A15K-11 |
| TCGA-E9-A1RF | 68 | female | White | Primary solid Tumor | postmenopausal | IDC | not evaluated | not evaluated | not evaluated | NA | NA | alive | 0.1 | European | TCGA.E9.A1RF.01A.11R.A157.07 | TCGA-E9-A1RF-01 |
| TCGA-E9-A1RF | 68 | female | White | Solid Tissue Normal | postmenopausal | IDC | not evaluated | not evaluated | not evaluated | NA | NA | alive | 0.1 | European | TCGA.E9.A1RF.11A.32R.A157.07 | TCGA-E9-A1RF-11 |
| TCGA-AC-A8OR | 75 | female | White | Primary solid Tumor | postmenopausal | mucinous carcinoma | positive | positive | negative | NA | NA | alive | 0.11 | European | TCGA.AC.A8OR.01A.21R.A41B.07 | TCGA-AC-A8OR-01 |
| TCGA-E2-A15H | 38 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 0.11 | European | TCGA.E2.A15H.01A.11R.A12D.07 | TCGA-E2-A15H-01 |
| TCGA-E9-A1R5 | 63 | female | White | Primary solid Tumor | postmenopausal | IDC | not evaluated | not evaluated | not evaluated | NA | NA | alive | 0.11 | European | TCGA.E9.A1R5.01A.11R.A14M.07 | TCGA-E9-A1R5-01 |
| TCGA-E9-A243 | 52 | female | White | Primary solid Tumor | perimenopausal | IDC | not evaluated | not evaluated | not evaluated | NA | NA | alive | 0.12 | European | TCGA.E9.A243.01A.21R.A169.07 | TCGA-E9-A243-01 |
| TCGA-AC-A2FB | 65 | female | White | Primary solid Tumor | not available | ILC | positive | positive | positive | NA | NA | alive | 0.12 | European | TCGA.AC.A2FB.01A.11R.A17B.07 | TCGA-AC-A2FB-01 |
| TCGA-AC-A2FB | 65 | female | White | Solid Tissue Normal | not available | ILC | positive | positive | positive | NA | NA | alive | 0.12 | European | TCGA.AC.A2FB.11A.13R.A17B.07 | TCGA-AC-A2FB-11 |
| TCGA-E9-A1RI | 43 | female | White | Primary solid Tumor | premenopausal | IDC/ILC | not evaluated | not evaluated | not evaluated | NA | NA | alive | 0.13 | European | TCGA.E9.A1RI.01A.11R.A169.07 | TCGA-E9-A1RI-01 |
| TCGA-E9-A1RI | 43 | female | White | Solid Tissue Normal | premenopausal | IDC/ILC | not evaluated | not evaluated | not evaluated | NA | NA | alive | 0.13 | European | TCGA.E9.A1RI.11A.41R.A169.07 | TCGA-E9-A1RI-11 |
| TCGA-D8-A145 | 80 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 0.13 | European | TCGA.D8.A145.01A.11R.A115.07 | TCGA-D8-A145-01 |
| TCGA-D8-A27P | 64 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.13 | European | TCGA.D8.A27P.01A.11R.A16F.07 | TCGA-D8-A27P-01 |
| TCGA-D8-A1XS | 48 | male | White | Primary solid Tumor | not applicable | ductal/micropapillary | positive | positive | positive | NA | NA | alive | 0.14 | European | TCGA.D8.A1XS.01A.11R.A14M.07 | TCGA-D8-A1XS-01 |
| TCGA-AC-A6NO | 43 | female | Black or African American | Primary solid Tumor | unknown | IDC | positive | positive | negative | NA | NA | alive | 0.14 | African_admix | TCGA.AC.A6NO.01A.12R.A33J.07 | TCGA-AC-A6NO-01 |
| TCGA-AN-A04D | 58 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 0.14 | European | TCGA.AN.A04D.01A.21R.A034.07 | TCGA-AN-A04D-01 |
| TCGA-A7-A3RF | 79 | female | White | Primary solid Tumor | postmenopausal | mucinous carcinoma | positive | positive | negative | metastasis | bone>liver | alive | 0.15 | European | TCGA.A7.A3RF.01A.11R.A22K.07 | TCGA-A7-A3RF-01 |
| TCGA-AN-A04C | 51 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | positive | NA | NA | alive | 0.15 | European | TCGA.AN.A04C.01A.21R.A034.07 | TCGA-AN-A04C-01 |
| TCGA-AC-A3W5 | 65 | female | Black or African American | Primary solid Tumor | not evaluated | ILC | positive | positive | not evaluated | NA | NA | alive | 0.15 | African | TCGA.AC.A3W5.01A.11R.A22K.07 | TCGA-AC-A3W5-01 |
| TCGA-AC-A62Y | 79 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 0.15 | European | TCGA.AC.A62Y.01A.11R.A29R.07 | TCGA-AC-A62Y-01 |
| TCGA-C8-A132 | 56 | female | Asian | Primary solid Tumor | postmenopausal | IDC | positive | positive | not evaluated | NA | NA | alive | 0.16 | East Asian | TCGA.C8.A132.01A.31R.A115.07 | TCGA-C8-A132-01 |
| TCGA-OL-A66P | 75 | female | Black or African American | Primary solid Tumor | not available | IDC | negative | negative | not evaluated | NA | NA | alive | 0.16 | African | TCGA.OL.A66P.01A.11R.A31O.07 | TCGA-OL-A66P-01 |
| TCGA-E9-A248 | 51 | female | White | Primary solid Tumor | perimenopausal | IDC | not evaluated | not evaluated | not evaluated | NA | NA | alive | 0.16 | European | TCGA.E9.A248.01A.11R.A169.07 | TCGA-E9-A248-01 |
| TCGA-BH-A18G | 81 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 0.17 | European | TCGA.BH.A18G.01A.11R.A12D.07 | TCGA-BH-A18G-01 |
| TCGA-D8-A142 | 74 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | equivocal | NA | NA | alive | 0.17 | European | TCGA.D8.A142.01A.11R.A115.07 | TCGA-D8-A142-01 |
| TCGA-AC-A5EH | 76 | female | Black or African American | Primary solid Tumor | not available | IDC | positive | negative | negative | NA | NA | alive | 0.17 | African_admix | TCGA.AC.A5EH.01A.11R.A28M.07 | TCGA-AC-A5EH-01 |
| TCGA-E9-A1R3 | 70 | female | White | Primary solid Tumor | postmenopausal | IDC | not evaluated | not evaluated | not evaluated | NA | NA | alive | 0.18 | European | TCGA.E9.A1R3.01A.31R.A14M.07 | TCGA-E9-A1R3-01 |
| TCGA-OK-A5Q2 | 59 | female | not available | Primary solid Tumor | unknown | ILC | positive | positive | negative | NA | NA | alive | 0.18 | African | TCGA.OK.A5Q2.01A.11R.A27Q.07 | TCGA-OK-A5Q2-01 |
| TCGA-A7-A26J | 49 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.19 | European | TCGA.A7.A26J.01A.11R.A169.07 | TCGA-A7-A26J-01 |
| TCGA-C8-A131 | 82 | female | Asian | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 0.19 | East Asian | TCGA.C8.A131.01A.11R.A115.07 | TCGA-C8-A131-01 |
| TCGA-AC-A8OS | 71 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | positive | NA | NA | alive | 0.19 | European | TCGA.AC.A8OS.01A.12R.A41B.07 | TCGA-AC-A8OS-01 |
| TCGA-C8-A1HM | 74 | female | Asian | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.19 | East Asian | TCGA.C8.A1HM.01A.12R.A137.07 | TCGA-C8-A1HM-01 |
| TCGA-AC-A23E | 50 | female | White | Primary solid Tumor | not available | IDC | positive | positive | not evaluated | NA | NA | alive | 0.2 | European | TCGA.AC.A23E.01A.11R.A157.07 | TCGA-AC-A23E-01 |
| TCGA-BH-A0HL | 56 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 0.2 | European | TCGA.BH.A0HL.01A.11R.A10U.07 | TCGA-BH-A0HL-01 |
| TCGA-D8-A1Y2 | 71 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | Indeterminate | NA | NA | alive | 0.2 | European | TCGA.D8.A1Y2.01A.11R.A157.07 | TCGA-D8-A1Y2-01 |
| TCGA-D8-A27V | 62 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 0.2 | European | TCGA.D8.A27V.01A.12R.A17B.07 | TCGA-D8-A27V-01 |
| TCGA-AC-A7VB | 51 | female | Black or African American | Primary solid Tumor | unknown | IDC | positive | negative | not evaluated | NA | NA | alive | 0.2 | African_admix | TCGA.AC.A7VB.01A.11R.A352.07 | TCGA-AC-A7VB-01 |
| TCGA-A7-A3J1 | 63 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 0.21 | European | TCGA.A7.A3J1.01A.11R.A213.07 | TCGA-A7-A3J1-01 |
| TCGA-D8-A1XG | 86 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | negative | negative | NA | NA | alive | 0.21 | European | TCGA.D8.A1XG.01A.11R.A14D.07 | TCGA-D8-A1XG-01 |
| TCGA-A7-A3J0 | 62 | female | White | Primary solid Tumor | postmenopausal | mucinous carcinoma | positive | positive | negative | NA | NA | alive | 0.21 | European | TCGA.A7.A3J0.01A.11R.A213.07 | TCGA-A7-A3J0-01 |
| TCGA-BH-A0HO | 48 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.21 | European | TCGA.BH.A0HO.01A.11R.A034.07 | TCGA-BH-A0HO-01 |
| TCGA-AQ-A54N | 51 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | negative | negative | equivocal | NA | NA | alive | 0.21 | African | TCGA.AQ.A54N.01A.11R.A266.07 | TCGA-AQ-A54N-01 |
| TCGA-BH-A0DS | 71 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.21 | European | TCGA.BH.A0DS.01A.11R.A056.07 | TCGA-BH-A0DS-01 |
| TCGA-HN-A2NL | 56 | female | not available | Primary solid Tumor | postmenopausal | ILC | negative | negative | negative | NA | NA | alive | 0.22 | European | TCGA.HN.A2NL.01A.11R.A18M.07 | TCGA-HN-A2NL-01 |
| TCGA-LL-A6FQ | 77 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.22 | African | TCGA.LL.A6FQ.01A.11R.A31O.07 | TCGA-LL-A6FQ-01 |
| TCGA-D8-A1XY | 74 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 0.22 | European | TCGA.D8.A1XY.01A.11R.A14M.07 | TCGA-D8-A1XY-01 |
| TCGA-AR-A24P | 47 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 0.23 | European | TCGA.AR.A24P.01A.11R.A169.07 | TCGA-AR-A24P-01 |
| TCGA-E9-A1R6 | 63 | female | White | Primary solid Tumor | postmenopausal | IDC | not evaluated | not evaluated | not evaluated | NA | NA | alive | 0.23 | European | TCGA.E9.A1R6.01A.11R.A14D.07 | TCGA-E9-A1R6-01 |
| TCGA-D8-A1X7 | 40 | female | White | Primary solid Tumor | premenopausal | ductal partially papillary | positive | positive | negative | NA | NA | alive | 0.23 | European | TCGA.D8.A1X7.01A.11R.A14M.07 | TCGA-D8-A1X7-01 |
| TCGA-MS-A51U | 44 | female | White | Primary solid Tumor | not available | ILC | positive | positive | negative | NA | NA | alive | 0.23 | European | TCGA.MS.A51U.01A.31R.A266.07 | TCGA-MS-A51U-01 |
| TCGA-AN-A04A | 36 | female | White | Primary solid Tumor | perimenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.25 | European | TCGA.AN.A04A.01A.21R.A034.07 | TCGA-AN-A04A-01 |
| TCGA-E9-A6HE | 45 | female | White | Primary solid Tumor | premenopausal | ILC | positive | positive | negative | NA | NA | alive | 0.25 | European | TCGA.E9.A6HE.01A.11R.A31O.07 | TCGA-E9-A6HE-01 |
| TCGA-AC-A3TM | 50 | female | White | Primary solid Tumor | perimenopausal | ILC | positive | positive | equivocal | NA | NA | alive | 0.25 | European | TCGA.AC.A3TM.01A.11R.A22K.07 | TCGA-AC-A3TM-01 |
| TCGA-C8-A130 | 52 | female | Asian | Primary solid Tumor | perimenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 0.26 | East Asian | TCGA.C8.A130.01A.31R.A115.07 | TCGA-C8-A130-01 |
| TCGA-D8-A1JF | 79 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 0.26 | European | TCGA.D8.A1JF.01A.11R.A13Q.07 | TCGA-D8-A1JF-01 |
| TCGA-D8-A1XF | 45 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.27 | European | TCGA.D8.A1XF.01A.11R.A14D.07 | TCGA-D8-A1XF-01 |
| TCGA-LL-A5YO | 50 | female | Black or African American | Primary solid Tumor | premenopausal | IDC | negative | negative | negative | NA | NA | alive | 0.27 | African | TCGA.LL.A5YO.01A.21R.A28M.07 | TCGA-LL-A5YO-01 |
| TCGA-BH-A0DQ | 42 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.27 | European | TCGA.BH.A0DQ.01A.11R.A084.07 | TCGA-BH-A0DQ-01 |
| TCGA-BH-A0DQ | 42 | female | White | Solid Tissue Normal | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.27 | European | TCGA.BH.A0DQ.11A.12R.A089.07 | TCGA-BH-A0DQ-11 |
| TCGA-BH-A5IZ | 51 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | positive | negative | negative | NA | NA | alive | 0.27 | African | TCGA.BH.A5IZ.01A.11R.A27Q.07 | TCGA-BH-A5IZ-01 |
| TCGA-LL-A7T0 | 70 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 0.27 | African | TCGA.LL.A7T0.01A.31R.A352.07 | TCGA-LL-A7T0-01 |
| TCGA-C8-A1HN | 56 | female | Asian | Primary solid Tumor | postmenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 0.27 | East Asian | TCGA.C8.A1HN.01A.11R.A137.07 | TCGA-C8-A1HN-01 |
| TCGA-LL-A5YP | 49 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | positive | negative | negative | NA | NA | alive | 0.27 | African | TCGA.LL.A5YP.01A.21R.A28M.07 | TCGA-LL-A5YP-01 |
| TCGA-BH-A0E0 | 38 | female | White | Primary solid Tumor | premenopausal | IDC | negative | negative | negative | NA | NA | alive | 0.37 | European | TCGA.BH.A0E0.01A.11R.A056.07 | TCGA-BH-A0E0-01 |
| TCGA-BH-A0E0 | 38 | female | White | Solid Tissue Normal | premenopausal | IDC | negative | negative | negative | NA | NA | alive | 0.37 | European | TCGA.BH.A0E0.11A.13R.A089.07 | TCGA-BH-A0E0-11 |
| TCGA-BH-A6R9 | 61 | female | White | Primary solid Tumor | postmenopausal | metaplastic carcinoma | negative | positive | negative | NA | NA | alive | 0.44 | European | TCGA.BH.A6R9.01A.21R.A32P.07 | TCGA-BH-A6R9-01 |
| TCGA-AN-A0XV | 67 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 0.44 | European | TCGA.AN.A0XV.01A.11R.A109.07 | TCGA-AN-A0XV-01 |
| TCGA-AN-A0XL | 61 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.45 | European | TCGA.AN.A0XL.01A.11R.A10J.07 | TCGA-AN-A0XL-01 |
| TCGA-E2-A2P6 | 77 | female | not available | Primary solid Tumor | postmenopausal | ILC | positive | positive | not evaluated | NA | NA | alive | 0.46 | American | TCGA.E2.A2P6.01A.11R.A19W.07 | TCGA-E2-A2P6-01 |
| TCGA-AN-A0XW | 36 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | positive | NA | NA | alive | 0.47 | European | TCGA.AN.A0XW.01A.11R.A109.07 | TCGA-AN-A0XW-01 |
| TCGA-BH-A0RX | 59 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 0.47 | European | TCGA.BH.A0RX.01A.21R.A084.07 | TCGA-BH-A0RX-01 |
| TCGA-AN-A0FF | 32 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.47 | European | TCGA.AN.A0FF.01A.11R.A034.07 | TCGA-AN-A0FF-01 |
| TCGA-BH-A0HK | 81 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | negative | negative | NA | NA | alive | 0.49 | European | TCGA.BH.A0HK.01A.11R.A056.07 | TCGA-BH-A0HK-01 |
| TCGA-BH-A0HK | 81 | female | White | Solid Tissue Normal | postmenopausal | IDC | positive | negative | negative | NA | NA | alive | 0.49 | European | TCGA.BH.A0HK.11A.11R.A089.07 | TCGA-BH-A0HK-11 |
| TCGA-EW-A1PC | 66 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.51 | African | TCGA.EW.A1PC.01B.11R.A21T.07 | TCGA-EW-A1PC-01 |
| TCGA-AN-A0FD | 71 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 0.54 | European | TCGA.AN.A0FD.01A.11R.A034.07 | TCGA-AN-A0FD-01 |
| TCGA-BH-A28Q | 46 | female | White | Primary solid Tumor | premenopausal | ILC | positive | positive | negative | NA | NA | alive | 0.54 | European | TCGA.BH.A28Q.01A.11R.A16F.07 | TCGA-BH-A28Q-01 |
| TCGA-AN-A0FS | 55 | female | White | Primary solid Tumor | perimenopausal | ILC | positive | negative | positive | NA | NA | alive | 0.57 | European | TCGA.AN.A0FS.01A.11R.A034.07 | TCGA-AN-A0FS-01 |
| TCGA-AN-A0FK | 88 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 0.58 | European | TCGA.AN.A0FK.01A.11R.A034.07 | TCGA-AN-A0FK-01 |
| TCGA-AN-A0FT | 63 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 0.59 | European | TCGA.AN.A0FT.01A.11R.A034.07 | TCGA-AN-A0FT-01 |
| TCGA-B6-A400 | 43 | female | Black or African American | Primary solid Tumor | unknown | IDC | negative | negative | negative | NA | NA | alive | 0.59 | African | TCGA.B6.A400.01A.11R.A239.07 | TCGA-B6-A400-01 |
| TCGA-LD-A7W5 | 52 | female | Black or African American | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.59 | African | TCGA.LD.A7W5.01A.22R.A352.07 | TCGA-LD-A7W5-01 |
| TCGA-AN-A0FN | 61 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | positive | NA | NA | alive | 0.6 | European | TCGA.AN.A0FN.01A.11R.A034.07 | TCGA-AN-A0FN-01 |
| TCGA-BH-A18I | 53 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 0.6 | European | TCGA.BH.A18I.01A.11R.A12D.07 | TCGA-BH-A18I-01 |
| TCGA-A2-A4RW | 49 | female | White | Primary solid Tumor | premenopausal | ILC | positive | positive | negative | NA | NA | alive | 0.61 | European | TCGA.A2.A4RW.01A.21R.A266.07 | TCGA-A2-A4RW-01 |
| TCGA-AN-A0AK | 76 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | negative | positive | NA | NA | alive | 0.61 | European | TCGA.AN.A0AK.01A.21R.A00Z.07 | TCGA-AN-A0AK-01 |
| TCGA-AR-A2LL | 70 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | equivocal | NA | NA | alive | 0.61 | European | TCGA.AR.A2LL.01A.11R.A180.07 | TCGA-AR-A2LL-01 |
| TCGA-GI-A2C8 | 63 | female | White | Primary solid Tumor | not available | IDC | positive | positive | negative | NA | NA | alive | 0.62 | European | TCGA.GI.A2C8.01A.11R.A16F.07 | TCGA-GI-A2C8-01 |
| TCGA-GI-A2C8 | 63 | female | White | Solid Tissue Normal | not available | IDC | positive | positive | negative | NA | NA | alive | 0.62 | European | TCGA.GI.A2C8.11A.22R.A16F.07 | TCGA-GI-A2C8-11 |
| TCGA-AN-A0AL | 41 | female | White | Primary solid Tumor | premenopausal | IDC | negative | negative | negative | NA | NA | alive | 0.62 | European | TCGA.AN.A0AL.01A.11R.A00Z.07 | TCGA-AN-A0AL-01 |
| TCGA-A7-A0CG | 78 | female | White | Primary solid Tumor | postmenopausal | ILC/IDC (grade 1) | positive | negative | negative | NA | NA | alive | 0.63 | European | TCGA.A7.A0CG.01A.12R.A056.07 | TCGA-A7-A0CG-01 |
| TCGA-AN-A0FL | 62 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | positive | NA | NA | alive | 0.63 | European | TCGA.AN.A0FL.01A.11R.A034.07 | TCGA-AN-A0FL-01 |
| TCGA-A7-A0CH | 79 | female | White | Primary solid Tumor | postmenopausal | IDC | not evaluated | not evaluated | not evaluated | NA | NA | alive | 0.64 | European | TCGA.A7.A0CH.01A.21R.A00Z.07 | TCGA-A7-A0CH-01 |
| TCGA-A7-A0CH | 79 | female | White | Solid Tissue Normal | postmenopausal | IDC | not evaluated | not evaluated | not evaluated | NA | NA | alive | 0.64 | European | TCGA.A7.A0CH.11A.32R.A089.07 | TCGA-A7-A0CH-11 |
| TCGA-A1-A0SM | 77 | male | White | Primary solid Tumor | not applicable | IDC | positive | negative | positive | NA | NA | alive | 0.66 | European | TCGA.A1.A0SM.01A.11R.A084.07 | TCGA-A1-A0SM-01 |
| TCGA-AN-A0FJ | 59 | female | White | Primary solid Tumor | perimenopausal | IDC | positive | negative | positive | NA | NA | alive | 0.66 | European | TCGA.AN.A0FJ.01A.11R.A00Z.07 | TCGA-AN-A0FJ-01 |
| TCGA-E2-A56Z | 69 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 0.69 | African_admix | TCGA.E2.A56Z.01A.12R.A29R.07 | TCGA-E2-A56Z-01 |
| TCGA-EW-A1IY | 38 | female | Asian | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.71 | East Asian | TCGA.EW.A1IY.01A.11R.A13Q.07 | TCGA-EW-A1IY-01 |
| TCGA-A1-A0SB | 70 | female | White | Primary solid Tumor | postmenopausal | adenoid cystic carcinoma | positive | negative | negative | NA | NA | alive | 0.71 | European | TCGA.A1.A0SB.01A.11R.A144.07 | TCGA-A1-A0SB-01 |
| TCGA-A7-A6VY | 48 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 0.73 | African_admix | TCGA.A7.A6VY.01A.12R.A33J.07 | TCGA-A7-A6VY-01 |
| TCGA-A7-A0DB | 56 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.73 | European | TCGA.A7.A0DB.01A.11R.A00Z.07 | TCGA-A7-A0DB-01 |
| TCGA-A7-A0DB | 56 | female | White | Solid Tissue Normal | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.73 | European | TCGA.A7.A0DB.11A.33R.A089.07 | TCGA-A7-A0DB-11 |
| TCGA-BH-A18F | 50 | female | White | Primary solid Tumor | perimenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.73 | European | TCGA.BH.A18F.01A.11R.A12D.07 | TCGA-BH-A18F-01 |
| TCGA-OL-A97C | 67 | female | Black or African American | Primary solid Tumor | postmenopausal | malignant phyllodes | negative | negative | not evaluated | metastasis | lung | alive | 0.74 | African | TCGA.OL.A97C.01A.32R.A41B.07 | TCGA-OL-A97C-01 |
| TCGA-A7-A0D9 | 37 | female | White | Primary solid Tumor | premenopausal | IDC | positive | negative | negative | NA | NA | alive | 0.75 | European | TCGA.A7.A0D9.01A.31R.A056.07 | TCGA-A7-A0D9-01 |
| TCGA-A7-A0D9 | 37 | female | White | Solid Tissue Normal | premenopausal | IDC | positive | negative | negative | NA | NA | alive | 0.75 | European | TCGA.A7.A0D9.11A.53R.A089.07 | TCGA-A7-A0D9-11 |
| TCGA-A8-A07R | 80 | female | not available | Primary solid Tumor | not available | IDC | negative | negative | positive | NA | NA | alive | 0.75 | European | TCGA.A8.A07R.01A.21R.A034.07 | TCGA-A8-A07R-01 |
| TCGA-A8-A09R | 82 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.75 | European | TCGA.A8.A09R.01A.11R.A00Z.07 | TCGA-A8-A09R-01 |
| TCGA-A8-A079 | 69 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.75 | European | TCGA.A8.A079.01A.21R.A00Z.07 | TCGA-A8-A079-01 |
| TCGA-A7-A6VW | 48 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 0.78 | African_admix | TCGA.A7.A6VW.01A.21R.A33J.07 | TCGA-A7-A6VW-01 |
| TCGA-BH-AB28 | 53 | female | White | Primary solid Tumor | unknown | ILC | positive | positive | negative | NA | NA | alive | 0.79 | European | TCGA.BH.AB28.01A.31R.A41B.07 | TCGA-BH-AB28-01 |
| TCGA-D8-A27K | 47 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.79 | European | TCGA.D8.A27K.01A.11R.A16F.07 | TCGA-D8-A27K-01 |
| TCGA-E9-A2JT | 63 | female | White | Primary solid Tumor | postmenopausal | ILC | not evaluated | not evaluated | not evaluated | NA | NA | alive | 0.79 | European | TCGA.E9.A2JT.01A.22R.A18M.07 | TCGA-E9-A2JT-01 |
| TCGA-E2-A15O | 89 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | positive | positive | equivocal | locoregional recurrence | not available | alive | 0.79 | African | TCGA.E2.A15O.01A.11R.A115.07 | TCGA-E2-A15O-01 |
| TCGA-BH-A0E6 | 69 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | equivocal | NA | NA | alive | 0.8 | European | TCGA.BH.A0E6.01A.11R.A034.07 | TCGA-BH-A0E6-01 |
| TCGA-BH-A6R8 | 46 | female | Black or African American | Primary solid Tumor | unknown | IDC | positive | positive | not evaluated | NA | NA | alive | 0.8 | African | TCGA.BH.A6R8.01A.21R.A33J.07 | TCGA-BH-A6R8-01 |
| TCGA-AO-A0J4 | 41 | female | Black or African American | Primary solid Tumor | premenopausal | IDC | negative | negative | negative | NA | NA | alive | 0.8 | African | TCGA.AO.A0J4.01A.11R.A034.07 | TCGA-AO-A0J4-01 |
| TCGA-PL-A8LZ | 29 | female | Black or African American | Primary solid Tumor | premenopausal | IDC | not evaluated | not evaluated | not evaluated | NA | NA | alive | 0.83 | African | TCGA.PL.A8LZ.01A.31R.A36F.07 | TCGA-PL-A8LZ-01 |
| TCGA-5T-A9QA | 52 | female | Black or African American | Primary solid Tumor | unknown | IDC/mucinous | positive | negative | equivocal | NA | NA | alive | 0.83 | African | TCGA.5T.A9QA.01A.11R.A41B.07 | TCGA-5T-A9QA-01 |
| TCGA-AN-A0AJ | 79 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 0.83 | European | TCGA.AN.A0AJ.01A.11R.A00Z.07 | TCGA-AN-A0AJ-01 |
| TCGA-A8-A07O | 51 | female | not available | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 0.83 | European | TCGA.A8.A07O.01A.11R.A00Z.07 | TCGA-A8-A07O-01 |
| TCGA-A8-A07W | 76 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.83 | European | TCGA.A8.A07W.01A.11R.A00Z.07 | TCGA-A8-A07W-01 |
| TCGA-A8-A099 | 76 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 0.83 | European | TCGA.A8.A099.01A.11R.A00Z.07 | TCGA-A8-A099-01 |
| TCGA-A8-A09A | 40 | female | not available | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.83 | European | TCGA.A8.A09A.01A.11R.A00Z.07 | TCGA-A8-A09A-01 |
| TCGA-A7-A0CE | 57 | female | White | Primary solid Tumor | indeterminate | IDC | negative | negative | equivocal | NA | NA | alive | 0.85 | European | TCGA.A7.A0CE.01A.11R.A00Z.07 | TCGA-A7-A0CE-01 |
| TCGA-A7-A0CE | 57 | female | White | Solid Tissue Normal | indeterminate | IDC | negative | negative | equivocal | NA | NA | alive | 0.85 | European | TCGA.A7.A0CE.11A.21R.A089.07 | TCGA-A7-A0CE-11 |
| TCGA-A7-A6VV | 51 | female | Black or African American | Primary solid Tumor | perimenopausal | IDC | negative | negative | negative | NA | NA | alive | 0.86 | African | TCGA.A7.A6VV.01A.22R.A33J.07 | TCGA-A7-A6VV-01 |
| TCGA-A7-A6VX | 68 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.87 | African | TCGA.A7.A6VX.01A.12R.A33J.07 | TCGA-A7-A6VX-01 |
| TCGA-C8-A1HL | 38 | female | Asian | Primary solid Tumor | premenopausal | Infiltrating mucinous-papillary ductal carcinoma | positive | negative | equivocal | NA | NA | alive | 0.87 | East Asian | TCGA.C8.A1HL.01A.11R.A137.07 | TCGA-C8-A1HL-01 |
| TCGA-A2-A25F | 66 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | positive | negative | NA | NA | alive | 0.88 | European | TCGA.A2.A25F.01A.11R.A169.07 | TCGA-A2-A25F-01 |
| TCGA-A7-A3IZ | 62 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | negative | equivocal | NA | NA | alive | 0.88 | European | TCGA.A7.A3IZ.01A.11R.A213.07 | TCGA-A7-A3IZ-01 |
| TCGA-LD-A9QF | 73 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | negative | negative | positive | NA | NA | alive | 0.88 | African_admix | TCGA.LD.A9QF.01A.32R.A41B.07 | TCGA-LD-A9QF-01 |
| TCGA-BH-A28O | 50 | female | White | Primary solid Tumor | not available | ILC | positive | positive | negative | NA | NA | alive | 0.89 | European | TCGA.BH.A28O.01A.11R.A22K.07 | TCGA-BH-A28O-01 |
| TCGA-A7-A5ZW | 47 | female | Black or African American | Primary solid Tumor | perimenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.89 | African_admix | TCGA.A7.A5ZW.01A.12R.A29R.07 | TCGA-A7-A5ZW-01 |
| TCGA-BH-A0GZ | 62 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 0.9 | European | TCGA.BH.A0GZ.01A.11R.A056.07 | TCGA-BH-A0GZ-01 |
| TCGA-AC-A23G | 76 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | positive | NA | NA | alive | 0.9 | European | TCGA.AC.A23G.01A.11R.A213.07 | TCGA-AC-A23G-01 |
| TCGA-C8-A1HF | 48 | female | Asian | Primary solid Tumor | premenopausal | IDC | negative | positive | positive | NA | NA | alive | 0.91 | East Asian | TCGA.C8.A1HF.01A.11R.A137.07 | TCGA-C8-A1HF-01 |
| TCGA-A8-A07P | 68 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 0.91 | European | TCGA.A8.A07P.01A.11R.A00Z.07 | TCGA-A8-A07P-01 |
| TCGA-A7-A5ZX | 48 | female | White | Primary solid Tumor | premenopausal | ILC | positive | positive | negative | NA | NA | alive | 0.92 | European | TCGA.A7.A5ZX.01A.12R.A29R.07 | TCGA-A7-A5ZX-01 |
| TCGA-E2-A1IU | 60 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.92 | European | TCGA.E2.A1IU.01A.11R.A14D.07 | TCGA-E2-A1IU-01 |
| TCGA-C8-A1HI | 40 | female | Asian | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.94 | East Asian | TCGA.C8.A1HI.01A.11R.A137.07 | TCGA-C8-A1HI-01 |
| TCGA-A7-A3IY | 71 | female | White | Primary solid Tumor | postmenopausal | mucinous carcinoma | positive | positive | negative | NA | NA | alive | 0.94 | European | TCGA.A7.A3IY.01A.21R.A21T.07 | TCGA-A7-A3IY-01 |
| TCGA-C8-A1HG | 50 | female | Asian | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.94 | East Asian | TCGA.C8.A1HG.01A.11R.A137.07 | TCGA-C8-A1HG-01 |
| TCGA-W8-A86G | 66 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 0.95 | European | TCGA.W8.A86G.01A.21R.A36F.07 | TCGA-W8-A86G-01 |
| TCGA-4H-AAAK | 50 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | equivocal | NA | NA | alive | 0.95 | European | TCGA.4H.AAAK.01A.12R.A41B.07 | TCGA-4H-AAAK-01 |
| TCGA-AO-A1KS | 69 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | equivocal | NA | NA | alive | 0.96 | European | TCGA.AO.A1KS.01A.11R.A13Q.07 | TCGA-AO-A1KS-01 |
| TCGA-JL-A3YX | 46 | female | Asian | Primary solid Tumor | postmenopausal | ILC | positive | positive | positive | NA | NA | alive | 0.96 | South Asian_admix | TCGA.JL.A3YX.01A.11R.A22U.07 | TCGA-JL-A3YX-01 |
| TCGA-BH-A0BW | 71 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | negative | negative | not available | NA | NA | alive | 0.97 | African_admix | TCGA.BH.A0BW.01A.11R.A115.07 | TCGA-BH-A0BW-01 |
| TCGA-BH-A0BW | 71 | female | Black or African American | Solid Tissue Normal | postmenopausal | IDC | negative | negative | not available | NA | NA | alive | 0.97 | African_admix | TCGA.BH.A0BW.11A.12R.A115.07 | TCGA-BH-A0BW-11 |
| TCGA-C8-A12M | 70 | female | Asian | Primary solid Tumor | postmenopausal | IDC | positive | negative | negative | NA | NA | alive | 0.98 | East Asian | TCGA.C8.A12M.01A.11R.A115.07 | TCGA-C8-A12M-01 |
| TCGA-C8-A12N | 58 | female | Asian | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.98 | East Asian | TCGA.C8.A12N.01A.11R.A115.07 | TCGA-C8-A12N-01 |
| TCGA-C8-A12P | 55 | female | Asian | Primary solid Tumor | postmenopausal | IDC | negative | negative | positive | NA | NA | alive | 0.98 | East Asian | TCGA.C8.A12P.01A.11R.A115.07 | TCGA-C8-A12P-01 |
| TCGA-JL-A3YW | 49 | female | Asian | Primary solid Tumor | postmenopausal | ILC | positive | positive | positive | NA | NA | alive | 0.99 | South Asian | TCGA.JL.A3YW.01A.12R.A239.07 | TCGA-JL-A3YW-01 |
| TCGA-D8-A13Y | 52 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.99 | European | TCGA.D8.A13Y.01A.11R.A115.07 | TCGA-D8-A13Y-01 |
| TCGA-C8-A12L | 67 | female | Asian | Primary solid Tumor | postmenopausal | IDC | negative | negative | equivocal | NA | NA | alive | 0.99 | East Asian | TCGA.C8.A12L.01A.11R.A115.07 | TCGA-C8-A12L-01 |
| TCGA-A7-A426 | 50 | female | White | Primary solid Tumor | premenopausal | ILC | positive | positive | negative | NA | NA | alive | 1.0 | European | TCGA.A7.A426.01A.22R.A24H.07 | TCGA-A7-A426-01 |
| TCGA-A8-A07J | 35 | female | not available | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.0 | European | TCGA.A8.A07J.01A.11R.A00Z.07 | TCGA-A8-A07J-01 |
| TCGA-A8-A08I | 53 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.0 | European | TCGA.A8.A08I.01A.11R.A00Z.07 | TCGA-A8-A08I-01 |
| TCGA-A8-A097 | 65 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 1.0 | European | TCGA.A8.A097.01A.11R.A034.07 | TCGA-A8-A097-01 |
| TCGA-A8-A09B | 58 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.0 | European | TCGA.A8.A09B.01A.11R.A00Z.07 | TCGA-A8-A09B-01 |
| TCGA-A8-A0A1 | 84 | female | not available | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 1.0 | European | TCGA.A8.A0A1.01A.11R.A00Z.07 | TCGA-A8-A0A1-01 |
| TCGA-E9-A1N8 | 48 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | not evaluated | negative | NA | NA | alive | 1.0 | European | TCGA.E9.A1N8.01A.11R.A144.07 | TCGA-E9-A1N8-01 |
| TCGA-D8-A1JG | 62 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | equivocal | NA | NA | alive | 1.0 | European | TCGA.D8.A1JG.01B.11R.A13Q.07 | TCGA-D8-A1JG-01 |
| TCGA-A7-A5ZV | 62 | female | Black or African American | Primary solid Tumor | postmenopausal | infiltrating carcinoma NOS | negative | negative | equivocal | NA | NA | alive | 1.01 | African | TCGA.A7.A5ZV.01A.11R.A28M.07 | TCGA-A7-A5ZV-01 |
| TCGA-D8-A1JS | 77 | female | White | Primary solid Tumor | postmenopausal | papillary | positive | positive | negative | NA | NA | alive | 1.02 | European | TCGA.D8.A1JS.01A.11R.A13Q.07 | TCGA-D8-A1JS-01 |
| TCGA-EW-A1IW | 80 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | positive | NA | NA | alive | 1.02 | European | TCGA.EW.A1IW.01A.11R.A13Q.07 | TCGA-EW-A1IW-01 |
| TCGA-A7-A0CD | 66 | female | White | Primary solid Tumor | indeterminate | IDC | positive | positive | equivocal | NA | NA | alive | 1.02 | European | TCGA.A7.A0CD.01A.11R.A00Z.07 | TCGA-A7-A0CD-01 |
| TCGA-A7-A0DA | 62 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 1.02 | European | TCGA.A7.A0DA.01A.31R.A115.07 | TCGA-A7-A0DA-01 |
| TCGA-AC-A6IX | 49 | female | White | Primary solid Tumor | perimenopausal | ILC | positive | positive | not evaluated | NA | NA | alive | 1.02 | European | TCGA.AC.A6IX.01A.12R.A32P.07 | TCGA-AC-A6IX-01 |
| TCGA-D8-A27W | 55 | female | White | Primary solid Tumor | postmenopausal | mucinous carcinoma | positive | positive | equivocal | NA | NA | alive | 1.02 | European | TCGA.D8.A27W.01A.11R.A16F.07 | TCGA-D8-A27W-01 |
| TCGA-AN-A0XO | 59 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | negative | negative | NA | NA | alive | 1.03 | European | TCGA.AN.A0XO.01A.11R.A109.07 | TCGA-AN-A0XO-01 |
| TCGA-C8-A1HE | 59 | female | Asian | Primary solid Tumor | postmenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 1.03 | East Asian | TCGA.C8.A1HE.01A.11R.A13Q.07 | TCGA-C8-A1HE-01 |
| TCGA-C8-A1HO | 34 | female | Asian | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.03 | East Asian | TCGA.C8.A1HO.01A.11R.A13Q.07 | TCGA-C8-A1HO-01 |
| TCGA-E9-A295 | 71 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | positive | NA | NA | alive | 1.03 | European | TCGA.E9.A295.01A.11R.A16F.07 | TCGA-E9-A295-01 |
| TCGA-C8-A26X | 58 | female | Asian | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 1.03 | East Asian | TCGA.C8.A26X.01A.31R.A16F.07 | TCGA-C8-A26X-01 |
| TCGA-C8-A137 | 34 | female | Asian | Primary solid Tumor | premenopausal | IDC | negative | negative | positive | locoregional recurrence | not available | alive | 1.04 | East Asian | TCGA.C8.A137.01A.11R.A115.07 | TCGA-C8-A137-01 |
| TCGA-E9-A228 | 58 | female | White | Primary solid Tumor | postmenopausal | IDC | not evaluated | not evaluated | not evaluated | NA | NA | alive | 1.04 | European | TCGA.E9.A228.01A.31R.A157.07 | TCGA-E9-A228-01 |
| TCGA-C8-A12Z | 45 | female | Asian | Primary solid Tumor | perimenopausal | IDC | negative | negative | positive | NA | NA | alive | 1.05 | East Asian | TCGA.C8.A12Z.01A.11R.A115.07 | TCGA-C8-A12Z-01 |
| TCGA-C8-A134 | 52 | female | Asian | Primary solid Tumor | perimenopausal | IDC | negative | negative | equivocal | NA | NA | alive | 1.05 | East Asian | TCGA.C8.A134.01A.11R.A115.07 | TCGA-C8-A134-01 |
| TCGA-C8-A12O | 50 | female | Asian | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.05 | East Asian | TCGA.C8.A12O.01A.11R.A115.07 | TCGA-C8-A12O-01 |
| TCGA-C8-A12U | 46 | female | Asian | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.05 | East Asian | TCGA.C8.A12U.01A.11R.A115.07 | TCGA-C8-A12U-01 |
| TCGA-C8-A12V | 55 | female | Asian | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 1.05 | East Asian | TCGA.C8.A12V.01A.11R.A115.07 | TCGA-C8-A12V-01 |
| TCGA-C8-A12X | 62 | female | Asian | Primary solid Tumor | postmenopausal | mucinous carcinoma | positive | positive | negative | NA | NA | alive | 1.05 | East Asian | TCGA.C8.A12X.01A.11R.A115.07 | TCGA-C8-A12X-01 |
| TCGA-D8-A1XW | 53 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | positive | negative | NA | NA | alive | 1.05 | European | TCGA.D8.A1XW.01A.11R.A14M.07 | TCGA-D8-A1XW-01 |
| TCGA-BH-A0HU | 52 | female | White | Primary solid Tumor | perimenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.07 | European | TCGA.BH.A0HU.01A.11R.A034.07 | TCGA-BH-A0HU-01 |
| TCGA-C8-A135 | 64 | female | Asian | Primary solid Tumor | postmenopausal | IDC | negative | negative | positive | NA | NA | alive | 1.08 | East Asian | TCGA.C8.A135.01A.11R.A115.07 | TCGA-C8-A135-01 |
| TCGA-LL-A5YM | 88 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | positive | positive | equivocal | locoregional recurrence | skin chest wall | alive | 1.08 | African | TCGA.LL.A5YM.01A.11R.A28M.07 | TCGA-LL-A5YM-01 |
| TCGA-D8-A1XU | 56 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.08 | European | TCGA.D8.A1XU.01A.11R.A14M.07 | TCGA-D8-A1XU-01 |
| TCGA-A8-A06O | 60 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.08 | European | TCGA.A8.A06O.01A.11R.A00Z.07 | TCGA-A8-A06O-01 |
| TCGA-A8-A06P | 63 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.08 | European | TCGA.A8.A06P.01A.11R.A00Z.07 | TCGA-A8-A06P-01 |
| TCGA-A8-A086 | 59 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.08 | European | TCGA.A8.A086.01A.11R.A00Z.07 | TCGA-A8-A086-01 |
| TCGA-A8-A09D | 47 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.08 | European | TCGA.A8.A09D.01A.11R.A00Z.07 | TCGA-A8-A09D-01 |
| TCGA-A8-A0A4 | 73 | female | not available | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 1.08 | European | TCGA.A8.A0A4.01A.11R.A00Z.07 | TCGA-A8-A0A4-01 |
| TCGA-D8-A27H | 72 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 1.09 | European | TCGA.D8.A27H.01A.11R.A16F.07 | TCGA-D8-A27H-01 |
| TCGA-D8-A27T | 53 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 1.09 | European | TCGA.D8.A27T.01A.11R.A16F.07 | TCGA-D8-A27T-01 |
| TCGA-E9-A1N9 | 58 | female | White | Primary solid Tumor | postmenopausal | IDC/ILC | negative | positive | positive | NA | NA | alive | 1.09 | European | TCGA.E9.A1N9.01A.11R.A14D.07 | TCGA-E9-A1N9-01 |
| TCGA-E9-A1N9 | 58 | female | White | Solid Tissue Normal | postmenopausal | IDC/ILC | negative | positive | positive | NA | NA | alive | 1.09 | European | TCGA.E9.A1N9.11A.71R.A14D.07 | TCGA-E9-A1N9-11 |
| TCGA-E9-A22D | 38 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | positive | NA | NA | alive | 1.1 | European | TCGA.E9.A22D.01A.11R.A157.07 | TCGA-E9-A22D-01 |
| TCGA-LD-A74U | 79 | female | White | Primary solid Tumor | not available | \ILC, classical type, focal pleomorphic type\"" | positive | negative | negative | NA | NA | alive | 1.1 | European | TCGA.LD.A74U.01A.13R.A33J.07 | TCGA-LD-A74U-01 |
| TCGA-D8-A140 | 62 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 1.1 | European | TCGA.D8.A140.01A.11R.A115.07 | TCGA-D8-A140-01 |
| TCGA-EW-A1J2 | 50 | female | Black or African American | Primary solid Tumor | premenopausal | ILC | positive | positive | negative | NA | NA | alive | 1.1 | South Asian | TCGA.EW.A1J2.01A.21R.A13Q.07 | TCGA-EW-A1J2-01 |
| TCGA-LD-A7W6 | 54 | female | White | Primary solid Tumor | postmenopausal | \ILC, mixed classical (70%) and pleomorphic/solid (30%) types\"" | positive | positive | negative | NA | NA | alive | 1.11 | European | TCGA.LD.A7W6.01A.81R.A352.07 | TCGA-LD-A7W6-01 |
| TCGA-D8-A1JT | 70 | female | White | Primary solid Tumor | postmenopausal | ductal and papillary | positive | positive | equivocal | NA | NA | alive | 1.11 | European | TCGA.D8.A1JT.01A.31R.A13Q.07 | TCGA-D8-A1JT-01 |
| TCGA-E9-A229 | 37 | female | White | Primary solid Tumor | premenopausal | IDC | not evaluated | not evaluated | not evaluated | NA | NA | alive | 1.11 | European | TCGA.E9.A229.01A.31R.A157.07 | TCGA-E9-A229-01 |
| TCGA-C8-A8HR | 49 | female | Asian | Primary solid Tumor | perimenopausal | ILC | not evaluated | not evaluated | not evaluated | NA | NA | alive | 1.12 | East Asian | TCGA.C8.A8HR.01A.11R.A36F.07 | TCGA-C8-A8HR-01 |
| TCGA-D8-A27G | 75 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | equivocal | NA | NA | alive | 1.12 | European | TCGA.D8.A27G.01A.11R.A16F.07 | TCGA-D8-A27G-01 |
| TCGA-D8-A27M | 59 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 1.12 | European | TCGA.D8.A27M.01A.11R.A16F.07 | TCGA-D8-A27M-01 |
| TCGA-GM-A5PV | 63 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | not evaluated | NA | NA | alive | 1.13 | European | TCGA.GM.A5PV.01A.11R.A28M.07 | TCGA-GM-A5PV-01 |
| TCGA-AC-A6IW | 73 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 1.13 | African | TCGA.AC.A6IW.01A.12R.A33J.07 | TCGA-AC-A6IW-01 |
| TCGA-BH-A0HP | 65 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | negative | negative | NA | NA | alive | 1.13 | European | TCGA.BH.A0HP.01A.12R.A084.07 | TCGA-BH-A0HP-01 |
| TCGA-A1-A0SJ | 39 | female | Black or African American | Primary solid Tumor | not available | IDC | positive | positive | equivocal | NA | NA | alive | 1.14 | African_admix | TCGA.A1.A0SJ.01A.11R.A084.07 | TCGA-A1-A0SJ-01 |
| TCGA-AC-A62X | 72 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | positive | negative | not evaluated | NA | NA | alive | 1.14 | African | TCGA.AC.A62X.01A.11R.A29R.07 | TCGA-AC-A62X-01 |
| TCGA-A7-A4SB | 56 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 1.14 | European | TCGA.A7.A4SB.01A.21R.A266.07 | TCGA-A7-A4SB-01 |
| TCGA-E9-A1NE | 28 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.15 | European | TCGA.E9.A1NE.01A.21R.A14M.07 | TCGA-E9-A1NE-01 |
| TCGA-S3-AA11 | 67 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 1.15 | African | TCGA.S3.AA11.01A.31R.A41B.07 | TCGA-S3-AA11-01 |
| TCGA-BH-A0DK | 49 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.16 | European | TCGA.BH.A0DK.01A.21R.A056.07 | TCGA-BH-A0DK-01 |
| TCGA-BH-A0DK | 49 | female | White | Solid Tissue Normal | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.16 | European | TCGA.BH.A0DK.11A.13R.A089.07 | TCGA-BH-A0DK-11 |
| TCGA-EW-A1PD | 61 | male | White | Primary solid Tumor | not applicable | IDC | positive | positive | equivocal | NA | NA | alive | 1.16 | European | TCGA.EW.A1PD.01A.11R.A144.07 | TCGA-EW-A1PD-01 |
| TCGA-S3-AA17 | 64 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 1.16 | African_admix | TCGA.S3.AA17.01A.11R.A41B.07 | TCGA-S3-AA17-01 |
| TCGA-A8-A07I | 69 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | negative | positive | NA | NA | alive | 1.17 | European | TCGA.A8.A07I.01A.11R.A00Z.07 | TCGA-A8-A07I-01 |
| TCGA-D8-A1JH | 56 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.17 | European | TCGA.D8.A1JH.01A.11R.A13Q.07 | TCGA-D8-A1JH-01 |
| TCGA-E2-A15S | 34 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | negative | equivocal | NA | NA | alive | 1.17 | European | TCGA.E2.A15S.01A.11R.A115.07 | TCGA-E2-A15S-01 |
| TCGA-D8-A1Y3 | 61 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | Indeterminate | NA | NA | alive | 1.18 | European | TCGA.D8.A1Y3.01A.11R.A157.07 | TCGA-D8-A1Y3-01 |
| TCGA-D8-A143 | 51 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 1.18 | European | TCGA.D8.A143.01A.11R.A115.07 | TCGA-D8-A143-01 |
| TCGA-D8-A1J8 | 77 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.18 | European | TCGA.D8.A1J8.01A.11R.A13Q.07 | TCGA-D8-A1J8-01 |
| TCGA-A1-A0SG | 61 | female | White | Primary solid Tumor | postmenopausal | micropapillary carcinoma invasive | positive | positive | negative | NA | NA | alive | 1.19 | European | TCGA.A1.A0SG.01A.11R.A144.07 | TCGA-A1-A0SG-01 |
| TCGA-BH-A0E2 | 49 | female | Black or African American | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.19 | African | TCGA.BH.A0E2.01A.11R.A056.07 | TCGA-BH-A0E2-01 |
| TCGA-A1-A0SD | 59 | female | White | Primary solid Tumor | not available | IDC | positive | positive | negative | NA | NA | alive | 1.2 | European | TCGA.A1.A0SD.01A.11R.A115.07 | TCGA-A1-A0SD-01 |
| TCGA-C8-A27B | 48 | female | Asian | Primary solid Tumor | perimenopausal | IDC | negative | negative | negative | NA | NA | alive | 1.2 | East Asian | TCGA.C8.A27B.01A.11R.A169.07 | TCGA-C8-A27B-01 |
| TCGA-D8-A27I | 58 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 1.2 | European | TCGA.D8.A27I.01A.11R.A16F.07 | TCGA-D8-A27I-01 |
| TCGA-A2-A0YI | 62 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.21 | European | TCGA.A2.A0YI.01A.31R.A10J.07 | TCGA-A2-A0YI-01 |
| TCGA-A7-A4SD | 52 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | negative | negative | equivocal | NA | NA | alive | 1.21 | African | TCGA.A7.A4SD.01A.11R.A266.07 | TCGA-A7-A4SD-01 |
| TCGA-D8-A1XK | 55 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 1.21 | European | TCGA.D8.A1XK.01A.21R.A14M.07 | TCGA-D8-A1XK-01 |
| TCGA-D8-A3Z5 | 54 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 1.21 | European | TCGA.D8.A3Z5.01A.41R.A24H.07 | TCGA-D8-A3Z5-01 |
| TCGA-LL-A740 | 61 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | negative | negative | equivocal | NA | NA | alive | 1.21 | African | TCGA.LL.A740.01A.21R.A32P.07 | TCGA-LL-A740-01 |
| TCGA-A2-A0YL | 48 | female | White | Primary solid Tumor | premenopausal | ILC | positive | positive | negative | NA | NA | alive | 1.22 | European | TCGA.A2.A0YL.01A.21R.A109.07 | TCGA-A2-A0YL-01 |
| TCGA-A7-A4SC | 62 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | negative | equivocal | NA | NA | alive | 1.22 | European | TCGA.A7.A4SC.01A.12R.A266.07 | TCGA-A7-A4SC-01 |
| TCGA-A7-A425 | 70 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | Indeterminate | locoregional recurrence | breast>bone | alive | 1.22 | European | TCGA.A7.A425.01A.11R.A24H.07 | TCGA-A7-A425-01 |
| TCGA-D8-A1JU | 51 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.22 | European | TCGA.D8.A1JU.01A.11R.A13Q.07 | TCGA-D8-A1JU-01 |
| TCGA-LL-A5YN | 46 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 1.22 | African | TCGA.LL.A5YN.01A.11R.A28M.07 | TCGA-LL-A5YN-01 |
| TCGA-A7-A56D | 84 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.23 | African | TCGA.A7.A56D.01A.11R.A27Q.07 | TCGA-A7-A56D-01 |
| TCGA-E2-A158 | 43 | female | White | Primary solid Tumor | premenopausal | IDC | negative | negative | negative | NA | NA | alive | 1.23 | European | TCGA.E2.A158.01A.11R.A12D.07 | TCGA-E2-A158-01 |
| TCGA-E2-A158 | 43 | female | White | Solid Tissue Normal | premenopausal | IDC | negative | negative | negative | NA | NA | alive | 1.23 | European | TCGA.E2.A158.11A.22R.A12D.07 | TCGA-E2-A158-11 |
| TCGA-AC-A3OD | 68 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 1.23 | European | TCGA.AC.A3OD.01A.11R.A21T.07 | TCGA-AC-A3OD-01 |
| TCGA-A7-A4SA | 40 | female | White | Primary solid Tumor | premenopausal | ILC | positive | negative | negative | NA | NA | alive | 1.24 | European | TCGA.A7.A4SA.01A.11R.A266.07 | TCGA-A7-A4SA-01 |
| TCGA-AC-A3TN | 75 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | positive | NA | NA | alive | 1.25 | European | TCGA.AC.A3TN.01A.11R.A22K.07 | TCGA-AC-A3TN-01 |
| TCGA-E2-A15T | 65 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 1.25 | European | TCGA.E2.A15T.01A.11R.A115.07 | TCGA-E2-A15T-01 |
| TCGA-A8-A09M | 75 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.25 | European | TCGA.A8.A09M.01A.11R.A00Z.07 | TCGA-A8-A09M-01 |
| TCGA-A8-A09V | 51 | female | not available | Primary solid Tumor | premenopausal | ILC | positive | positive | negative | NA | NA | alive | 1.25 | European | TCGA.A8.A09V.01A.11R.A034.07 | TCGA-A8-A09V-01 |
| TCGA-A8-A084 | 81 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | negative | negative | NA | NA | alive | 1.25 | European | TCGA.A8.A084.01A.21R.A00Z.07 | TCGA-A8-A084-01 |
| TCGA-BH-A0H0 | 69 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.26 | European | TCGA.BH.A0H0.01A.11R.A056.07 | TCGA-BH-A0H0-01 |
| TCGA-D8-A1XV | 84 | female | White | Primary solid Tumor | postmenopausal | mucinous carcinoma | positive | positive | equivocal | NA | NA | alive | 1.26 | European | TCGA.D8.A1XV.01A.11R.A14M.07 | TCGA-D8-A1XV-01 |
| TCGA-EW-A6S9 | 34 | female | Black or African American | Primary solid Tumor | not available | IDC | positive | positive | positive | NA | NA | alive | 1.27 | African_admix | TCGA.EW.A6S9.01A.22R.A33J.07 | TCGA-EW-A6S9-01 |
| TCGA-D8-A1XZ | 81 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | negative | negative | NA | NA | alive | 1.28 | European | TCGA.D8.A1XZ.01A.11R.A14M.07 | TCGA-D8-A1XZ-01 |
| TCGA-XX-A899 | 46 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 1.28 | European | TCGA.XX.A899.01A.11R.A36F.07 | TCGA-XX-A899-01 |
| TCGA-A2-A0YF | 67 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | positive | negative | negative | NA | NA | alive | 1.28 | African_admix | TCGA.A2.A0YF.01A.21R.A109.07 | TCGA-A2-A0YF-01 |
| TCGA-C8-A26Z | 59 | female | Asian | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.29 | East Asian | TCGA.C8.A26Z.01A.11R.A16F.07 | TCGA-C8-A26Z-01 |
| TCGA-E2-A1LS | 46 | female | White | Primary solid Tumor | premenopausal | IDC | negative | negative | negative | NA | NA | alive | 1.29 | European | TCGA.E2.A1LS.01A.12R.A157.07 | TCGA-E2-A1LS-01 |
| TCGA-E2-A1LS | 46 | female | White | Solid Tissue Normal | premenopausal | IDC | negative | negative | negative | NA | NA | alive | 1.29 | European | TCGA.E2.A1LS.11A.32R.A157.07 | TCGA-E2-A1LS-11 |
| TCGA-AC-A3W7 | 66 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | negative | negative | NA | NA | alive | 1.29 | European | TCGA.AC.A3W7.01A.11R.A22K.07 | TCGA-AC-A3W7-01 |
| TCGA-D8-A1Y0 | 65 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.29 | European | TCGA.D8.A1Y0.01A.11R.A14M.07 | TCGA-D8-A1Y0-01 |
| TCGA-D8-A1XO | 56 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 1.3 | European | TCGA.D8.A1XO.01A.11R.A14M.07 | TCGA-D8-A1XO-01 |
| TCGA-AQ-A1H2 | 84 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | Indeterminate | NA | NA | alive | 1.3 | European | TCGA.AQ.A1H2.01A.11R.A13Q.07 | TCGA-AQ-A1H2-01 |
| TCGA-BH-A0DP | 60 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 1.3 | European | TCGA.BH.A0DP.01A.21R.A056.07 | TCGA-BH-A0DP-01 |
| TCGA-BH-A0DP | 60 | female | White | Solid Tissue Normal | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 1.3 | European | TCGA.BH.A0DP.11A.12R.A089.07 | TCGA-BH-A0DP-11 |
| TCGA-BH-A0E1 | 52 | female | White | Primary solid Tumor | perimenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 1.31 | European | TCGA.BH.A0E1.01A.11R.A056.07 | TCGA-BH-A0E1-01 |
| TCGA-BH-A0E1 | 52 | female | White | Solid Tissue Normal | perimenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 1.31 | European | TCGA.BH.A0E1.11A.13R.A089.07 | TCGA-BH-A0E1-11 |
| TCGA-EW-A1J5 | 59 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 1.31 | European | TCGA.EW.A1J5.01A.11R.A13Q.07 | TCGA-EW-A1J5-01 |
| TCGA-LL-A73Y | 67 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 1.31 | African | TCGA.LL.A73Y.01A.11R.A33J.07 | TCGA-LL-A73Y-01 |
| TCGA-E2-A3DX | 43 | female | White | Primary solid Tumor | premenopausal | ILC | positive | positive | not evaluated | NA | NA | alive | 1.31 | European | TCGA.E2.A3DX.01A.21R.A213.07 | TCGA-E2-A3DX-01 |
| TCGA-D8-A1JC | 59 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.31 | European | TCGA.D8.A1JC.01A.11R.A13Q.07 | TCGA-D8-A1JC-01 |
| TCGA-D8-A1XR | 56 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.32 | European | TCGA.D8.A1XR.01A.11R.A14M.07 | TCGA-D8-A1XR-01 |
| TCGA-A2-A0EY | 62 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | negative | positive | NA | NA | alive | 1.33 | European | TCGA.A2.A0EY.01A.11R.A034.07 | TCGA-A2-A0EY-01 |
| TCGA-E2-A14P | 79 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | positive | NA | NA | alive | 1.33 | European | TCGA.E2.A14P.01A.31R.A12D.07 | TCGA-E2-A14P-01 |
| TCGA-AR-A5QN | 68 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | positive | NA | NA | alive | 1.34 | European | TCGA.AR.A5QN.01A.12R.A28M.07 | TCGA-AR-A5QN-01 |
| TCGA-D8-A27F | 40 | female | White | Primary solid Tumor | premenopausal | IDC | negative | negative | negative | NA | NA | alive | 1.34 | European | TCGA.D8.A27F.01A.11R.A16F.07 | TCGA-D8-A27F-01 |
| TCGA-XX-A89A | 68 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 1.34 | European | TCGA.XX.A89A.01A.11R.A36F.07 | TCGA-XX-A89A-01 |
| TCGA-LL-A6FR | 50 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | negative | positive | equivocal | NA | NA | alive | 1.34 | African | TCGA.LL.A6FR.01A.12R.A31O.07 | TCGA-LL-A6FR-01 |
| TCGA-D8-A73U | 88 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 1.35 | European | TCGA.D8.A73U.01A.11R.A33J.07 | TCGA-D8-A73U-01 |
| TCGA-BH-A0DZ | 43 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | positive | NA | NA | alive | 1.36 | European | TCGA.BH.A0DZ.01A.11R.A00Z.07 | TCGA-BH-A0DZ-01 |
| TCGA-BH-A0DZ | 43 | female | White | Solid Tissue Normal | premenopausal | IDC | positive | positive | positive | NA | NA | alive | 1.36 | European | TCGA.BH.A0DZ.11A.22R.A089.07 | TCGA-BH-A0DZ-11 |
| TCGA-A2-A25B | 39 | female | Black or African American | Primary solid Tumor | premenopausal | IDC | positive | positive | equivocal | metastasis | bone | alive | 1.36 | African | TCGA.A2.A25B.01A.11R.A169.07 | TCGA-A2-A25B-01 |
| TCGA-AC-A3HN | 87 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 1.36 | European | TCGA.AC.A3HN.01A.11R.A213.07 | TCGA-AC-A3HN-01 |
| TCGA-D8-A1XQ | 69 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 1.37 | European | TCGA.D8.A1XQ.01A.11R.A14M.07 | TCGA-D8-A1XQ-01 |
| TCGA-D8-A27L | 49 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.37 | European | TCGA.D8.A27L.01A.11R.A16F.07 | TCGA-D8-A27L-01 |
| TCGA-A2-A1G6 | 50 | female | White | Primary solid Tumor | premenopausal | IDC | negative | negative | negative | NA | NA | alive | 1.37 | European | TCGA.A2.A1G6.01A.11R.A13Q.07 | TCGA-A2-A1G6-01 |
| TCGA-E2-A1BC | 63 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.37 | European | TCGA.E2.A1BC.01A.11R.A12P.07 | TCGA-E2-A1BC-01 |
| TCGA-E2-A1BC | 63 | female | not available | Solid Tissue Normal | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.37 | European | TCGA.E2.A1BC.11A.32R.A12P.07 | TCGA-E2-A1BC-11 |
| TCGA-D8-A1JA | 60 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | positive | locoregional disease | NA | alive | 1.37 | European | TCGA.D8.A1JA.01A.11R.A13Q.07 | TCGA-D8-A1JA-01 |
| TCGA-EW-A1J3 | 61 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | positive | NA | NA | alive | 1.38 | European | TCGA.EW.A1J3.01A.11R.A13Q.07 | TCGA-EW-A1J3-01 |
| TCGA-D8-A1XT | 61 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | positive | NA | NA | alive | 1.39 | European | TCGA.D8.A1XT.01A.11R.A14M.07 | TCGA-D8-A1XT-01 |
| TCGA-C8-A274 | 63 | female | Asian | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.39 | East Asian | TCGA.C8.A274.01A.11R.A16F.07 | TCGA-C8-A274-01 |
| TCGA-E9-A1N5 | 45 | female | White | Primary solid Tumor | postmenopausal | IDC/ILC | positive | positive | positive | NA | NA | alive | 1.39 | European | TCGA.E9.A1N5.01A.11R.A14D.07 | TCGA-E9-A1N5-01 |
| TCGA-E9-A1N5 | 45 | female | White | Solid Tissue Normal | postmenopausal | IDC/ILC | positive | positive | positive | NA | NA | alive | 1.39 | European | TCGA.E9.A1N5.11A.41R.A14D.07 | TCGA-E9-A1N5-11 |
| TCGA-EW-A6SA | 59 | male | Black or African American | Primary solid Tumor | not applicable | IDC | positive | negative | negative | NA | NA | alive | 1.4 | African | TCGA.EW.A6SA.01A.21R.A32P.07 | TCGA-EW-A6SA-01 |
| TCGA-BH-A0HN | 67 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 1.41 | European | TCGA.BH.A0HN.01A.11R.A10U.07 | TCGA-BH-A0HN-01 |
| TCGA-A8-A075 | 42 | female | not available | Primary solid Tumor | premenopausal | IDC | positive | positive | positive | NA | NA | alive | 1.42 | European | TCGA.A8.A075.01A.11R.A084.07 | TCGA-A8-A075-01 |
| TCGA-A8-A0AB | 54 | female | not available | Primary solid Tumor | postmenopausal | ILC | positive | positive | positive | NA | NA | alive | 1.42 | European | TCGA.A8.A0AB.01A.11R.A034.07 | TCGA-A8-A0AB-01 |
| TCGA-UL-AAZ6 | 73 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 1.42 | African | TCGA.UL.AAZ6.01A.11R.A41B.07 | TCGA-UL-AAZ6-01 |
| TCGA-D8-A27N | 36 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | positive | NA | NA | alive | 1.42 | European | TCGA.D8.A27N.01A.11R.A16F.07 | TCGA-D8-A27N-01 |
| TCGA-E2-A15R | 64 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 1.42 | European | TCGA.E2.A15R.01A.11R.A115.07 | TCGA-E2-A15R-01 |
| TCGA-LL-A5YL | 64 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | negative | positive | NA | NA | alive | 1.42 | European | TCGA.LL.A5YL.01A.12R.A29R.07 | TCGA-LL-A5YL-01 |
| TCGA-E2-A1BD | 53 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 1.42 | European | TCGA.E2.A1BD.01A.11R.A12P.07 | TCGA-E2-A1BD-01 |
| TCGA-D8-A1XD | 36 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.43 | European | TCGA.D8.A1XD.01A.11R.A14D.07 | TCGA-D8-A1XD-01 |
| TCGA-A2-A25C | 50 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.43 | European | TCGA.A2.A25C.01A.11R.A169.07 | TCGA-A2-A25C-01 |
| TCGA-BH-A0DO | 78 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.44 | European | TCGA.BH.A0DO.01B.11R.A12D.07 | TCGA-BH-A0DO-01 |
| TCGA-BH-A0DO | 78 | female | White | Solid Tissue Normal | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.44 | European | TCGA.BH.A0DO.11A.22R.A12D.07 | TCGA-BH-A0DO-11 |
| TCGA-S3-AA15 | 51 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 1.44 | African | TCGA.S3.AA15.01A.11R.A41B.07 | TCGA-S3-AA15-01 |
| TCGA-E2-A15D | 47 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 1.44 | European | TCGA.E2.A15D.01A.11R.A115.07 | TCGA-E2-A15D-01 |
| TCGA-A2-A1FW | 62 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | negative | negative | NA | NA | alive | 1.45 | European | TCGA.A2.A1FW.01A.11R.A13Q.07 | TCGA-A2-A1FW-01 |
| TCGA-OL-A66O | 39 | female | Black or African American | Primary solid Tumor | premenopausal | IDC | positive | positive | not evaluated | NA | NA | alive | 1.45 | African | TCGA.OL.A66O.01A.11R.A31O.07 | TCGA-OL-A66O-01 |
| TCGA-S3-AA14 | 47 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 1.45 | African | TCGA.S3.AA14.01A.11R.A41B.07 | TCGA-S3-AA14-01 |
| TCGA-D8-A27E | 66 | female | White | Primary solid Tumor | postmenopausal | IDC/mucinous | positive | positive | negative | NA | NA | alive | 1.45 | European | TCGA.D8.A27E.01A.11R.A16F.07 | TCGA-D8-A27E-01 |
| TCGA-E2-A15I | 44 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 1.45 | European | TCGA.E2.A15I.01A.21R.A137.07 | TCGA-E2-A15I-01 |
| TCGA-E2-A15I | 44 | female | White | Solid Tissue Normal | premenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 1.45 | European | TCGA.E2.A15I.11A.32R.A137.07 | TCGA-E2-A15I-11 |
| TCGA-A2-A0T5 | 39 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.45 | European | TCGA.A2.A0T5.01A.21R.A084.07 | TCGA-A2-A0T5-01 |
| TCGA-D8-A1J9 | 48 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | negative | positive | NA | NA | alive | 1.46 | European | TCGA.D8.A1J9.01A.11R.A13Q.07 | TCGA-D8-A1J9-01 |
| TCGA-EW-A3U0 | 61 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 1.46 | African_admix | TCGA.EW.A3U0.01A.11R.A22K.07 | TCGA-EW-A3U0-01 |
| TCGA-LL-A9Q3 | 69 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | positive | NA | NA | alive | 1.46 | European | TCGA.LL.A9Q3.01A.11R.A41B.07 | TCGA-LL-A9Q3-01 |
| TCGA-A2-A0T0 | 59 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 1.46 | European | TCGA.A2.A0T0.01A.22R.A084.07 | TCGA-A2-A0T0-01 |
| TCGA-D8-A1XM | 57 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.47 | European | TCGA.D8.A1XM.01A.21R.A14M.07 | TCGA-D8-A1XM-01 |
| TCGA-AO-A1KT | 78 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 1.48 | European | TCGA.AO.A1KT.01A.11R.A13Q.07 | TCGA-AO-A1KT-01 |
| TCGA-D8-A1X6 | 80 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.48 | European | TCGA.D8.A1X6.01A.11R.A14M.07 | TCGA-D8-A1X6-01 |
| TCGA-E9-A1N3 | 70 | female | White | Primary solid Tumor | postmenopausal | IDC/ILC | not evaluated | not evaluated | not evaluated | NA | NA | alive | 1.48 | European | TCGA.E9.A1N3.01A.12R.A157.07 | TCGA-E9-A1N3-01 |
| TCGA-BH-A0W5 | 77 | female | White | Primary solid Tumor | not available | IDC | positive | positive | equivocal | NA | NA | alive | 1.49 | European | TCGA.BH.A0W5.01A.11R.A109.07 | TCGA-BH-A0W5-01 |
| TCGA-A7-A4SF | 54 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | positive | negative | positive | NA | NA | alive | 1.49 | African | TCGA.A7.A4SF.01A.11R.A266.07 | TCGA-A7-A4SF-01 |
| TCGA-A8-A093 | 61 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.49 | European | TCGA.A8.A093.01A.11R.A00Z.07 | TCGA-A8-A093-01 |
| TCGA-A8-A06R | 69 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | negative | positive | NA | NA | alive | 1.5 | European | TCGA.A8.A06R.01A.11R.A00Z.07 | TCGA-A8-A06R-01 |
| TCGA-A8-A082 | 58 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.5 | European | TCGA.A8.A082.01A.11R.A00Z.07 | TCGA-A8-A082-01 |
| TCGA-A8-A08F | 59 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.5 | European | TCGA.A8.A08F.01A.11R.A00Z.07 | TCGA-A8-A08F-01 |
| TCGA-GM-A5PX | 65 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 1.51 | European | TCGA.GM.A5PX.01A.12R.A28M.07 | TCGA-GM-A5PX-01 |
| TCGA-D8-A1JD | 41 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.51 | European | TCGA.D8.A1JD.01A.11R.A13Q.07 | TCGA-D8-A1JD-01 |
| TCGA-D8-A1XB | 62 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.51 | European | TCGA.D8.A1XB.01A.11R.A14D.07 | TCGA-D8-A1XB-01 |
| TCGA-A1-A0SQ | 45 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.52 | European | TCGA.A1.A0SQ.01A.21R.A144.07 | TCGA-A1-A0SQ-01 |
| TCGA-A2-A0YE | 48 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 1.52 | European | TCGA.A2.A0YE.01A.11R.A109.07 | TCGA-A2-A0YE-01 |
| TCGA-BH-A0BD | 47 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.52 | European | TCGA.BH.A0BD.01A.11R.A034.07 | TCGA-BH-A0BD-01 |
| TCGA-E2-A15G | 76 | female | White | Primary solid Tumor | postmenopausal | IDC/ILC | positive | positive | negative | NA | NA | alive | 1.52 | European | TCGA.E2.A15G.01A.11R.A12D.07 | TCGA-E2-A15G-01 |
| TCGA-BH-A0W7 | 49 | female | White | Primary solid Tumor | not available | IDC | positive | positive | negative | NA | NA | alive | 1.53 | European | TCGA.BH.A0W7.01A.11R.A115.07 | TCGA-BH-A0W7-01 |
| TCGA-E9-A3Q9 | 78 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | Indeterminate | NA | NA | alive | 1.53 | European | TCGA.E9.A3Q9.01A.11R.A21T.07 | TCGA-E9-A3Q9-01 |
| TCGA-EW-A1P6 | 64 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.54 | European | TCGA.EW.A1P6.01A.11R.A144.07 | TCGA-EW-A1P6-01 |
| TCGA-S3-A6ZG | 71 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC/ILC | positive | positive | negative | NA | NA | alive | 1.54 | African_admix | TCGA.S3.A6ZG.01A.22R.A32P.07 | TCGA-S3-A6ZG-01 |
| TCGA-D8-A3Z6 | 56 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 1.54 | European | TCGA.D8.A3Z6.01A.11R.A239.07 | TCGA-D8-A3Z6-01 |
| TCGA-D8-A1X5 | 81 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 1.55 | European | TCGA.D8.A1X5.01A.11R.A14D.07 | TCGA-D8-A1X5-01 |
| TCGA-A2-A0YJ | 39 | female | White | Primary solid Tumor | premenopausal | IDC | positive | negative | negative | metastasis | cervical lymph node | alive | 1.55 | European | TCGA.A2.A0YJ.01A.11R.A109.07 | TCGA-A2-A0YJ-01 |
| TCGA-AC-A6IV | 47 | female | White | Primary solid Tumor | not available | ILC | positive | positive | equivocal | NA | NA | alive | 1.56 | European | TCGA.AC.A6IV.01A.12R.A33J.07 | TCGA-AC-A6IV-01 |
| TCGA-A2-A0T3 | 37 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 1.56 | European | TCGA.A2.A0T3.01A.21R.A115.07 | TCGA-A2-A0T3-01 |
| TCGA-D8-A1JB | 54 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 1.56 | European | TCGA.D8.A1JB.01A.11R.A13Q.07 | TCGA-D8-A1JB-01 |
| TCGA-S3-A6ZF | 64 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 1.57 | African | TCGA.S3.A6ZF.01A.32R.A32P.07 | TCGA-S3-A6ZF-01 |
| TCGA-BH-A8FZ | 58 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | equivocal | NA | NA | alive | 1.57 | European | TCGA.BH.A8FZ.01A.11R.A352.07 | TCGA-BH-A8FZ-01 |
| TCGA-E2-A1LG | 50 | female | Black or African American | Primary solid Tumor | perimenopausal | ILC | negative | negative | equivocal | NA | NA | alive | 1.57 | African | TCGA.E2.A1LG.01A.21R.A14M.07 | TCGA-E2-A1LG-01 |
| TCGA-S3-AA12 | 82 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | positive | negative | negative | metastasis | lung|adrenal gland | alive | 1.57 | African | TCGA.S3.AA12.01A.11R.A41B.07 | TCGA-S3-AA12-01 |
| TCGA-A2-A0T6 | 50 | female | White | Primary solid Tumor | premenopausal | ILC | positive | positive | negative | NA | NA | alive | 1.57 | European | TCGA.A2.A0T6.01A.11R.A084.07 | TCGA-A2-A0T6-01 |
| TCGA-D8-A1JE | 62 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.57 | European | TCGA.D8.A1JE.01A.11R.A13Q.07 | TCGA-D8-A1JE-01 |
| TCGA-EW-A1PA | 59 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.57 | European | TCGA.EW.A1PA.01A.11R.A144.07 | TCGA-EW-A1PA-01 |
| TCGA-E9-A1NH | 71 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.58 | European | TCGA.E9.A1NH.01A.11R.A14D.07 | TCGA-E9-A1NH-01 |
| TCGA-A8-A07F | 65 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.58 | European | TCGA.A8.A07F.01A.11R.A00Z.07 | TCGA-A8-A07F-01 |
| TCGA-A8-A07G | 65 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.58 | European | TCGA.A8.A07G.01A.11R.A034.07 | TCGA-A8-A07G-01 |
| TCGA-D8-A1JI | 54 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.58 | European | TCGA.D8.A1JI.01A.11R.A13Q.07 | TCGA-D8-A1JI-01 |
| TCGA-E2-A576 | 69 | female | Black or African American | Primary solid Tumor | postmenopausal | ILC | positive | positive | equivocal | NA | NA | alive | 1.58 | African | TCGA.E2.A576.01A.11R.A31O.07 | TCGA-E2-A576-01 |
| TCGA-A8-A09T | 68 | female | not available | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 1.59 | European | TCGA.A8.A09T.01A.11R.A00Z.07 | TCGA-A8-A09T-01 |
| TCGA-A8-A0A2 | 66 | female | not available | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 1.59 | European | TCGA.A8.A0A2.01A.11R.A034.07 | TCGA-A8-A0A2-01 |
| TCGA-A8-A07C | 57 | female | not available | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 1.59 | European | TCGA.A8.A07C.01A.11R.A034.07 | TCGA-A8-A07C-01 |
| TCGA-A8-A08S | 71 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 1.59 | European | TCGA.A8.A08S.01A.11R.A034.07 | TCGA-A8-A08S-01 |
| TCGA-A8-A091 | 61 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | negative | negative | not available | NA | alive | 1.59 | European | TCGA.A8.A091.01A.11R.A00Z.07 | TCGA-A8-A091-01 |
| TCGA-A1-A0SP | 40 | female | not available | Primary solid Tumor | not available | IDC | negative | negative | negative | NA | NA | alive | 1.6 | European | TCGA.A1.A0SP.01A.11R.A084.07 | TCGA-A1-A0SP-01 |
| TCGA-A2-A1G1 | 85 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | equivocal | NA | NA | alive | 1.6 | European | TCGA.A2.A1G1.01A.21R.A13Q.07 | TCGA-A2-A1G1-01 |
| TCGA-D8-A147 | 45 | female | White | Primary solid Tumor | indeterminate | IDC | negative | negative | negative | NA | NA | alive | 1.6 | European | TCGA.D8.A147.01A.11R.A115.07 | TCGA-D8-A147-01 |
| TCGA-AC-A23C | 62 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 1.6 | European | TCGA.AC.A23C.01A.12R.A169.07 | TCGA-AC-A23C-01 |
| TCGA-S3-AA10 | 65 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 1.6 | African | TCGA.S3.AA10.01A.21R.A41B.07 | TCGA-S3-AA10-01 |
| TCGA-A2-A0YK | 61 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | negative | negative | NA | NA | alive | 1.61 | European | TCGA.A2.A0YK.01A.22R.A109.07 | TCGA-A2-A0YK-01 |
| TCGA-AC-A2QI | 76 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | negative | negative | NA | NA | alive | 1.61 | European | TCGA.AC.A2QI.01A.12R.A19W.07 | TCGA-AC-A2QI-01 |
| TCGA-AC-A5XS | 74 | female | White | Primary solid Tumor | not available | ILC | positive | positive | negative | NA | NA | alive | 1.61 | European | TCGA.AC.A5XS.01A.11R.A29R.07 | TCGA-AC-A5XS-01 |
| TCGA-D8-A1JM | 59 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | negative | negative | NA | NA | alive | 1.62 | European | TCGA.D8.A1JM.01A.11R.A13Q.07 | TCGA-D8-A1JM-01 |
| TCGA-E2-A15J | 51 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 1.62 | European | TCGA.E2.A15J.01A.11R.A12P.07 | TCGA-E2-A15J-01 |
| TCGA-E2-A154 | 68 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.62 | European | TCGA.E2.A154.01A.11R.A115.07 | TCGA-E2-A154-01 |
| TCGA-LL-A7SZ | 49 | female | Black or African American | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.63 | African | TCGA.LL.A7SZ.01A.32R.A352.07 | TCGA-LL-A7SZ-01 |
| TCGA-A2-A1G4 | 71 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.63 | European | TCGA.A2.A1G4.01A.11R.A13Q.07 | TCGA-A2-A1G4-01 |
| TCGA-E2-A15P | 61 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.63 | European | TCGA.E2.A15P.01A.11R.A115.07 | TCGA-E2-A15P-01 |
| TCGA-LL-A8F5 | 61 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | positive | negative | negative | NA | NA | alive | 1.63 | African | TCGA.LL.A8F5.01A.11R.A36F.07 | TCGA-LL-A8F5-01 |
| TCGA-E2-A1L9 | 40 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.64 | European | TCGA.E2.A1L9.01A.11R.A13Q.07 | TCGA-E2-A1L9-01 |
| TCGA-D8-A1XL | 34 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 1.66 | European | TCGA.D8.A1XL.01A.11R.A14M.07 | TCGA-D8-A1XL-01 |
| TCGA-A8-A08G | 41 | female | not available | Primary solid Tumor | premenopausal | IDC | positive | positive | positive | NA | NA | alive | 1.66 | European | TCGA.A8.A08G.01A.11R.A00Z.07 | TCGA-A8-A08G-01 |
| TCGA-EW-A1PH | 52 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 1.66 | European | TCGA.EW.A1PH.01A.11R.A14M.07 | TCGA-EW-A1PH-01 |
| TCGA-A8-A07E | 81 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.66 | European | TCGA.A8.A07E.01A.11R.A034.07 | TCGA-A8-A07E-01 |
| TCGA-EW-A1PB | 70 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 1.66 | African | TCGA.EW.A1PB.01A.11R.A144.07 | TCGA-EW-A1PB-01 |
| TCGA-D8-A1JJ | 54 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.67 | European | TCGA.D8.A1JJ.01A.31R.A14M.07 | TCGA-D8-A1JJ-01 |
| TCGA-D8-A1JL | 72 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 1.67 | European | TCGA.D8.A1JL.01A.11R.A13Q.07 | TCGA-D8-A1JL-01 |
| TCGA-BH-A2L8 | 45 | female | White | Primary solid Tumor | premenopausal | ILC | positive | positive | negative | NA | NA | alive | 1.68 | European | TCGA.BH.A2L8.01A.11R.A18M.07 | TCGA-BH-A2L8-01 |
| TCGA-AC-A8OP | 72 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | positive | positive | Indeterminate | NA | NA | alive | 1.68 | African | TCGA.AC.A8OP.01A.11R.A36F.07 | TCGA-AC-A8OP-01 |
| TCGA-AR-A1AY | 65 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 1.68 | European | TCGA.AR.A1AY.01A.21R.A12P.07 | TCGA-AR-A1AY-01 |
| TCGA-A2-A1G0 | 49 | female | White | Primary solid Tumor | premenopausal | Infiltrating Tubulolobular Carcinoma | positive | positive | equivocal | NA | NA | alive | 1.69 | European | TCGA.A2.A1G0.01A.11R.A13Q.07 | TCGA-A2-A1G0-01 |
| TCGA-AO-A0J7 | 71 | female | White | Primary solid Tumor | postmenopausal | ductal/mucinous | positive | positive | negative | NA | NA | alive | 1.69 | European | TCGA.AO.A0J7.01A.11R.A034.07 | TCGA-AO-A0J7-01 |
| TCGA-BH-A0HI | 78 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.7 | European | TCGA.BH.A0HI.01A.11R.A084.07 | TCGA-BH-A0HI-01 |
| TCGA-D8-A1JN | 80 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | Indeterminate | NA | NA | alive | 1.7 | European | TCGA.D8.A1JN.01A.11R.A13Q.07 | TCGA-D8-A1JN-01 |
| TCGA-OL-A5S0 | 66 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | positive | negative | not evaluated | NA | NA | alive | 1.7 | African_admix | TCGA.OL.A5S0.01A.11R.A28M.07 | TCGA-OL-A5S0-01 |
| TCGA-AO-A1KO | 46 | female | White | Primary solid Tumor | premenopausal | ILC | positive | positive | negative | NA | NA | alive | 1.7 | European | TCGA.AO.A1KO.01A.31R.A13Q.07 | TCGA-AO-A1KO-01 |
| TCGA-AR-A5QP | 54 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | equivocal | NA | NA | alive | 1.7 | European | TCGA.AR.A5QP.01A.11R.A28M.07 | TCGA-AR-A5QP-01 |
| TCGA-BH-A0AW | 56 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | negative | positive | NA | NA | alive | 1.7 | European | TCGA.BH.A0AW.01A.11R.A056.07 | TCGA-BH-A0AW-01 |
| TCGA-A2-A0T4 | 62 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | equivocal | NA | NA | alive | 1.71 | European | TCGA.A2.A0T4.01A.31R.A084.07 | TCGA-A2-A0T4-01 |
| TCGA-D8-A141 | 40 | female | White | Primary solid Tumor | indeterminate | IDC | positive | positive | negative | NA | NA | alive | 1.71 | European | TCGA.D8.A141.01A.11R.A115.07 | TCGA-D8-A141-01 |
| TCGA-E2-A15L | 65 | female | Black or African American | Primary solid Tumor | postmenopausal | ILC | positive | positive | equivocal | NA | NA | alive | 1.71 | African | TCGA.E2.A15L.01A.11R.A12D.07 | TCGA-E2-A15L-01 |
| TCGA-E9-A1RH | 63 | female | White | Primary solid Tumor | postmenopausal | IDC | not evaluated | not evaluated | not evaluated | NA | NA | alive | 1.71 | European | TCGA.E9.A1RH.01A.21R.A169.07 | TCGA-E9-A1RH-01 |
| TCGA-E9-A1RH | 63 | female | White | Solid Tissue Normal | postmenopausal | IDC | not evaluated | not evaluated | not evaluated | NA | NA | alive | 1.71 | European | TCGA.E9.A1RH.11A.34R.A169.07 | TCGA-E9-A1RH-11 |
| TCGA-S3-AA0Z | 63 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 1.72 | African | TCGA.S3.AA0Z.01A.11R.A41B.07 | TCGA-S3-AA0Z-01 |
| TCGA-E2-A15E | 40 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | not evaluated | NA | NA | alive | 1.72 | European | TCGA.E2.A15E.01A.11R.A12D.07 | TCGA-E2-A15E-01 |
| TCGA-E9-A22H | 42 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | positive | NA | NA | alive | 1.72 | European_admix | TCGA.E9.A22H.01A.11R.A157.07 | TCGA-E9-A22H-01 |
| TCGA-A2-A0T7 | 51 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.73 | European | TCGA.A2.A0T7.01A.21R.A084.07 | TCGA-A2-A0T7-01 |
| TCGA-A1-A0SI | 52 | female | White | Primary solid Tumor | not available | IDC | positive | positive | negative | NA | NA | alive | 1.74 | European | TCGA.A1.A0SI.01A.11R.A144.07 | TCGA-A1-A0SI-01 |
| TCGA-A2-A3KC | 55 | female | Black or African American | Primary solid Tumor | premenopausal | ILC | positive | positive | equivocal | NA | NA | alive | 1.74 | African_admix | TCGA.A2.A3KC.01A.11R.A213.07 | TCGA-A2-A3KC-01 |
| TCGA-BH-A42V | 41 | female | Black or African American | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.74 | African | TCGA.BH.A42V.01A.11R.A24H.07 | TCGA-BH-A42V-01 |
| TCGA-D8-A13Z | 51 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 1.74 | European | TCGA.D8.A13Z.01A.11R.A115.07 | TCGA-D8-A13Z-01 |
| TCGA-D8-A1JP | 73 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.75 | European | TCGA.D8.A1JP.01A.11R.A13Q.07 | TCGA-D8-A1JP-01 |
| TCGA-A8-A0A6 | 64 | female | not available | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 1.75 | European | TCGA.A8.A0A6.01A.12R.A056.07 | TCGA-A8-A0A6-01 |
| TCGA-E2-A155 | 58 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | negative | negative | NA | NA | alive | 1.75 | European | TCGA.E2.A155.01A.11R.A12D.07 | TCGA-E2-A155-01 |
| TCGA-S3-A6ZH | 29 | female | Black or African American | Primary solid Tumor | unknown | IDC | positive | positive | equivocal | NA | NA | alive | 1.75 | African | TCGA.S3.A6ZH.01A.22R.A32P.07 | TCGA-S3-A6ZH-01 |
| TCGA-A2-A0D0 | 60 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 1.76 | African | TCGA.A2.A0D0.01A.11R.A00Z.07 | TCGA-A2-A0D0-01 |
| TCGA-A2-A4S2 | 62 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 1.76 | European | TCGA.A2.A4S2.01A.12R.A266.07 | TCGA-A2-A4S2-01 |
| TCGA-D8-A146 | 57 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.76 | European | TCGA.D8.A146.01A.31R.A115.07 | TCGA-D8-A146-01 |
| TCGA-A7-A4SE | 54 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 1.76 | African | TCGA.A7.A4SE.01A.11R.A266.07 | TCGA-A7-A4SE-01 |
| TCGA-E9-A1R7 | 64 | female | White | Primary solid Tumor | postmenopausal | IDC | not evaluated | not evaluated | not evaluated | NA | NA | alive | 1.77 | European | TCGA.E9.A1R7.01A.11R.A14M.07 | TCGA-E9-A1R7-01 |
| TCGA-E9-A1R7 | 64 | female | White | Solid Tissue Normal | postmenopausal | IDC | not evaluated | not evaluated | not evaluated | NA | NA | alive | 1.77 | European | TCGA.E9.A1R7.11A.42R.A14M.07 | TCGA-E9-A1R7-11 |
| TCGA-LD-A66U | 44 | female | White | Primary solid Tumor | not evaluated | ILC | positive | positive | negative | NA | NA | alive | 1.77 | European | TCGA.LD.A66U.01A.11R.A31O.07 | TCGA-LD-A66U-01 |
| TCGA-E9-A1RG | 62 | female | White | Primary solid Tumor | postmenopausal | IDC | not evaluated | not evaluated | not evaluated | NA | NA | alive | 1.77 | European | TCGA.E9.A1RG.01A.11R.A14D.07 | TCGA-E9-A1RG-01 |
| TCGA-EW-A3E8 | 60 | female | White | Primary solid Tumor | not evaluated | ILC | positive | negative | negative | NA | NA | alive | 1.77 | European | TCGA.EW.A3E8.01B.11R.A24H.07 | TCGA-EW-A3E8-01 |
| TCGA-A2-A4RY | 46 | female | White | Primary solid Tumor | premenopausal | ILC | positive | positive | negative | NA | NA | alive | 1.77 | European | TCGA.A2.A4RY.01A.31R.A266.07 | TCGA-A2-A4RY-01 |
| TCGA-AO-A0JF | 68 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.78 | European | TCGA.AO.A0JF.01A.11R.A056.07 | TCGA-AO-A0JF-01 |
| TCGA-AO-A0J3 | 67 | female | White | Primary solid Tumor | postmenopausal | neuroendocrine and ductal | positive | positive | equivocal | NA | NA | alive | 1.78 | European | TCGA.AO.A0J3.01A.11R.A034.07 | TCGA-AO-A0J3-01 |
| TCGA-BH-A18H | 63 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 1.79 | European | TCGA.BH.A18H.01A.11R.A12D.07 | TCGA-BH-A18H-01 |
| TCGA-E9-A1NA | 58 | female | White | Primary solid Tumor | postmenopausal | IDC/ILC | positive | positive | positive | NA | NA | alive | 1.79 | European | TCGA.E9.A1NA.01A.11R.A144.07 | TCGA-E9-A1NA-01 |
| TCGA-E9-A1NA | 58 | female | White | Solid Tissue Normal | postmenopausal | IDC/ILC | positive | positive | positive | NA | NA | alive | 1.79 | European | TCGA.E9.A1NA.11A.33R.A144.07 | TCGA-E9-A1NA-11 |
| TCGA-AO-A0JA | 36 | female | Black or African American | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | metastasis | bone | alive | 1.79 | African_admix | TCGA.AO.A0JA.01A.11R.A056.07 | TCGA-AO-A0JA-01 |
| TCGA-E2-A15F | 64 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.8 | European | TCGA.E2.A15F.01A.11R.A115.07 | TCGA-E2-A15F-01 |
| TCGA-E2-A1IH | 80 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | equivocal | NA | NA | alive | 1.8 | European | TCGA.E2.A1IH.01A.11R.A13Q.07 | TCGA-E2-A1IH-01 |
| TCGA-A2-A0YH | 53 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.8 | European | TCGA.A2.A0YH.01A.11R.A109.07 | TCGA-A2-A0YH-01 |
| TCGA-D8-A4Z1 | 68 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 1.8 | European | TCGA.D8.A4Z1.01A.21R.A266.07 | TCGA-D8-A4Z1-01 |
| TCGA-E9-A1RE | 74 | female | White | Primary solid Tumor | postmenopausal | IDC | not evaluated | not evaluated | not evaluated | NA | NA | alive | 1.8 | European | TCGA.E9.A1RE.01A.11R.A157.07 | TCGA-E9-A1RE-01 |
| TCGA-BH-A0BJ | 41 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.81 | European | TCGA.BH.A0BJ.01A.11R.A056.07 | TCGA-BH-A0BJ-01 |
| TCGA-BH-A0BJ | 41 | female | White | Solid Tissue Normal | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.81 | European | TCGA.BH.A0BJ.11A.23R.A089.07 | TCGA-BH-A0BJ-11 |
| TCGA-A7-A26I | 65 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | equivocal | NA | NA | alive | 1.81 | European | TCGA.A7.A26I.01A.11R.A169.07 | TCGA-A7-A26I-01 |
| TCGA-BH-A8G0 | 54 | female | White | Primary solid Tumor | perimenopausal | ILC | positive | positive | negative | NA | NA | alive | 1.81 | European | TCGA.BH.A8G0.01A.11R.A352.07 | TCGA-BH-A8G0-01 |
| TCGA-D8-A1XJ | 76 | female | White | Primary solid Tumor | postmenopausal | ductal/mucinous | positive | positive | positive | NA | NA | alive | 1.82 | European | TCGA.D8.A1XJ.01A.11R.A14M.07 | TCGA-D8-A1XJ-01 |
| TCGA-AQ-A54O | 51 | male | Black or African American | Primary solid Tumor | not applicable | IDC | positive | positive | negative | NA | NA | alive | 1.82 | African | TCGA.AQ.A54O.01A.11R.A266.07 | TCGA-AQ-A54O-01 |
| TCGA-A2-A0YG | 63 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 1.82 | European | TCGA.A2.A0YG.01A.21R.A109.07 | TCGA-A2-A0YG-01 |
| TCGA-A2-A4S3 | 59 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.82 | African_admix | TCGA.A2.A4S3.01A.21R.A266.07 | TCGA-A2-A4S3-01 |
| TCGA-A2-A04U | 47 | female | White | Primary solid Tumor | perimenopausal | IDC | negative | negative | negative | NA | NA | alive | 1.84 | European | TCGA.A2.A04U.01A.11R.A115.07 | TCGA-A2-A04U-01 |
| TCGA-AC-A3QP | 79 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | equivocal | NA | NA | alive | 1.85 | European | TCGA.AC.A3QP.01A.11R.A22U.07 | TCGA-AC-A3QP-01 |
| TCGA-E2-A1IN | 60 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.85 | European | TCGA.E2.A1IN.01A.11R.A13Q.07 | TCGA-E2-A1IN-01 |
| TCGA-AC-A2B8 | 84 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | new primary | rectum | alive | 1.85 | European | TCGA.AC.A2B8.01A.11R.A17B.07 | TCGA-AC-A2B8-01 |
| TCGA-E2-A573 | 48 | female | Black or African American | Primary solid Tumor | perimenopausal | IDC | negative | negative | equivocal | NA | NA | alive | 1.85 | African | TCGA.E2.A573.01A.11R.A29R.07 | TCGA-E2-A573-01 |
| TCGA-A7-A2KD | 53 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 1.86 | African | TCGA.A7.A2KD.01A.31R.A21T.07 | TCGA-A7-A2KD-01 |
| TCGA-OL-A5RZ | 57 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | positive | negative | not evaluated | NA | NA | alive | 1.86 | African | TCGA.OL.A5RZ.01A.11R.A28M.07 | TCGA-OL-A5RZ-01 |
| TCGA-AO-A0J8 | 61 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 1.86 | European | TCGA.AO.A0J8.01A.21R.A034.07 | TCGA-AO-A0J8-01 |
| TCGA-A2-A1FZ | 63 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.87 | European | TCGA.A2.A1FZ.01A.51R.A14D.07 | TCGA-A2-A1FZ-01 |
| TCGA-E2-A1IO | 37 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 1.88 | European | TCGA.E2.A1IO.01A.11R.A144.07 | TCGA-E2-A1IO-01 |
| TCGA-E2-A1IK | 71 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.89 | European | TCGA.E2.A1IK.01A.11R.A144.07 | TCGA-E2-A1IK-01 |
| TCGA-E9-A22B | 71 | female | White | Primary solid Tumor | postmenopausal | IDC/ILC | positive | negative | negative | NA | NA | alive | 1.89 | European | TCGA.E9.A22B.01A.11R.A157.07 | TCGA-E9-A22B-01 |
| TCGA-E2-A15C | 61 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 1.9 | European | TCGA.E2.A15C.01A.31R.A12D.07 | TCGA-E2-A15C-01 |
| TCGA-EW-A1OW | 58 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 1.9 | African | TCGA.EW.A1OW.01A.21R.A144.07 | TCGA-EW-A1OW-01 |
| TCGA-BH-A0WA | 82 | female | White | Primary solid Tumor | not available | not available | negative | negative | negative | NA | NA | alive | 1.92 | European | TCGA.BH.A0WA.01A.11R.A109.07 | TCGA-BH-A0WA-01 |
| TCGA-A8-A08B | 52 | female | not available | Primary solid Tumor | premenopausal | IDC | positive | negative | positive | NA | NA | alive | 1.92 | European | TCGA.A8.A08B.01A.11R.A00Z.07 | TCGA-A8-A08B-01 |
| TCGA-BH-A0H7 | 65 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.92 | European | TCGA.BH.A0H7.01A.13R.A056.07 | TCGA-BH-A0H7-01 |
| TCGA-BH-A0H7 | 65 | female | White | Solid Tissue Normal | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.92 | European | TCGA.BH.A0H7.11A.13R.A089.07 | TCGA-BH-A0H7-11 |
| TCGA-EW-A1P5 | 77 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.92 | European | TCGA.EW.A1P5.01A.11R.A144.07 | TCGA-EW-A1P5-01 |
| TCGA-A2-A4S0 | 77 | female | White | Primary solid Tumor | postmenopausal | mucinous carcinoma | positive | positive | negative | NA | NA | alive | 1.93 | European | TCGA.A2.A4S0.01A.21R.A266.07 | TCGA-A2-A4S0-01 |
| TCGA-AC-A3YI | 74 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | positive | NA | NA | alive | 1.94 | European | TCGA.AC.A3YI.01A.21R.A239.07 | TCGA-AC-A3YI-01 |
| TCGA-E2-A153 | 51 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.94 | European | TCGA.E2.A153.01A.12R.A12D.07 | TCGA-E2-A153-01 |
| TCGA-E2-A153 | 51 | female | White | Solid Tissue Normal | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.94 | European | TCGA.E2.A153.11A.31R.A12D.07 | TCGA-E2-A153-11 |
| TCGA-E9-A1NC | 61 | female | White | Primary solid Tumor | postmenopausal | IDC/ILC | negative | positive | positive | NA | NA | alive | 1.94 | European | TCGA.E9.A1NC.01A.21R.A26B.07 | TCGA-E9-A1NC-01 |
| TCGA-AR-A0TU | 35 | female | not available | Primary solid Tumor | premenopausal | IDC | negative | negative | negative | NA | NA | alive | 1.94 | European | TCGA.AR.A0TU.01A.31R.A109.07 | TCGA-AR-A0TU-01 |
| TCGA-E2-A15A | 45 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.94 | European | TCGA.E2.A15A.01A.11R.A12D.07 | TCGA-E2-A15A-01 |
| TCGA-GI-A2C9 | 58 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 1.95 | African | TCGA.GI.A2C9.01A.11R.A21T.07 | TCGA-GI-A2C9-01 |
| TCGA-GI-A2C9 | 58 | female | Black or African American | Solid Tissue Normal | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 1.95 | African | TCGA.GI.A2C9.11A.22R.A21T.07 | TCGA-GI-A2C9-11 |
| TCGA-BH-A0DG | 30 | female | Black or African American | Primary solid Tumor | premenopausal | IDC | positive | negative | negative | NA | NA | alive | 1.95 | African | TCGA.BH.A0DG.01A.21R.A12P.07 | TCGA-BH-A0DG-01 |
| TCGA-BH-A0DG | 30 | female | Black or African American | Solid Tissue Normal | premenopausal | IDC | positive | negative | negative | NA | NA | alive | 1.95 | African | TCGA.BH.A0DG.11A.43R.A12P.07 | TCGA-BH-A0DG-11 |
| TCGA-E9-A22A | 74 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | negative | negative | NA | NA | alive | 1.95 | European | TCGA.E9.A22A.01A.11R.A157.07 | TCGA-E9-A22A-01 |
| TCGA-A2-A1FV | 74 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 1.95 | European | TCGA.A2.A1FV.01A.11R.A13Q.07 | TCGA-A2-A1FV-01 |
| TCGA-OL-A66I | 36 | female | Black or African American | Primary solid Tumor | not evaluated | IDC | negative | negative | not evaluated | NA | NA | alive | 1.95 | African | TCGA.OL.A66I.01A.21R.A29R.07 | TCGA-OL-A66I-01 |
| TCGA-BH-A5J0 | 63 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.96 | African | TCGA.BH.A5J0.01A.11R.A27Q.07 | TCGA-BH-A5J0-01 |
| TCGA-E9-A22G | 47 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | positive | NA | NA | alive | 1.96 | European | TCGA.E9.A22G.01A.11R.A157.07 | TCGA-E9-A22G-01 |
| TCGA-A7-A26G | 50 | female | Black or African American | Primary solid Tumor | premenopausal | IDC with Metaplastic features (area of sarcomatoid carcinoma) | negative | negative | negative | NA | NA | alive | 1.98 | African | TCGA.A7.A26G.01A.21R.A169.07 | TCGA-A7-A26G-01 |
| TCGA-A7-A26H | 72 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | negative | equivocal | not available | NA | alive | 1.98 | European | TCGA.A7.A26H.01A.11R.A169.07 | TCGA-A7-A26H-01 |
| TCGA-E9-A54Y | 63 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 1.98 | European | TCGA.E9.A54Y.01A.11R.A466.07 | TCGA-E9-A54Y-01 |
| TCGA-E2-A156 | 61 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.99 | European | TCGA.E2.A156.01A.11R.A12D.07 | TCGA-E2-A156-01 |
| TCGA-BH-A0HF | 77 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 1.99 | European | TCGA.BH.A0HF.01A.11R.A056.07 | TCGA-BH-A0HF-01 |
| TCGA-D8-A1X9 | 66 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | Indeterminate | NA | NA | alive | 1.99 | European | TCGA.D8.A1X9.01A.12R.A157.07 | TCGA-D8-A1X9-01 |
| TCGA-E9-A54X | 85 | female | White | Primary solid Tumor | postmenopausal | mucinous carcinoma | positive | positive | negative | NA | NA | alive | 1.99 | European | TCGA.E9.A54X.01A.11R.A266.07 | TCGA-E9-A54X-01 |
| TCGA-BH-A0W3 | 58 | female | White | Primary solid Tumor | indeterminate | IDC | positive | positive | equivocal | NA | NA | alive | 1.99 | European | TCGA.BH.A0W3.01A.11R.A109.07 | TCGA-BH-A0W3-01 |
| TCGA-A2-A0EU | 79 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 2.01 | European | TCGA.A2.A0EU.01A.22R.A056.07 | TCGA-A2-A0EU-01 |
| TCGA-OL-A5RV | 43 | female | Black or African American | Primary solid Tumor | premenopausal | IDC | positive | positive | not evaluated | NA | NA | alive | 2.01 | African | TCGA.OL.A5RV.01A.12R.A28M.07 | TCGA-OL-A5RV-01 |
| TCGA-AC-A3QQ | 54 | female | White | Primary solid Tumor | perimenopausal | ILC | positive | positive | positive | NA | NA | alive | 2.01 | European | TCGA.AC.A3QQ.01A.11R.A22K.07 | TCGA-AC-A3QQ-01 |
| TCGA-A7-A26F | 55 | female | White | Primary solid Tumor | postmenopausal | \adenocarcinoma with squamous differentiation, metaplastic\"" | negative | negative | equivocal | NA | NA | alive | 2.02 | European | TCGA.A7.A26F.01A.21R.A169.07 | TCGA-A7-A26F-01 |
| TCGA-AR-A0TW | 50 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 2.02 | European | TCGA.AR.A0TW.01A.11R.A084.07 | TCGA-AR-A0TW-01 |
| TCGA-A2-A4RX | 67 | female | Black or African American | Primary solid Tumor | postmenopausal | metaplastic carcinoma | positive | positive | negative | NA | NA | alive | 2.03 | African | TCGA.A2.A4RX.01A.11R.A266.07 | TCGA-A2-A4RX-01 |
| TCGA-BH-A0EI | 51 | female | White | Primary solid Tumor | perimenopausal | IDC | positive | positive | negative | NA | NA | alive | 2.03 | European | TCGA.BH.A0EI.01A.11R.A115.07 | TCGA-BH-A0EI-01 |
| TCGA-GM-A3NY | 72 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 2.03 | European | TCGA.GM.A3NY.01A.11R.A21T.07 | TCGA-GM-A3NY-01 |
| TCGA-BH-A0EB | 69 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 2.04 | European | TCGA.BH.A0EB.01A.11R.A034.07 | TCGA-BH-A0EB-01 |
| TCGA-BH-A0AU | 45 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | positive | NA | NA | alive | 2.04 | European | TCGA.BH.A0AU.01A.11R.A12P.07 | TCGA-BH-A0AU-01 |
| TCGA-BH-A0AU | 45 | female | White | Solid Tissue Normal | premenopausal | IDC | positive | positive | positive | NA | NA | alive | 2.04 | European | TCGA.BH.A0AU.11A.11R.A12P.07 | TCGA-BH-A0AU-11 |
| TCGA-BH-A0H6 | 82 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 2.05 | European | TCGA.BH.A0H6.01A.21R.A056.07 | TCGA-BH-A0H6-01 |
| TCGA-C8-A27A | 48 | female | Asian | Primary solid Tumor | perimenopausal | IDC | positive | positive | negative | NA | NA | alive | 2.05 | East Asian | TCGA.C8.A27A.01A.11R.A169.07 | TCGA-C8-A27A-01 |
| TCGA-E9-A24A | 69 | female | White | Primary solid Tumor | postmenopausal | IDC | not evaluated | not evaluated | not evaluated | NA | NA | alive | 2.05 | European | TCGA.E9.A24A.01A.11R.A169.07 | TCGA-E9-A24A-01 |
| TCGA-E2-A14V | 53 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 2.05 | European | TCGA.E2.A14V.01A.11R.A12D.07 | TCGA-E2-A14V-01 |
| TCGA-A2-A0EX | 46 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 2.06 | European | TCGA.A2.A0EX.01A.21R.A034.07 | TCGA-A2-A0EX-01 |
| TCGA-OL-A5RY | 52 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | positive | negative | not evaluated | NA | NA | alive | 2.06 | African | TCGA.OL.A5RY.01A.21R.A28M.07 | TCGA-OL-A5RY-01 |
| TCGA-AC-A3YJ | 66 | female | White | Primary solid Tumor | postmenopausal | invasive papillary carcinoma | positive | positive | not available | NA | NA | alive | 2.06 | European | TCGA.AC.A3YJ.01A.11R.A22U.07 | TCGA-AC-A3YJ-01 |
| TCGA-AQ-A04H | 61 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | Indeterminate | NA | NA | alive | 2.06 | European | TCGA.AQ.A04H.01B.11R.A10J.07 | TCGA-AQ-A04H-01 |
| TCGA-E9-A1QZ | 61 | female | White | Primary solid Tumor | postmenopausal | IDC | not evaluated | not evaluated | not evaluated | NA | NA | alive | 2.07 | European | TCGA.E9.A1QZ.01A.21R.A169.07 | TCGA-E9-A1QZ-01 |
| TCGA-BH-A0BG | 73 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 2.07 | European | TCGA.BH.A0BG.01A.11R.A115.07 | TCGA-BH-A0BG-01 |
| TCGA-BH-A0W4 | 46 | female | White | Primary solid Tumor | not available | IDC | positive | positive | negative | NA | NA | alive | 2.08 | European | TCGA.BH.A0W4.01A.11R.A109.07 | TCGA-BH-A0W4-01 |
| TCGA-LL-A440 | 61 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | equivocal | NA | NA | alive | 2.08 | European | TCGA.LL.A440.01A.11R.A24H.07 | TCGA-LL-A440-01 |
| TCGA-A8-A07U | 66 | female | not available | Primary solid Tumor | postmenopausal | IDC | negative | positive | negative | NA | NA | alive | 2.08 | European | TCGA.A8.A07U.01A.11R.A034.07 | TCGA-A8-A07U-01 |
| TCGA-EW-A6SB | 62 | female | Black or African American | Primary solid Tumor | not available | IDC | negative | negative | negative | NA | NA | alive | 2.08 | African | TCGA.EW.A6SB.01A.12R.A32P.07 | TCGA-EW-A6SB-01 |
| TCGA-A2-A0D2 | 45 | female | White | Primary solid Tumor | premenopausal | IDC | negative | negative | negative | NA | NA | alive | 2.08 | European | TCGA.A2.A0D2.01A.21R.A034.07 | TCGA-A2-A0D2-01 |
| TCGA-A8-A09Q | 83 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 2.08 | European | TCGA.A8.A09Q.01A.11R.A00Z.07 | TCGA-A8-A09Q-01 |
| TCGA-LL-A50Y | 84 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | equivocal | NA | NA | alive | 2.09 | European | TCGA.LL.A50Y.01A.11R.A266.07 | TCGA-LL-A50Y-01 |
| TCGA-E2-A107 | 54 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | negative | equivocal | NA | NA | alive | 2.09 | European | TCGA.E2.A107.01A.11R.A10J.07 | TCGA-E2-A107-01 |
| TCGA-A2-A04Y | 53 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 2.09 | European | TCGA.A2.A04Y.01A.21R.A034.07 | TCGA-A2-A04Y-01 |
| TCGA-A7-A13F | 44 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 2.09 | European | TCGA.A7.A13F.01A.11R.A12P.07 | TCGA-A7-A13F-01 |
| TCGA-A7-A13F | 44 | female | White | Solid Tissue Normal | premenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 2.09 | European | TCGA.A7.A13F.11A.42R.A12P.07 | TCGA-A7-A13F-11 |
| TCGA-A2-A0D4 | 37 | female | Black or African American | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 2.1 | African_admix | TCGA.A2.A0D4.01A.11R.A00Z.07 | TCGA-A2-A0D4-01 |
| TCGA-D8-A73X | 53 | female | White | Primary solid Tumor | postmenopausal | tubular carcinoma | positive | positive | negative | NA | NA | alive | 2.1 | European | TCGA.D8.A73X.01A.11R.A32P.07 | TCGA-D8-A73X-01 |
| TCGA-A2-A0YD | 63 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | not evaluated | NA | NA | alive | 2.11 | European | TCGA.A2.A0YD.01A.11R.A109.07 | TCGA-A2-A0YD-01 |
| TCGA-E2-A150 | 48 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 2.12 | European | TCGA.E2.A150.01A.11R.A12D.07 | TCGA-E2-A150-01 |
| TCGA-AO-A0J6 | 61 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 2.12 | European | TCGA.AO.A0J6.01A.11R.A034.07 | TCGA-AO-A0J6-01 |
| TCGA-BH-A0AY | 62 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 2.13 | European | TCGA.BH.A0AY.01A.21R.A00Z.07 | TCGA-BH-A0AY-01 |
| TCGA-BH-A0AY | 62 | female | White | Solid Tissue Normal | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 2.13 | European | TCGA.BH.A0AY.11A.23R.A089.07 | TCGA-BH-A0AY-11 |
| TCGA-D8-A1X8 | 62 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | Indeterminate | negative | NA | NA | alive | 2.14 | European | TCGA.D8.A1X8.01A.11R.A14M.07 | TCGA-D8-A1X8-01 |
| TCGA-E9-A5UO | 41 | female | White | Primary solid Tumor | premenopausal | mucinous carcinoma | not evaluated | not evaluated | not evaluated | NA | NA | alive | 2.15 | European | TCGA.E9.A5UO.01A.11R.A28M.07 | TCGA-E9-A5UO-01 |
| TCGA-A2-A0D1 | 76 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | positive | NA | NA | alive | 2.15 | European | TCGA.A2.A0D1.01A.11R.A034.07 | TCGA-A2-A0D1-01 |
| TCGA-EW-A2FV | 39 | female | White | Primary solid Tumor | premenopausal | invasive micropapillary ductal carcinoma | positive | positive | negative | NA | NA | alive | 2.16 | European | TCGA.EW.A2FV.01A.11R.A17B.07 | TCGA-EW-A2FV-01 |
| TCGA-EW-A1OV | 56 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 2.16 | European | TCGA.EW.A1OV.01A.11R.A144.07 | TCGA-EW-A1OV-01 |
| TCGA-A8-A06Y | 66 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | not available | not available | alive | 2.17 | European | TCGA.A8.A06Y.01A.21R.A00Z.07 | TCGA-A8-A06Y-01 |
| TCGA-OL-A66N | 59 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | negative | not evaluated | NA | NA | alive | 2.17 | European | TCGA.OL.A66N.01A.12R.A31O.07 | TCGA-OL-A66N-01 |
| TCGA-E9-A3HO | 49 | female | White | Primary solid Tumor | premenopausal | ILC | not evaluated | not evaluated | not evaluated | NA | NA | alive | 2.17 | European | TCGA.E9.A3HO.01A.11R.A213.07 | TCGA-E9-A3HO-01 |
| TCGA-BH-A202 | 60 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 2.18 | European | TCGA.BH.A202.01A.11R.A14M.07 | TCGA-BH-A202-01 |
| TCGA-OL-A5RW | 40 | female | Black or African American | Primary solid Tumor | premenopausal | IDC | negative | negative | not evaluated | NA | NA | alive | 2.18 | African | TCGA.OL.A5RW.01A.11R.A28M.07 | TCGA-OL-A5RW-01 |
| TCGA-AO-A0JG | 49 | female | White | Primary solid Tumor | postmenopausal | ductal/mucinous | positive | positive | negative | NA | NA | alive | 2.18 | European | TCGA.AO.A0JG.01A.31R.A084.07 | TCGA-AO-A0JG-01 |
| TCGA-E9-A5UP | 63 | female | White | Primary solid Tumor | postmenopausal | infiltrating papillary adenocarcinoma | not evaluated | not evaluated | not evaluated | NA | NA | alive | 2.2 | European | TCGA.E9.A5UP.01A.11R.A28M.07 | TCGA-E9-A5UP-01 |
| TCGA-A2-A3KD | 47 | female | White | Primary solid Tumor | premenopausal | mucinous carcinoma | positive | positive | negative | NA | NA | alive | 2.2 | European | TCGA.A2.A3KD.01A.12R.A213.07 | TCGA-A2-A3KD-01 |
| TCGA-BH-A0HB | 55 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 2.21 | European | TCGA.BH.A0HB.01A.11R.A056.07 | TCGA-BH-A0HB-01 |
| TCGA-A2-A0ET | 58 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 2.21 | European | TCGA.A2.A0ET.01A.31R.A034.07 | TCGA-A2-A0ET-01 |
| TCGA-E2-A574 | 44 | female | Black or African American | Primary solid Tumor | premenopausal | IDC | negative | negative | equivocal | NA | NA | alive | 2.21 | African_admix | TCGA.E2.A574.01A.11R.A29R.07 | TCGA-E2-A574-01 |
| TCGA-E9-A5FK | 60 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 2.22 | European | TCGA.E9.A5FK.01A.11R.A27Q.07 | TCGA-E9-A5FK-01 |
| TCGA-OL-A66H | 74 | female | Black or African American | Primary solid Tumor | postmenopausal | mucinous carcinoma | positive | positive | not evaluated | NA | NA | alive | 2.22 | African_admix | TCGA.OL.A66H.01A.11R.A29R.07 | TCGA-OL-A66H-01 |
| TCGA-AQ-A04J | 45 | female | White | Primary solid Tumor | premenopausal | IDC | negative | negative | negative | NA | NA | alive | 2.24 | European | TCGA.AQ.A04J.01A.02R.A034.07 | TCGA-AQ-A04J-01 |
| TCGA-A2-A4S1 | 66 | female | White | Primary solid Tumor | postmenopausal | metaplastic carcinoma | positive | negative | negative | NA | NA | alive | 2.25 | European | TCGA.A2.A4S1.01A.21R.A266.07 | TCGA-A2-A4S1-01 |
| TCGA-A8-A0A9 | 80 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 2.25 | European | TCGA.A8.A0A9.01A.11R.A00Z.07 | TCGA-A8-A0A9-01 |
| TCGA-E2-A152 | 56 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | negative | positive | metastasis | liver>breast recur | alive | 2.26 | European | TCGA.E2.A152.01A.11R.A12D.07 | TCGA-E2-A152-01 |
| TCGA-BH-A0BQ | 39 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | positive | locoregional recurrence | dermis|epidermis | alive | 2.26 | European | TCGA.BH.A0BQ.01A.21R.A115.07 | TCGA-BH-A0BQ-01 |
| TCGA-BH-A0BQ | 39 | female | White | Solid Tissue Normal | premenopausal | IDC | positive | positive | positive | locoregional recurrence | dermis|epidermis | alive | 2.26 | European | TCGA.BH.A0BQ.11A.33R.A115.07 | TCGA-BH-A0BQ-11 |
| TCGA-E9-A247 | 59 | female | White | Primary solid Tumor | postmenopausal | IDC | not evaluated | not evaluated | not evaluated | NA | NA | alive | 2.27 | European | TCGA.E9.A247.01A.11R.A169.07 | TCGA-E9-A247-01 |
| TCGA-BH-A0HX | 54 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 2.27 | European | TCGA.BH.A0HX.01A.21R.A056.07 | TCGA-BH-A0HX-01 |
| TCGA-E2-A572 | 72 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 2.28 | African_admix | TCGA.E2.A572.01A.13R.A31O.07 | TCGA-E2-A572-01 |
| TCGA-E2-A14S | 65 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 2.28 | European | TCGA.E2.A14S.01A.11R.A12D.07 | TCGA-E2-A14S-01 |
| TCGA-E2-A1L7 | 40 | female | White | Primary solid Tumor | premenopausal | IDC | negative | negative | negative | new primary | contralateral | alive | 2.28 | European | TCGA.E2.A1L7.01A.11R.A144.07 | TCGA-E2-A1L7-01 |
| TCGA-E2-A1L7 | 40 | female | White | Solid Tissue Normal | premenopausal | IDC | negative | negative | negative | new primary | contralateral | alive | 2.28 | European | TCGA.E2.A1L7.11A.33R.A144.07 | TCGA-E2-A1L7-11 |
| TCGA-E2-A108 | 64 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 2.29 | European | TCGA.E2.A108.01A.13R.A10J.07 | TCGA-E2-A108-01 |
| TCGA-E2-A14U | 74 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | equivocal | NA | NA | alive | 2.29 | European_admix | TCGA.E2.A14U.01A.11R.A22K.07 | TCGA-E2-A14U-01 |
| TCGA-E9-A1ND | 75 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | positive | NA | NA | alive | 2.29 | European | TCGA.E9.A1ND.01A.11R.A144.07 | TCGA-E9-A1ND-01 |
| TCGA-E9-A1ND | 75 | female | White | Solid Tissue Normal | postmenopausal | IDC | negative | negative | positive | NA | NA | alive | 2.29 | European | TCGA.E9.A1ND.11A.43R.A144.07 | TCGA-E9-A1ND-11 |
| TCGA-D8-A1XA | 64 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 2.3 | European | TCGA.D8.A1XA.01A.11R.A14D.07 | TCGA-D8-A1XA-01 |
| TCGA-OL-A5RU | 63 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | positive | positive | not evaluated | NA | NA | alive | 2.3 | African | TCGA.OL.A5RU.01A.11R.A28M.07 | TCGA-OL-A5RU-01 |
| TCGA-AR-A2LR | 49 | female | White | Primary solid Tumor | postmenopausal | metaplastic carcinoma | negative | negative | negative | NA | NA | alive | 2.32 | European | TCGA.AR.A2LR.01A.12R.A18M.07 | TCGA-AR-A2LR-01 |
| TCGA-OL-A6VR | 48 | female | Black or African American | Primary solid Tumor | unknown | IDC | positive | positive | negative | NA | NA | alive | 2.32 | African_admix | TCGA.OL.A6VR.01A.32R.A33J.07 | TCGA-OL-A6VR-01 |
| TCGA-LQ-A4E4 | 73 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | not evaluated | metastasis | bone | alive | 2.32 | European | TCGA.LQ.A4E4.01A.11R.A266.07 | TCGA-LQ-A4E4-01 |
| TCGA-E2-A1II | 51 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | positive | negative | NA | NA | alive | 2.33 | European | TCGA.E2.A1II.01A.11R.A144.07 | TCGA-E2-A1II-01 |
| TCGA-A1-A0SO | 67 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | equivocal | NA | NA | alive | 2.33 | European | TCGA.A1.A0SO.01A.22R.A084.07 | TCGA-A1-A0SO-01 |
| TCGA-A8-A07Z | 85 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 2.34 | European | TCGA.A8.A07Z.01A.11R.A00Z.07 | TCGA-A8-A07Z-01 |
| TCGA-E2-A10C | 54 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 2.34 | European | TCGA.E2.A10C.01A.21R.A10J.07 | TCGA-E2-A10C-01 |
| TCGA-BH-A0HA | 31 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | not available | NA | NA | alive | 2.34 | European | TCGA.BH.A0HA.01A.11R.A12P.07 | TCGA-BH-A0HA-01 |
| TCGA-BH-A0HA | 31 | female | White | Solid Tissue Normal | premenopausal | IDC | positive | positive | not available | NA | NA | alive | 2.34 | European | TCGA.BH.A0HA.11A.31R.A12P.07 | TCGA-BH-A0HA-11 |
| TCGA-BH-A201 | 64 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 2.34 | European | TCGA.BH.A201.01A.11R.A14M.07 | TCGA-BH-A201-01 |
| TCGA-OL-A6VO | 43 | female | Black or African American | Primary solid Tumor | unknown | IDC | negative | negative | negative | NA | NA | alive | 2.35 | African_admix | TCGA.OL.A6VO.01A.12R.A33J.07 | TCGA-OL-A6VO-01 |
| TCGA-A2-A3Y0 | 57 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | positive | negative | negative | NA | NA | alive | 2.35 | African | TCGA.A2.A3Y0.01A.11R.A239.07 | TCGA-A2-A3Y0-01 |
| TCGA-E9-A1R0 | 58 | female | White | Primary solid Tumor | postmenopausal | IDC | not evaluated | not evaluated | not evaluated | NA | NA | alive | 2.35 | European | TCGA.E9.A1R0.01A.22R.A16F.07 | TCGA-E9-A1R0-01 |
| TCGA-AO-A12H | 69 | female | Black or African American | Primary solid Tumor | premenopausal | mucinous/papillary | positive | positive | negative | NA | NA | alive | 2.36 | African | TCGA.AO.A12H.01A.11R.A115.07 | TCGA-AO-A12H-01 |
| TCGA-E2-A10E | 64 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 2.37 | European | TCGA.E2.A10E.01A.21R.A10J.07 | TCGA-E2-A10E-01 |
| TCGA-E2-A1IJ | 57 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | equivocal | NA | NA | alive | 2.37 | European | TCGA.E2.A1IJ.01A.11R.A144.07 | TCGA-E2-A1IJ-01 |
| TCGA-BH-A0AZ | 47 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 2.37 | European | TCGA.BH.A0AZ.01A.21R.A12P.07 | TCGA-BH-A0AZ-01 |
| TCGA-BH-A0AZ | 47 | female | White | Solid Tissue Normal | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 2.37 | European | TCGA.BH.A0AZ.11A.22R.A12P.07 | TCGA-BH-A0AZ-11 |
| TCGA-E2-A1B6 | 44 | female | White | Primary solid Tumor | premenopausal | IDC | negative | negative | equivocal | NA | NA | alive | 2.37 | European | TCGA.E2.A1B6.01A.31R.A12P.07 | TCGA-E2-A1B6-01 |
| TCGA-BH-A0HY | 60 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | negative | positive | NA | NA | alive | 2.38 | European | TCGA.BH.A0HY.01A.11R.A056.07 | TCGA-BH-A0HY-01 |
| TCGA-E2-A14Y | 35 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 2.38 | European | TCGA.E2.A14Y.01A.21R.A12D.07 | TCGA-E2-A14Y-01 |
| TCGA-A2-A0D3 | 42 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 2.4 | European | TCGA.A2.A0D3.01A.11R.A115.07 | TCGA-A2-A0D3-01 |
| TCGA-EW-A1PG | 53 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | equivocal | NA | NA | alive | 2.4 | European | TCGA.EW.A1PG.01A.11R.A144.07 | TCGA-EW-A1PG-01 |
| TCGA-E2-A10F | 47 | female | White | Primary solid Tumor | premenopausal | ILC | positive | positive | equivocal | NA | NA | alive | 2.4 | European | TCGA.E2.A10F.01A.11R.A10J.07 | TCGA-E2-A10F-01 |
| TCGA-OL-A5RX | 51 | female | Black or African American | Primary solid Tumor | premenopausal | IDC | positive | positive | not evaluated | NA | NA | alive | 2.4 | African | TCGA.OL.A5RX.01A.11R.A28M.07 | TCGA-OL-A5RX-01 |
| TCGA-A8-A08C | 65 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 2.41 | European | TCGA.A8.A08C.01A.11R.A00Z.07 | TCGA-A8-A08C-01 |
| TCGA-WT-AB44 | 77 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 2.42 | European | TCGA.WT.AB44.01A.11R.A41B.07 | TCGA-WT-AB44-01 |
| TCGA-AO-A03V | 41 | female | White | Primary solid Tumor | perimenopausal | IDC | positive | positive | negative | NA | NA | alive | 2.43 | European | TCGA.AO.A03V.01A.11R.A115.07 | TCGA-AO-A03V-01 |
| TCGA-LL-A442 | 56 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 2.43 | African | TCGA.LL.A442.01A.11R.A24H.07 | TCGA-LL-A442-01 |
| TCGA-AC-A4ZE | 63 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | positive | NA | NA | alive | 2.44 | European | TCGA.AC.A4ZE.01A.11R.A41B.07 | TCGA-AC-A4ZE-01 |
| TCGA-E2-A14T | 52 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 2.44 | European | TCGA.E2.A14T.01A.11R.A115.07 | TCGA-E2-A14T-01 |
| TCGA-AR-A2LQ | 59 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 2.45 | European | TCGA.AR.A2LQ.01A.22R.A18M.07 | TCGA-AR-A2LQ-01 |
| TCGA-AR-A0TV | 66 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 2.48 | European | TCGA.AR.A0TV.01A.21R.A084.07 | TCGA-AR-A0TV-01 |
| TCGA-EW-A1OY | 63 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 2.49 | European | TCGA.EW.A1OY.01A.11R.A144.07 | TCGA-EW-A1OY-01 |
| TCGA-EW-A1OX | 43 | female | White | Primary solid Tumor | premenopausal | mucinous carcinoma | positive | positive | negative | NA | NA | alive | 2.49 | African_admix | TCGA.EW.A1OX.01A.11R.A144.07 | TCGA-EW-A1OX-01 |
| TCGA-A8-A09K | 68 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 2.5 | European | TCGA.A8.A09K.01A.11R.A00Z.07 | TCGA-A8-A09K-01 |
| TCGA-BH-A0DI | 63 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 2.5 | European | TCGA.BH.A0DI.01A.21R.A12P.07 | TCGA-BH-A0DI-01 |
| TCGA-E9-A22E | 56 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 2.5 | European | TCGA.E9.A22E.01A.11R.A157.07 | TCGA-E9-A22E-01 |
| TCGA-E9-A3QA | 33 | female | White | Primary solid Tumor | premenopausal | medullary carcinoma | not evaluated | not evaluated | not evaluated | NA | NA | alive | 2.51 | European | TCGA.E9.A3QA.01A.61R.A22K.07 | TCGA-E9-A3QA-01 |
| TCGA-EW-A1P1 | 68 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | equivocal | metastasis | lung | alive | 2.52 | European | TCGA.EW.A1P1.01A.31R.A14D.07 | TCGA-EW-A1P1-01 |
| TCGA-BH-A0GY | 67 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 2.53 | European | TCGA.BH.A0GY.01A.11R.A056.07 | TCGA-BH-A0GY-01 |
| TCGA-E9-A3X8 | 48 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | positive | NA | NA | alive | 2.54 | European | TCGA.E9.A3X8.01A.31R.A22U.07 | TCGA-E9-A3X8-01 |
| TCGA-A7-A0CJ | 57 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 2.55 | European | TCGA.A7.A0CJ.01A.21R.A00Z.07 | TCGA-A7-A0CJ-01 |
| TCGA-E2-A570 | 47 | female | Black or African American | Primary solid Tumor | premenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 2.55 | African | TCGA.E2.A570.01A.11R.A29R.07 | TCGA-E2-A570-01 |
| TCGA-A2-A1FX | 61 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | not evaluated | NA | NA | alive | 2.56 | European | TCGA.A2.A1FX.01A.11R.A13Q.07 | TCGA-A2-A1FX-01 |
| TCGA-AR-A2LO | 46 | female | White | Primary solid Tumor | premenopausal | ILC | positive | positive | equivocal | NA | NA | alive | 2.56 | European | TCGA.AR.A2LO.01A.31R.A18M.07 | TCGA-AR-A2LO-01 |
| TCGA-EW-A1OZ | 56 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | positive | negative | equivocal | NA | NA | alive | 2.58 | African | TCGA.EW.A1OZ.01A.11R.A144.07 | TCGA-EW-A1OZ-01 |
| TCGA-A8-A092 | 48 | female | not available | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 2.58 | European | TCGA.A8.A092.01A.11R.A00Z.07 | TCGA-A8-A092-01 |
| TCGA-A8-A08O | 45 | female | not available | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | not available | not available | alive | 2.58 | European | TCGA.A8.A08O.01A.21R.A056.07 | TCGA-A8-A08O-01 |
| TCGA-A8-A08P | 70 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 2.58 | European | TCGA.A8.A08P.01A.11R.A00Z.07 | TCGA-A8-A08P-01 |
| TCGA-A8-A09E | 73 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 2.58 | European | TCGA.A8.A09E.01A.11R.A00Z.07 | TCGA-A8-A09E-01 |
| TCGA-BH-A0EE | 68 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | positive | NA | NA | alive | 2.58 | European | TCGA.BH.A0EE.01A.11R.A034.07 | TCGA-BH-A0EE-01 |
| TCGA-OL-A66L | 71 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | positive | positive | not evaluated | NA | NA | alive | 2.59 | African | TCGA.OL.A66L.01A.12R.A31O.07 | TCGA-OL-A66L-01 |
| TCGA-BH-A0DE | 62 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 2.6 | European | TCGA.BH.A0DE.01A.11R.A115.07 | TCGA-BH-A0DE-01 |
| TCGA-EW-A6SC | 60 | female | Black or African American | Primary solid Tumor | not available | ILC | positive | positive | negative | NA | NA | alive | 2.61 | African | TCGA.EW.A6SC.01A.12R.A32P.07 | TCGA-EW-A6SC-01 |
| TCGA-A7-A26E | 71 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 2.61 | European | TCGA.A7.A26E.01A.11R.A169.07 | TCGA-A7-A26E-01 |
| TCGA-E2-A1IF | 74 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 2.62 | European | TCGA.E2.A1IF.01A.11R.A144.07 | TCGA-E2-A1IF-01 |
| TCGA-A2-A0YM | 67 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | not evaluated | NA | NA | alive | 2.64 | European | TCGA.A2.A0YM.01A.11R.A109.07 | TCGA-A2-A0YM-01 |
| TCGA-A7-A13D | 46 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | negative | positive | equivocal | NA | NA | alive | 2.64 | African | TCGA.A7.A13D.01A.13R.A12P.07 | TCGA-A7-A13D-01 |
| TCGA-A2-A0EV | 80 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 2.65 | European | TCGA.A2.A0EV.01A.11R.A034.07 | TCGA-A2-A0EV-01 |
| TCGA-E2-A14X | 55 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 2.66 | African_admix | TCGA.E2.A14X.01A.11R.A115.07 | TCGA-E2-A14X-01 |
| TCGA-E2-A1LB | 41 | female | Black or African American | Primary solid Tumor | premenopausal | IDC | negative | negative | positive | NA | NA | alive | 2.66 | African | TCGA.E2.A1LB.01A.11R.A144.07 | TCGA-E2-A1LB-01 |
| TCGA-E2-A1LB | 41 | female | Black or African American | Solid Tissue Normal | premenopausal | IDC | negative | negative | positive | NA | NA | alive | 2.66 | African | TCGA.E2.A1LB.11A.22R.A144.07 | TCGA-E2-A1LB-11 |
| TCGA-A2-A3XZ | 46 | female | Black or African American | Primary solid Tumor | premenopausal | IDC | negative | negative | positive | NA | NA | alive | 2.66 | African | TCGA.A2.A3XZ.01A.42R.A239.07 | TCGA-A2-A3XZ-01 |
| TCGA-OL-A5D8 | 40 | female | Black or African American | Primary solid Tumor | premenopausal | IDC | positive | positive | not evaluated | NA | NA | alive | 2.66 | African | TCGA.OL.A5D8.01A.11R.A27Q.07 | TCGA-OL-A5D8-01 |
| TCGA-BH-A0BC | 60 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 2.67 | European | TCGA.BH.A0BC.01A.22R.A084.07 | TCGA-BH-A0BC-01 |
| TCGA-BH-A0BC | 60 | female | White | Solid Tissue Normal | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 2.67 | European | TCGA.BH.A0BC.11A.22R.A089.07 | TCGA-BH-A0BC-11 |
| TCGA-E2-A14Q | 50 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 2.67 | European | TCGA.E2.A14Q.01A.11R.A12D.07 | TCGA-E2-A14Q-01 |
| TCGA-E2-A14W | 78 | male | White | Primary solid Tumor | not applicable | IDC | positive | positive | not evaluated | NA | NA | alive | 2.67 | European | TCGA.E2.A14W.01A.11R.A12D.07 | TCGA-E2-A14W-01 |
| TCGA-A8-A07L | 58 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 2.67 | European | TCGA.A8.A07L.01A.11R.A00Z.07 | TCGA-A8-A07L-01 |
| TCGA-E9-A1RA | 48 | female | White | Primary solid Tumor | premenopausal | IDC | not evaluated | not evaluated | not evaluated | NA | NA | alive | 2.67 | European | TCGA.E9.A1RA.01A.11R.A14D.07 | TCGA-E9-A1RA-01 |
| TCGA-GM-A3XG | 46 | female | White | Primary solid Tumor | premenopausal | ILC | positive | positive | negative | NA | NA | alive | 2.69 | European | TCGA.GM.A3XG.01A.31R.A24H.07 | TCGA-GM-A3XG-01 |
| TCGA-E2-A1IE | 61 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | equivocal | metastasis | liver | alive | 2.69 | European | TCGA.E2.A1IE.01A.11R.A13Q.07 | TCGA-E2-A1IE-01 |
| TCGA-E2-A1B5 | 46 | female | White | Primary solid Tumor | premenopausal | ILC | positive | positive | negative | NA | NA | alive | 2.69 | European | TCGA.E2.A1B5.01A.21R.A12P.07 | TCGA-E2-A1B5-01 |
| TCGA-AC-A3BB | 46 | female | Black or African American | Primary solid Tumor | not available | ILC | positive | positive | negative | NA | NA | alive | 2.7 | African | TCGA.AC.A3BB.01A.21R.A19W.07 | TCGA-AC-A3BB-01 |
| TCGA-EW-A1P3 | 48 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 2.7 | European | TCGA.EW.A1P3.01A.11R.A144.07 | TCGA-EW-A1P3-01 |
| TCGA-AQ-A1H3 | 49 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 2.71 | European | TCGA.AQ.A1H3.01A.31R.A13Q.07 | TCGA-AQ-A1H3-01 |
| TCGA-A2-A0YC | 59 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | not evaluated | metastasis | bone | alive | 2.71 | European | TCGA.A2.A0YC.01A.11R.A109.07 | TCGA-A2-A0YC-01 |
| TCGA-AR-A24W | 55 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 2.71 | European | TCGA.AR.A24W.01A.11R.A169.07 | TCGA-AR-A24W-01 |
| TCGA-A2-A3XV | 46 | female | Black or African American | Primary solid Tumor | premenopausal | IDC | positive | negative | equivocal | NA | NA | alive | 2.73 | African_admix | TCGA.A2.A3XV.01A.21R.A239.07 | TCGA-A2-A3XV-01 |
| TCGA-LL-A441 | 62 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 2.73 | African | TCGA.LL.A441.01A.11R.A24H.07 | TCGA-LL-A441-01 |
| TCGA-AO-A0J2 | 41 | female | White | Primary solid Tumor | premenopausal | IDC | negative | negative | equivocal | NA | NA | alive | 2.73 | European | TCGA.AO.A0J2.01A.11R.A034.07 | TCGA-AO-A0J2-01 |
| TCGA-AR-A2LN | 65 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 2.73 | European | TCGA.AR.A2LN.01A.21R.A18M.07 | TCGA-AR-A2LN-01 |
| TCGA-E2-A1IG | 45 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 2.73 | European | TCGA.E2.A1IG.01A.11R.A144.07 | TCGA-E2-A1IG-01 |
| TCGA-E2-A1IG | 45 | female | White | Solid Tissue Normal | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 2.73 | European | TCGA.E2.A1IG.11A.22R.A144.07 | TCGA-E2-A1IG-11 |
| TCGA-EW-A6SD | 32 | female | Black or African American | Primary solid Tumor | not available | IDC | negative | negative | not evaluated | NA | NA | alive | 2.77 | African | TCGA.EW.A6SD.01A.12R.A33J.07 | TCGA-EW-A6SD-01 |
| TCGA-BH-A0HQ | 56 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 3.07 | European | TCGA.BH.A0HQ.01A.11R.A034.07 | TCGA-BH-A0HQ-01 |
| TCGA-A8-A085 | 44 | male | not available | Primary solid Tumor | not applicable | IDC | positive | positive | negative | NA | NA | alive | 3.08 | European | TCGA.A8.A085.01A.11R.A00Z.07 | TCGA-A8-A085-01 |
| TCGA-BH-A0BA | 51 | female | White | Primary solid Tumor | premenopausal | IDC/ILC | positive | positive | negative | NA | NA | alive | 3.1 | European | TCGA.BH.A0BA.01A.11R.A056.07 | TCGA-BH-A0BA-01 |
| TCGA-BH-A0BA | 51 | female | White | Solid Tissue Normal | premenopausal | IDC/ILC | positive | positive | negative | NA | NA | alive | 3.1 | European | TCGA.BH.A0BA.11A.22R.A19E.07 | TCGA-BH-A0BA-11 |
| TCGA-BH-A0B1 | 66 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 3.14 | European | TCGA.BH.A0B1.01A.12R.A056.07 | TCGA-BH-A0B1-01 |
| TCGA-AR-A1AS | 54 | female | Asian | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 3.15 | South Asian | TCGA.AR.A1AS.01A.11R.A12P.07 | TCGA-AR-A1AS-01 |
| TCGA-BH-A0DH | 63 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 3.16 | European | TCGA.BH.A0DH.01A.11R.A084.07 | TCGA-BH-A0DH-01 |
| TCGA-BH-A0DH | 63 | female | White | Solid Tissue Normal | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 3.16 | European | TCGA.BH.A0DH.11A.31R.A089.07 | TCGA-BH-A0DH-11 |
| TCGA-A8-A0AD | 83 | female | not available | Primary solid Tumor | postmenopausal | IDC/ILC | positive | positive | negative | NA | NA | alive | 3.17 | European | TCGA.A8.A0AD.01A.11R.A056.07 | TCGA-A8-A0AD-01 |
| TCGA-BH-A0B4 | 65 | male | White | Primary solid Tumor | not applicable | IDC | positive | positive | equivocal | NA | NA | alive | 3.26 | European | TCGA.BH.A0B4.01A.11R.A00Z.07 | TCGA-BH-A0B4-01 |
| TCGA-A1-A0SN | 50 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 3.27 | European | TCGA.A1.A0SN.01A.11R.A144.07 | TCGA-A1-A0SN-01 |
| TCGA-BH-A0B3 | 53 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 3.29 | European | TCGA.BH.A0B3.01A.11R.A056.07 | TCGA-BH-A0B3-01 |
| TCGA-BH-A0B3 | 53 | female | White | Solid Tissue Normal | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 3.29 | European | TCGA.BH.A0B3.11B.21R.A089.07 | TCGA-BH-A0B3-11 |
| TCGA-EW-A1IX | 48 | female | Asian | Primary solid Tumor | perimenopausal | invasive tubulolobular carcinoma | positive | positive | negative | NA | NA | alive | 3.31 | East Asian | TCGA.EW.A1IX.01A.12R.A144.07 | TCGA-EW-A1IX-01 |
| TCGA-A8-A08Z | 76 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 3.33 | European | TCGA.A8.A08Z.01A.21R.A00Z.07 | TCGA-A8-A08Z-01 |
| TCGA-E9-A1RC | 56 | female | White | Primary solid Tumor | postmenopausal | IDC/ILC | not evaluated | not evaluated | not evaluated | NA | NA | alive | 3.35 | European | TCGA.E9.A1RC.01A.11R.A157.07 | TCGA-E9-A1RC-01 |
| TCGA-E9-A1RC | 56 | female | White | Solid Tissue Normal | postmenopausal | IDC/ILC | not evaluated | not evaluated | not evaluated | NA | NA | alive | 3.35 | European | TCGA.E9.A1RC.11A.33R.A157.07 | TCGA-E9-A1RC-11 |
| TCGA-BH-A0H9 | 69 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 3.41 | European | TCGA.BH.A0H9.01A.11R.A056.07 | TCGA-BH-A0H9-01 |
| TCGA-BH-A0H9 | 69 | female | White | Solid Tissue Normal | postmenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 3.41 | European | TCGA.BH.A0H9.11A.22R.A466.07 | TCGA-BH-A0H9-11 |
| TCGA-EW-A1P0 | 55 | female | White | Primary solid Tumor | postmenopausal | IDC/mucinous | positive | negative | negative | metastasis | mediastinal lymph node | alive | 3.43 | European | TCGA.EW.A1P0.01A.11R.A144.07 | TCGA-EW-A1P0-01 |
| TCGA-BH-A0C0 | 62 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 3.48 | European | TCGA.BH.A0C0.01A.21R.A056.07 | TCGA-BH-A0C0-01 |
| TCGA-BH-A0C0 | 62 | female | White | Solid Tissue Normal | postmenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 3.48 | European | TCGA.BH.A0C0.11A.21R.A089.07 | TCGA-BH-A0C0-11 |
| TCGA-A8-A095 | 45 | female | not available | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 3.5 | European | TCGA.A8.A095.01A.11R.A00Z.07 | TCGA-A8-A095-01 |
| TCGA-A8-A07B | 69 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 3.58 | European | TCGA.A8.A07B.01A.11R.A00Z.07 | TCGA-A8-A07B-01 |
| TCGA-A8-A08X | 43 | female | not available | Primary solid Tumor | premenopausal | IDC | negative | negative | positive | not available | not available | alive | 3.58 | European | TCGA.A8.A08X.01A.21R.A00Z.07 | TCGA-A8-A08X-01 |
| TCGA-E2-A105 | 79 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 3.58 | European | TCGA.E2.A105.01A.11R.A10J.07 | TCGA-E2-A105-01 |
| TCGA-E2-A1LL | 73 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | metastasis | liver | alive | 3.58 | African_admix | TCGA.E2.A1LL.01A.11R.A144.07 | TCGA-E2-A1LL-01 |
| TCGA-A1-A0SE | 56 | female | White | Primary solid Tumor | premenopausal | IDC/ILC | positive | positive | negative | NA | NA | alive | 3.62 | European | TCGA.A1.A0SE.01A.11R.A084.07 | TCGA-A1-A0SE-01 |
| TCGA-B6-A1KC | 67 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | negative | negative | NA | NA | alive | 3.63 | European | TCGA.B6.A1KC.01B.11R.A157.07 | TCGA-B6-A1KC-01 |
| TCGA-A2-A0SY | 62 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | not evaluated | NA | NA | alive | 3.69 | European | TCGA.A2.A0SY.01A.31R.A084.07 | TCGA-A2-A0SY-01 |
| TCGA-E2-A14O | 76 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 3.72 | European | TCGA.E2.A14O.01A.31R.A115.07 | TCGA-E2-A14O-01 |
| TCGA-BH-A0E7 | 79 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 3.73 | European | TCGA.BH.A0E7.01A.11R.A034.07 | TCGA-BH-A0E7-01 |
| TCGA-A8-A09I | 84 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 3.75 | European | TCGA.A8.A09I.01A.22R.A034.07 | TCGA-A8-A09I-01 |
| TCGA-E2-A109 | 64 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | negative | equivocal | NA | NA | alive | 3.88 | European | TCGA.E2.A109.01A.11R.A10J.07 | TCGA-E2-A109-01 |
| TCGA-E2-A14N | 37 | female | White | Primary solid Tumor | premenopausal | IDC | negative | negative | negative | NA | NA | alive | 3.93 | European | TCGA.E2.A14N.01A.31R.A137.07 | TCGA-E2-A14N-01 |
| TCGA-A1-A0SH | 39 | female | White | Primary solid Tumor | premenopausal | IDC | negative | positive | equivocal | NA | NA | alive | 3.93 | European | TCGA.A1.A0SH.01A.11R.A084.07 | TCGA-A1-A0SH-01 |
| TCGA-3C-AALK | 52 | female | Black or African American | Primary solid Tumor | unknown | IDC | positive | positive | positive | NA | NA | alive | 3.96 | African | TCGA.3C.AALK.01A.11R.A41B.07 | TCGA-3C-AALK-01 |
| TCGA-A1-A0SF | 54 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 4.01 | European | TCGA.A1.A0SF.01A.11R.A144.07 | TCGA-A1-A0SF-01 |
| TCGA-5L-AAT1 | 63 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | equivocal | metastasis | bone | alive | 4.03 | European | TCGA.5L.AAT1.01A.12R.A41B.07 | TCGA-5L-AAT1-01 |
| TCGA-3C-AALJ | 62 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | positive | positive | Indeterminate | NA | NA | alive | 4.04 | African_admix | TCGA.3C.AALJ.01A.31R.A41B.07 | TCGA-3C-AALJ-01 |
| TCGA-C8-A12Y | 44 | female | Asian | Primary solid Tumor | premenopausal | IDC | not evaluated | not evaluated | not evaluated | NA | NA | alive | 4.04 | East Asian | TCGA.C8.A12Y.01A.11R.A12D.07 | TCGA-C8-A12Y-01 |
| TCGA-BH-A0BV | 78 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 4.16 | European | TCGA.BH.A0BV.01A.11R.A00Z.07 | TCGA-BH-A0BV-01 |
| TCGA-BH-A0BV | 78 | female | White | Solid Tissue Normal | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 4.16 | European | TCGA.BH.A0BV.11A.31R.A089.07 | TCGA-BH-A0BV-11 |
| TCGA-AO-A0JI | 56 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | negative | negative | NA | NA | alive | 4.18 | European | TCGA.AO.A0JI.01A.21R.A056.07 | TCGA-AO-A0JI-01 |
| TCGA-A2-A0SX | 48 | female | White | Primary solid Tumor | premenopausal | IDC | negative | negative | negative | NA | NA | alive | 4.2 | European | TCGA.A2.A0SX.01A.12R.A084.07 | TCGA-A2-A0SX-01 |
| TCGA-AO-A0JB | 50 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 4.22 | European | TCGA.AO.A0JB.01A.11R.A32Y.07 | TCGA-AO-A0JB-01 |
| TCGA-AO-A0JC | 64 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 4.24 | European | TCGA.AO.A0JC.01A.11R.A056.07 | TCGA-AO-A0JC-01 |
| TCGA-AR-A24K | 46 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 4.24 | European | TCGA.AR.A24K.01A.11R.A169.07 | TCGA-AR-A24K-01 |
| TCGA-BH-A0HW | 62 | female | Asian | Primary solid Tumor | postmenopausal | IDC | positive | negative | equivocal | NA | NA | alive | 4.27 | East Asian | TCGA.BH.A0HW.01A.11R.A034.07 | TCGA-BH-A0HW-01 |
| TCGA-BH-A0B8 | 64 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 4.3 | European | TCGA.BH.A0B8.01A.21R.A056.07 | TCGA-BH-A0B8-01 |
| TCGA-BH-A0B8 | 64 | female | White | Solid Tissue Normal | postmenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 4.3 | European | TCGA.BH.A0B8.11A.41R.A089.07 | TCGA-BH-A0B8-11 |
| TCGA-BH-A0B9 | 44 | female | White | Primary solid Tumor | premenopausal | IDC | negative | negative | negative | NA | NA | alive | 4.3 | European | TCGA.BH.A0B9.01A.11R.A056.07 | TCGA-BH-A0B9-01 |
| TCGA-A2-A259 | 70 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 4.37 | African_admix | TCGA.A2.A259.01A.11R.A16F.07 | TCGA-A2-A259-01 |
| TCGA-EW-A2FS | 41 | female | Black or African American | Primary solid Tumor | premenopausal | IDC | positive | negative | negative | NA | NA | alive | 4.39 | African | TCGA.EW.A2FS.01A.11R.A17B.07 | TCGA-EW-A2FS-01 |
| TCGA-WT-AB41 | 55 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | positive | positive | not evaluated | NA | NA | alive | 4.41 | African | TCGA.WT.AB41.01A.11R.A41B.07 | TCGA-WT-AB41-01 |
| TCGA-AO-A0J9 | 61 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | not evaluated | metastasis | bone | alive | 4.42 | European | TCGA.AO.A0J9.01A.11R.A034.07 | TCGA-AO-A0J9-01 |
| TCGA-A8-A06T | 75 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 4.42 | European | TCGA.A8.A06T.01A.11R.A00Z.07 | TCGA-A8-A06T-01 |
| TCGA-A2-A0CZ | 46 | female | White | Primary solid Tumor | perimenopausal | IDC | positive | positive | negative | NA | NA | alive | 4.42 | European | TCGA.A2.A0CZ.01A.11R.A034.07 | TCGA-A2-A0CZ-01 |
| TCGA-BH-A0H5 | 45 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | not available | NA | NA | alive | 4.44 | European | TCGA.BH.A0H5.01A.21R.A115.07 | TCGA-BH-A0H5-01 |
| TCGA-BH-A0H5 | 45 | female | White | Solid Tissue Normal | postmenopausal | IDC | positive | positive | not available | NA | NA | alive | 4.44 | European | TCGA.BH.A0H5.11A.62R.A115.07 | TCGA-BH-A0H5-11 |
| TCGA-E2-A1B0 | 50 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | positive | NA | NA | alive | 4.47 | European | TCGA.E2.A1B0.01A.11R.A12P.07 | TCGA-E2-A1B0-01 |
| TCGA-AO-A12G | 75 | female | White | Primary solid Tumor | postmenopausal | pleomorphic ILC | positive | positive | positive | NA | NA | alive | 4.49 | European | TCGA.AO.A12G.01A.11R.A10J.07 | TCGA-AO-A12G-01 |
| TCGA-A8-A076 | 66 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 4.5 | European | TCGA.A8.A076.01A.21R.A00Z.07 | TCGA-A8-A076-01 |
| TCGA-E2-A1L6 | 44 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 4.51 | European | TCGA.E2.A1L6.01A.11R.A13Q.07 | TCGA-E2-A1L6-01 |
| TCGA-A2-A0SU | 66 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 4.55 | European | TCGA.A2.A0SU.01A.11R.A084.07 | TCGA-A2-A0SU-01 |
| TCGA-A2-A0CY | 63 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 4.58 | European | TCGA.A2.A0CY.01A.12R.A034.07 | TCGA-A2-A0CY-01 |
| TCGA-EW-A2FR | 59 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | negative | negative | equivocal | NA | NA | alive | 4.58 | South Asian | TCGA.EW.A2FR.01A.11R.A21T.07 | TCGA-EW-A2FR-01 |
| TCGA-AO-A0JL | 59 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 4.61 | European | TCGA.AO.A0JL.01A.11R.A056.07 | TCGA-AO-A0JL-01 |
| TCGA-A2-A04X | 34 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | positive | NA | NA | alive | 4.62 | European | TCGA.A2.A04X.01A.21R.A034.07 | TCGA-A2-A04X-01 |
| TCGA-A2-A3XW | 42 | female | Black or African American | Primary solid Tumor | premenopausal | IDC | positive | negative | negative | NA | NA | alive | 4.69 | African_admix | TCGA.A2.A3XW.01A.11R.A239.07 | TCGA-A2-A3XW-01 |
| TCGA-A2-A0CX | 52 | female | White | Primary solid Tumor | premenopausal | IDC | positive | negative | positive | NA | NA | alive | 4.73 | European | TCGA.A2.A0CX.01A.21R.A00Z.07 | TCGA-A2-A0CX-01 |
| TCGA-OL-A5D7 | 70 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | negative | negative | not evaluated | NA | NA | alive | 4.87 | African_admix | TCGA.OL.A5D7.01A.11R.A27Q.07 | TCGA-OL-A5D7-01 |
| TCGA-OL-A5DA | 61 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | not evaluated | NA | NA | alive | 4.88 | European | TCGA.OL.A5DA.01A.11R.A27Q.07 | TCGA-OL-A5DA-01 |
| TCGA-BH-A0AV | 52 | female | Black or African American | Primary solid Tumor | not available | IDC | negative | negative | not available | NA | NA | alive | 4.98 | African_admix | TCGA.BH.A0AV.01A.31R.A115.07 | TCGA-BH-A0AV-01 |
| TCGA-AO-A12F | 36 | female | White | Primary solid Tumor | premenopausal | IDC | negative | negative | negative | NA | NA | alive | 5.04 | European | TCGA.AO.A12F.01A.11R.A115.07 | TCGA-AO-A12F-01 |
| TCGA-AC-A2FG | 79 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | negative | not evaluated | NA | NA | alive | 5.07 | European | TCGA.AC.A2FG.01A.11R.A17B.07 | TCGA-AC-A2FG-01 |
| TCGA-AR-A1AV | 68 | male | White | Primary solid Tumor | not applicable | IDC | positive | positive | negative | NA | NA | alive | 5.1 | European | TCGA.AR.A1AV.01A.21R.A12P.07 | TCGA-AR-A1AV-01 |
| TCGA-AO-A03M | 29 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 5.11 | European | TCGA.AO.A03M.01B.11R.A10J.07 | TCGA-AO-A03M-01 |
| TCGA-BH-A0BM | 54 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | negative | negative | NA | NA | alive | 5.14 | European | TCGA.BH.A0BM.01A.11R.A056.07 | TCGA-BH-A0BM-01 |
| TCGA-BH-A0BM | 54 | female | White | Solid Tissue Normal | postmenopausal | IDC | positive | negative | negative | NA | NA | alive | 5.14 | European | TCGA.BH.A0BM.11A.12R.A089.07 | TCGA-BH-A0BM-11 |
| TCGA-AO-A1KQ | 84 | male | White | Primary solid Tumor | not applicable | IDC | positive | positive | negative | NA | NA | alive | 5.15 | European | TCGA.AO.A1KQ.01A.11R.A13Q.07 | TCGA-AO-A1KQ-01 |
| TCGA-AO-A0JJ | 54 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 5.17 | European | TCGA.AO.A0JJ.01A.11R.A056.07 | TCGA-AO-A0JJ-01 |
| TCGA-BH-A0H3 | 46 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | not available | NA | NA | alive | 5.28 | European | TCGA.BH.A0H3.01A.11R.A12P.07 | TCGA-BH-A0H3-01 |
| TCGA-AR-A2LM | 49 | female | White | Primary solid Tumor | premenopausal | ILC | positive | positive | not evaluated | NA | NA | alive | 5.3 | European | TCGA.AR.A2LM.01A.11R.A180.07 | TCGA-AR-A2LM-01 |
| TCGA-PE-A5DD | 64 | female | Asian | Primary solid Tumor | postmenopausal | ILC | positive | negative | positive | NA | NA | alive | 5.35 | East Asian_admix | TCGA.PE.A5DD.01A.12R.A27Q.07 | TCGA-PE-A5DD-01 |
| TCGA-AR-A0TX | 64 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 5.4 | European | TCGA.AR.A0TX.01A.11R.A084.07 | TCGA-AR-A0TX-01 |
| TCGA-OL-A66J | 80 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | not evaluated | NA | NA | alive | 5.46 | European | TCGA.OL.A66J.01A.11R.A29R.07 | TCGA-OL-A66J-01 |
| TCGA-GM-A3XN | 44 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 5.53 | European | TCGA.GM.A3XN.01A.12R.A22U.07 | TCGA-GM-A3XN-01 |
| TCGA-AO-A03N | 59 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | locoregional disease | NA | alive | 5.56 | European | TCGA.AO.A03N.01B.11R.A10J.07 | TCGA-AO-A03N-01 |
| TCGA-V7-A7HQ | 75 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | positive | positive | not evaluated | NA | NA | alive | 5.57 | African_admix | TCGA.V7.A7HQ.01A.11R.A33J.07 | TCGA-V7-A7HQ-01 |
| TCGA-BH-A0DV | 54 | female | White | Primary solid Tumor | perimenopausal | IDC | positive | positive | negative | NA | NA | alive | 5.65 | European | TCGA.BH.A0DV.01A.21R.A12P.07 | TCGA-BH-A0DV-01 |
| TCGA-BH-A0DV | 54 | female | White | Solid Tissue Normal | perimenopausal | IDC | positive | positive | negative | NA | NA | alive | 5.65 | European | TCGA.BH.A0DV.11A.22R.A12P.07 | TCGA-BH-A0DV-11 |
| TCGA-B6-A408 | 55 | female | Black or African American | Primary solid Tumor | unknown | IDC/ILC | positive | positive | equivocal | NA | NA | alive | 5.67 | African | TCGA.B6.A408.01A.12R.A24H.07 | TCGA-B6-A408-01 |
| TCGA-B6-A0RG | 26 | female | White | Primary solid Tumor | indeterminate | IDC | negative | negative | not evaluated | NA | NA | alive | 5.7 | European | TCGA.B6.A0RG.01A.11R.A056.07 | TCGA-B6-A0RG-01 |
| TCGA-AO-A03R | 57 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 5.72 | European | TCGA.AO.A03R.01A.21R.A034.07 | TCGA-AO-A03R-01 |
| TCGA-GM-A3XL | 49 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | negative | negative | not evaluated | NA | NA | alive | 5.77 | African | TCGA.GM.A3XL.01A.11R.A22U.07 | TCGA-GM-A3XL-01 |
| TCGA-AO-A03T | 42 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 5.82 | European | TCGA.AO.A03T.01A.21R.A034.07 | TCGA-AO-A03T-01 |
| TCGA-BH-A0B5 | 40 | female | White | Primary solid Tumor | premenopausal | ILC | positive | positive | negative | NA | NA | alive | 5.85 | European | TCGA.BH.A0B5.01A.11R.A12P.07 | TCGA-BH-A0B5-01 |
| TCGA-BH-A0B5 | 40 | female | White | Solid Tissue Normal | premenopausal | ILC | positive | positive | negative | NA | NA | alive | 5.85 | European | TCGA.BH.A0B5.11A.23R.A12P.07 | TCGA-BH-A0B5-11 |
| TCGA-AO-A12E | 51 | female | White | Primary solid Tumor | premenopausal | ILC | positive | positive | negative | NA | NA | alive | 5.86 | European | TCGA.AO.A12E.01A.11R.A10J.07 | TCGA-AO-A12E-01 |
| TCGA-GM-A2DF | 53 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 5.9 | African | TCGA.GM.A2DF.01A.11R.A180.07 | TCGA-GM-A2DF-01 |
| TCGA-BH-A0DX | 62 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 5.9 | European | TCGA.BH.A0DX.01A.11R.A115.07 | TCGA-BH-A0DX-01 |
| TCGA-AR-A255 | 62 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 5.92 | European | TCGA.AR.A255.01A.11R.A169.07 | TCGA-AR-A255-01 |
| TCGA-B6-A40C | 51 | female | White | Primary solid Tumor | unknown | ILC | positive | positive | negative | NA | NA | alive | 5.92 | European | TCGA.B6.A40C.01A.11R.A239.07 | TCGA-B6-A40C-01 |
| TCGA-A2-A0ES | 52 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 6.0 | European | TCGA.A2.A0ES.01A.11R.A115.07 | TCGA-A2-A0ES-01 |
| TCGA-AO-A0JD | 59 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 6.0 | European | TCGA.AO.A0JD.01A.11R.A056.07 | TCGA-AO-A0JD-01 |
| TCGA-GM-A4E0 | 67 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | not evaluated | NA | NA | alive | 6.0 | European | TCGA.GM.A4E0.01A.12R.A266.07 | TCGA-GM-A4E0-01 |
| TCGA-GM-A2DH | 58 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 6.0 | European | TCGA.GM.A2DH.01A.11R.A180.07 | TCGA-GM-A2DH-01 |
| TCGA-BH-A0BO | 54 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 6.02 | European | TCGA.BH.A0BO.01A.23R.A12D.07 | TCGA-BH-A0BO-01 |
| TCGA-AC-A2BK | 78 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 6.08 | African | TCGA.AC.A2BK.01A.11R.A21T.07 | TCGA-AC-A2BK-01 |
| TCGA-B6-A1KI | 63 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 6.12 | European | TCGA.B6.A1KI.01A.11R.A14M.07 | TCGA-B6-A1KI-01 |
| TCGA-E2-A1L8 | 52 | female | Black or African American | Primary solid Tumor | postmenopausal | ILC | positive | positive | equivocal | NA | NA | alive | 6.13 | African | TCGA.E2.A1L8.01A.11R.A13Q.07 | TCGA-E2-A1L8-01 |
| TCGA-A2-A04T | 62 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | equivocal | NA | NA | alive | 6.15 | European | TCGA.A2.A04T.01A.21R.A034.07 | TCGA-A2-A04T-01 |
| TCGA-AC-A2FO | 65 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | negative | negative | NA | NA | alive | 6.17 | European | TCGA.AC.A2FO.01A.11R.A180.07 | TCGA-AC-A2FO-01 |
| TCGA-BH-A0BZ | 59 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 6.17 | European | TCGA.BH.A0BZ.01A.31R.A12P.07 | TCGA-BH-A0BZ-01 |
| TCGA-BH-A0BZ | 59 | female | White | Solid Tissue Normal | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 6.17 | European | TCGA.BH.A0BZ.11A.61R.A12P.07 | TCGA-BH-A0BZ-11 |
| TCGA-A2-A0ER | 63 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 6.2 | European | TCGA.A2.A0ER.01A.21R.A034.07 | TCGA-A2-A0ER-01 |
| TCGA-BH-A0BL | 35 | female | White | Primary solid Tumor | premenopausal | IDC | negative | negative | negative | NA | NA | alive | 6.24 | European | TCGA.BH.A0BL.01A.11R.A115.07 | TCGA-BH-A0BL-01 |
| TCGA-B6-A402 | 47 | female | Black or African American | Primary solid Tumor | unknown | IDC | negative | negative | negative | locoregional recurrence | breast>lymph node | alive | 6.25 | African | TCGA.B6.A402.01A.11R.A239.07 | TCGA-B6-A402-01 |
| TCGA-GM-A2DD | 53 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | equivocal | NA | NA | alive | 6.25 | European | TCGA.GM.A2DD.01A.11R.A180.07 | TCGA-GM-A2DD-01 |
| TCGA-A2-A0CT | 71 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | negative | equivocal | NA | NA | alive | 6.27 | European | TCGA.A2.A0CT.01A.31R.A056.07 | TCGA-A2-A0CT-01 |
| TCGA-E2-A1AZ | 63 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | Indeterminate | NA | NA | alive | 6.38 | American | TCGA.E2.A1AZ.01A.11R.A12P.07 | TCGA-E2-A1AZ-01 |
| TCGA-BH-A0BR | 59 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 6.38 | European | TCGA.BH.A0BR.01A.21R.A115.07 | TCGA-BH-A0BR-01 |
| TCGA-AO-A0JE | 53 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | negative | negative | positive | NA | NA | alive | 6.39 | African | TCGA.AO.A0JE.01A.11R.A056.07 | TCGA-AO-A0JE-01 |
| TCGA-BH-A0BT | 56 | female | White | Primary solid Tumor | not available | IDC | positive | positive | negative | NA | NA | alive | 6.48 | European | TCGA.BH.A0BT.01A.11R.A12P.07 | TCGA-BH-A0BT-01 |
| TCGA-BH-A0BT | 56 | female | White | Solid Tissue Normal | not available | IDC | positive | positive | negative | NA | NA | alive | 6.48 | European | TCGA.BH.A0BT.11A.21R.A12P.07 | TCGA-BH-A0BT-11 |
| TCGA-AO-A12C | 42 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | positive | NA | NA | alive | 6.49 | European | TCGA.AO.A12C.01A.11R.A10J.07 | TCGA-AO-A12C-01 |
| TCGA-BH-A0DL | 64 | female | White | Primary solid Tumor | postmenopausal | IDC with metaplastic carcinoma and focal apocrine features | positive | negative | negative | NA | NA | alive | 6.52 | European | TCGA.BH.A0DL.01A.11R.A115.07 | TCGA-BH-A0DL-01 |
| TCGA-BH-A0DL | 64 | female | White | Solid Tissue Normal | postmenopausal | IDC with metaplastic carcinoma and focal apocrine features | positive | negative | negative | NA | NA | alive | 6.52 | European | TCGA.BH.A0DL.11A.13R.A115.07 | TCGA-BH-A0DL-11 |
| TCGA-AR-A1AJ | 83 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | negative | negative | NA | NA | alive | 6.52 | European | TCGA.AR.A1AJ.01A.21R.A12P.07 | TCGA-AR-A1AJ-01 |
| TCGA-A2-A04Q | 48 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | equivocal | NA | NA | alive | 6.53 | European | TCGA.A2.A04Q.01A.21R.A034.07 | TCGA-A2-A04Q-01 |
| TCGA-BH-A0DT | 41 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 6.58 | European | TCGA.BH.A0DT.01A.21R.A12D.07 | TCGA-BH-A0DT-01 |
| TCGA-BH-A0DT | 41 | female | White | Solid Tissue Normal | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 6.58 | European | TCGA.BH.A0DT.11A.12R.A12D.07 | TCGA-BH-A0DT-11 |
| TCGA-GM-A2DB | 62 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 6.59 | European | TCGA.GM.A2DB.01A.31R.A18M.07 | TCGA-GM-A2DB-01 |
| TCGA-A2-A0EQ | 64 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | negative | negative | positive | NA | NA | alive | 6.64 | African | TCGA.A2.A0EQ.01A.11R.A034.07 | TCGA-A2-A0EQ-01 |
| TCGA-A2-A0EO | 54 | female | White | Primary solid Tumor | perimenopausal | IDC | positive | positive | negative | NA | NA | alive | 6.69 | European | TCGA.A2.A0EO.01A.11R.A034.07 | TCGA-A2-A0EO-01 |
| TCGA-AO-A03L | 34 | female | Asian | Primary solid Tumor | premenopausal | IDC | positive | positive | positive | NA | NA | alive | 6.69 | South Asian_admix | TCGA.AO.A03L.01A.41R.A056.07 | TCGA-AO-A03L-01 |
| TCGA-BH-A0B0 | 56 | female | Black or African American | Primary solid Tumor | perimenopausal | IDC | positive | positive | negative | NA | NA | alive | 6.78 | African_admix | TCGA.BH.A0B0.01A.21R.A115.07 | TCGA-BH-A0B0-01 |
| TCGA-BH-A0B6 | 47 | female | White | Primary solid Tumor | not available | IDC | positive | positive | positive | NA | NA | alive | 6.8 | European | TCGA.BH.A0B6.01A.11R.A19W.07 | TCGA-BH-A0B6-01 |
| TCGA-BH-A0DD | 58 | male | White | Primary solid Tumor | not applicable | IDC | positive | positive | positive | NA | NA | alive | 6.81 | European | TCGA.BH.A0DD.01A.31R.A12P.07 | TCGA-BH-A0DD-01 |
| TCGA-BH-A0DD | 58 | male | White | Solid Tissue Normal | not applicable | IDC | positive | positive | positive | NA | NA | alive | 6.81 | European | TCGA.BH.A0DD.11A.23R.A12P.07 | TCGA-BH-A0DD-11 |
| TCGA-BH-A0E9 | 53 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 6.81 | European | TCGA.BH.A0E9.01B.11R.A115.07 | TCGA-BH-A0E9-01 |
| TCGA-AO-A1KR | 51 | female | White | Primary solid Tumor | premenopausal | IDC | negative | negative | negative | NA | NA | alive | 6.88 | European | TCGA.AO.A1KR.01A.12R.A144.07 | TCGA-AO-A1KR-01 |
| TCGA-AO-A12D | 43 | female | White | Primary solid Tumor | premenopausal | IDC | negative | negative | positive | NA | NA | alive | 6.89 | European | TCGA.AO.A12D.01A.11R.A115.07 | TCGA-AO-A12D-01 |
| TCGA-GM-A2DC | 57 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | not evaluated | NA | NA | alive | 6.94 | European | TCGA.GM.A2DC.01A.11R.A18M.07 | TCGA-GM-A2DC-01 |
| TCGA-E2-A106 | 34 | female | Asian | Primary solid Tumor | premenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 6.96 | East Asian | TCGA.E2.A106.01A.11R.A10J.07 | TCGA-E2-A106-01 |
| TCGA-AR-A0TS | 46 | female | White | Primary solid Tumor | premenopausal | IDC | negative | negative | negative | NA | NA | alive | 7.0 | European | TCGA.AR.A0TS.01A.11R.A115.07 | TCGA-AR-A0TS-01 |
| TCGA-BH-A0B7 | 42 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | positive | NA | NA | alive | 7.01 | European | TCGA.BH.A0B7.01A.12R.A115.07 | TCGA-BH-A0B7-01 |
| TCGA-BH-A0B7 | 42 | female | White | Solid Tissue Normal | premenopausal | IDC | positive | positive | positive | NA | NA | alive | 7.01 | European | TCGA.BH.A0B7.11A.34R.A115.07 | TCGA-BH-A0B7-11 |
| TCGA-GM-A2DI | 52 | female | White | Primary solid Tumor | premenopausal | IDC | negative | negative | not evaluated | NA | NA | alive | 7.09 | European | TCGA.GM.A2DI.01A.31R.A18M.07 | TCGA-GM-A2DI-01 |
| TCGA-B6-A401 | 47 | female | Black or African American | Primary solid Tumor | unknown | IDC | positive | positive | negative | NA | NA | alive | 7.11 | African_admix | TCGA.B6.A401.01A.11R.A239.07 | TCGA-B6-A401-01 |
| TCGA-GM-A2DO | 54 | female | Black or African American | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 7.11 | African | TCGA.GM.A2DO.01A.11R.A18M.07 | TCGA-GM-A2DO-01 |
| TCGA-AR-A254 | 50 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | positive | NA | NA | alive | 7.13 | European | TCGA.AR.A254.01A.21R.A169.07 | TCGA-AR-A254-01 |
| TCGA-BH-A0BS | 55 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | not available | NA | NA | alive | 7.15 | European | TCGA.BH.A0BS.01A.11R.A12P.07 | TCGA-BH-A0BS-01 |
| TCGA-BH-A0BS | 55 | female | White | Solid Tissue Normal | postmenopausal | IDC | positive | positive | not available | NA | NA | alive | 7.15 | European | TCGA.BH.A0BS.11A.11R.A12P.07 | TCGA-BH-A0BS-11 |
| TCGA-AR-A1AO | 47 | female | White | Primary solid Tumor | premenopausal | IDC | positive | negative | negative | NA | NA | alive | 7.17 | European | TCGA.AR.A1AO.01A.11R.A12P.07 | TCGA-AR-A1AO-01 |
| TCGA-AR-A1AX | 64 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 7.2 | European | TCGA.AR.A1AX.01A.11R.A12P.07 | TCGA-AR-A1AX-01 |
| TCGA-AR-A1AW | 65 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 7.21 | European | TCGA.AR.A1AW.01A.21R.A12P.07 | TCGA-AR-A1AW-01 |
| TCGA-AR-A2LJ | 40 | female | White | Primary solid Tumor | premenopausal | ILC | positive | positive | positive | NA | NA | alive | 7.21 | European | TCGA.AR.A2LJ.01A.12R.A19W.07 | TCGA-AR-A2LJ-01 |
| TCGA-GM-A2DK | 58 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | negative | negative | NA | NA | alive | 7.24 | European | TCGA.GM.A2DK.01A.21R.A180.07 | TCGA-GM-A2DK-01 |
| TCGA-PE-A5DE | 41 | female | White | Primary solid Tumor | premenopausal | ILC | positive | positive | negative | NA | NA | alive | 7.24 | European | TCGA.PE.A5DE.01A.11R.A27Q.07 | TCGA-PE-A5DE-01 |
| TCGA-AC-A2FK | 45 | female | White | Primary solid Tumor | not available | ILC | positive | positive | not evaluated | NA | NA | alive | 7.26 | American | TCGA.AC.A2FK.01A.12R.A180.07 | TCGA-AC-A2FK-01 |
| TCGA-E2-A1B1 | 45 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 7.26 | European | TCGA.E2.A1B1.01A.21R.A12P.07 | TCGA-E2-A1B1-01 |
| TCGA-A2-A0CQ | 62 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 7.38 | African_admix | TCGA.A2.A0CQ.01A.21R.A034.07 | TCGA-A2-A0CQ-01 |
| TCGA-AR-A250 | 58 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | negative | equivocal | NA | NA | alive | 7.41 | European | TCGA.AR.A250.01A.31R.A169.07 | TCGA-AR-A250-01 |
| TCGA-BH-A0C3 | 47 | female | White | Primary solid Tumor | premenopausal | with IDC/ILC phenotypes | positive | negative | negative | metastasis | bone | alive | 7.42 | European | TCGA.BH.A0C3.01A.21R.A12P.07 | TCGA-BH-A0C3-01 |
| TCGA-BH-A0C3 | 47 | female | White | Solid Tissue Normal | premenopausal | with IDC/ILC phenotypes | positive | negative | negative | metastasis | bone | alive | 7.42 | European | TCGA.BH.A0C3.11A.23R.A12P.07 | TCGA-BH-A0C3-11 |
| TCGA-B6-A0RT | 39 | female | White | Primary solid Tumor | indeterminate | IDC | negative | negative | not evaluated | NA | NA | alive | 7.45 | European | TCGA.B6.A0RT.01A.21R.A084.07 | TCGA-B6-A0RT-01 |
| TCGA-AC-A2FF | 40 | female | Asian | Primary solid Tumor | not available | ILC | positive | positive | not evaluated | NA | NA | alive | 7.55 | South Asian_admix | TCGA.AC.A2FF.01A.11R.A17B.07 | TCGA-AC-A2FF-01 |
| TCGA-AC-A2FF | 40 | female | Asian | Solid Tissue Normal | not available | ILC | positive | positive | not evaluated | NA | NA | alive | 7.55 | South Asian_admix | TCGA.AC.A2FF.11A.13R.A17B.07 | TCGA-AC-A2FF-11 |
| TCGA-BH-A0C7 | 48 | female | White | Primary solid Tumor | perimenopausal | IDC | positive | negative | not available | NA | NA | alive | 7.58 | European | TCGA.BH.A0C7.01B.11R.A115.07 | TCGA-BH-A0C7-01 |
| TCGA-A2-A3XT | 45 | female | Black or African American | Primary solid Tumor | premenopausal | IDC | negative | negative | negative | NA | NA | alive | 7.58 | African | TCGA.A2.A3XT.01A.11R.A22U.07 | TCGA-A2-A3XT-01 |
| TCGA-A2-A0CP | 60 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | not evaluated | NA | NA | alive | 7.7 | European | TCGA.A2.A0CP.01A.11R.A034.07 | TCGA-A2-A0CP-01 |
| TCGA-AR-A252 | 50 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 7.77 | European | TCGA.AR.A252.01A.11R.A169.07 | TCGA-AR-A252-01 |
| TCGA-AR-A1AP | 80 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 7.82 | European | TCGA.AR.A1AP.01A.11R.A12P.07 | TCGA-AR-A1AP-01 |
| TCGA-AR-A1AU | 39 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 7.85 | European | TCGA.AR.A1AU.01A.11R.A12P.07 | TCGA-AR-A1AU-01 |
| TCGA-AR-A1AN | 46 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 7.99 | European | TCGA.AR.A1AN.01A.11R.A12P.07 | TCGA-AR-A1AN-01 |
| TCGA-AO-A1KP | 77 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 8.08 | European | TCGA.AO.A1KP.01A.11R.A13Q.07 | TCGA-AO-A1KP-01 |
| TCGA-AR-A1AL | 60 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 8.13 | European | TCGA.AR.A1AL.01A.21R.A12P.07 | TCGA-AR-A1AL-01 |
| TCGA-AR-A24S | 61 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 8.15 | European | TCGA.AR.A24S.01A.11R.A169.07 | TCGA-AR-A24S-01 |
| TCGA-AR-A0TQ | 27 | female | White | Primary solid Tumor | premenopausal | IDC | positive | negative | equivocal | NA | NA | alive | 8.19 | European | TCGA.AR.A0TQ.01A.11R.A084.07 | TCGA-AR-A0TQ-01 |
| TCGA-AR-A1AM | 52 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | equivocal | NA | NA | alive | 8.19 | European | TCGA.AR.A1AM.01A.41R.A22K.07 | TCGA-AR-A1AM-01 |
| TCGA-AR-A24Z | 57 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 8.22 | European | TCGA.AR.A24Z.01A.11R.A169.07 | TCGA-AR-A24Z-01 |
| TCGA-AR-A24X | 52 | female | White | Primary solid Tumor | premenopausal | IDC/ILC | positive | positive | equivocal | NA | NA | alive | 8.22 | European | TCGA.AR.A24X.01A.11R.A169.07 | TCGA-AR-A24X-01 |
| TCGA-A2-A0CV | 41 | female | Asian | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 8.24 | East Asian | TCGA.A2.A0CV.01A.31R.A115.07 | TCGA-A2-A0CV-01 |
| TCGA-A2-A0CL | 37 | female | Black or African American | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 8.25 | African | TCGA.A2.A0CL.01A.11R.A115.07 | TCGA-A2-A0CL-01 |
| TCGA-A2-A0ST | 62 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | not evaluated | NA | NA | alive | 8.26 | European | TCGA.A2.A0ST.01A.12R.A084.07 | TCGA-A2-A0ST-01 |
| TCGA-AR-A1AQ | 49 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | equivocal | NA | NA | alive | 8.27 | European | TCGA.AR.A1AQ.01A.11R.A12P.07 | TCGA-AR-A1AQ-01 |
| TCGA-AC-A2BM | 41 | female | Black or African American | Primary solid Tumor | not available | IDC | positive | positive | not evaluated | NA | NA | alive | 8.27 | African | TCGA.AC.A2BM.01A.11R.A21T.07 | TCGA-AC-A2BM-01 |
| TCGA-AR-A251 | 51 | female | White | Primary solid Tumor | premenopausal | IDC | positive | negative | equivocal | NA | NA | alive | 8.3 | European | TCGA.AR.A251.01A.12R.A169.07 | TCGA-AR-A251-01 |
| TCGA-AR-A24N | 54 | female | White | Primary solid Tumor | perimenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 8.31 | European | TCGA.AR.A24N.01A.11R.A169.07 | TCGA-AR-A24N-01 |
| TCGA-B6-A1KF | 68 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | equivocal | NA | NA | alive | 8.45 | European | TCGA.B6.A1KF.01A.11R.A13Q.07 | TCGA-B6-A1KF-01 |
| TCGA-GM-A2DN | 58 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 8.46 | European | TCGA.GM.A2DN.01A.11R.A180.07 | TCGA-GM-A2DN-01 |
| TCGA-A2-A0EM | 73 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | not evaluated | NA | NA | alive | 8.47 | European | TCGA.A2.A0EM.01A.11R.A034.07 | TCGA-A2-A0EM-01 |
| TCGA-A2-A04W | 50 | female | White | Primary solid Tumor | premenopausal | apocrine | negative | negative | positive | NA | NA | alive | 8.49 | European | TCGA.A2.A04W.01A.31R.A115.07 | TCGA-A2-A04W-01 |
| TCGA-AO-A12A | 47 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 8.52 | European | TCGA.AO.A12A.01A.21R.A115.07 | TCGA-AO-A12A-01 |
| TCGA-E2-A1LI | 57 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | equivocal | NA | NA | alive | 8.54 | European | TCGA.E2.A1LI.01A.12R.A157.07 | TCGA-E2-A1LI-01 |
| TCGA-AR-A24U | 47 | female | White | Primary solid Tumor | premenopausal | IDC | negative | negative | positive | NA | NA | alive | 8.56 | European | TCGA.AR.A24U.01A.11R.A169.07 | TCGA-AR-A24U-01 |
| TCGA-B6-A40B | 76 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 8.63 | European | TCGA.B6.A40B.01A.11R.A239.07 | TCGA-B6-A40B-01 |
| TCGA-AR-A1AK | 70 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 8.65 | European | TCGA.AR.A1AK.01A.21R.A12P.07 | TCGA-AR-A1AK-01 |
| TCGA-AR-A24Q | 49 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | negative | negative | NA | NA | alive | 8.68 | European | TCGA.AR.A24Q.01A.12R.A169.07 | TCGA-AR-A24Q-01 |
| TCGA-AR-A24T | 46 | female | White | Primary solid Tumor | premenopausal | ILC | positive | positive | equivocal | NA | NA | alive | 8.77 | European | TCGA.AR.A24T.01A.11R.A169.07 | TCGA-AR-A24T-01 |
| TCGA-AR-A24V | 52 | female | White | Primary solid Tumor | perimenopausal | IDC | positive | positive | negative | NA | NA | alive | 8.77 | European | TCGA.AR.A24V.01A.21R.A169.07 | TCGA-AR-A24V-01 |
| TCGA-A2-A25E | 34 | female | Black or African American | Primary solid Tumor | premenopausal | IDC | positive | positive | equivocal | locoregional recurrence | chest wall | alive | 8.77 | African | TCGA.A2.A25E.01A.11R.A169.07 | TCGA-A2-A25E-01 |
| TCGA-GM-A2DM | 57 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 8.83 | American | TCGA.GM.A2DM.01A.11R.A180.07 | TCGA-GM-A2DM-01 |
| TCGA-E2-A1LH | 59 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 8.89 | European | TCGA.E2.A1LH.01A.11R.A14D.07 | TCGA-E2-A1LH-01 |
| TCGA-E2-A1LH | 59 | female | White | Solid Tissue Normal | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 8.89 | European | TCGA.E2.A1LH.11A.22R.A14D.07 | TCGA-E2-A1LH-11 |
| TCGA-AO-A128 | 61 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 8.89 | European | TCGA.AO.A128.01A.11R.A10J.07 | TCGA-AO-A128-01 |
| TCGA-Z7-A8R6 | 46 | female | White | Primary solid Tumor | premenopausal | ILC | positive | positive | negative | NA | NA | alive | 8.91 | European | TCGA.Z7.A8R6.01A.11R.A41B.07 | TCGA-Z7-A8R6-01 |
| TCGA-AR-A0U4 | 54 | female | White | Primary solid Tumor | premenopausal | IDC | negative | negative | negative | NA | NA | alive | 8.93 | European | TCGA.AR.A0U4.01A.11R.A109.07 | TCGA-AR-A0U4-01 |
| TCGA-A2-A25A | 44 | female | White | Primary solid Tumor | premenopausal | ILC | positive | positive | equivocal | NA | NA | alive | 8.97 | European | TCGA.A2.A25A.01A.12R.A16F.07 | TCGA-A2-A25A-01 |
| TCGA-A2-A0CR | 54 | female | Asian | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 8.99 | East Asian | TCGA.A2.A0CR.01A.11R.A22K.07 | TCGA-A2-A0CR-01 |
| TCGA-A2-A0CW | 67 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 8.99 | European | TCGA.A2.A0CW.01A.21R.A115.07 | TCGA-A2-A0CW-01 |
| TCGA-AO-A129 | 29 | female | White | Primary solid Tumor | premenopausal | IDC | negative | negative | negative | NA | NA | alive | 9.0 | European | TCGA.AO.A129.01A.21R.A10J.07 | TCGA-AO-A129-01 |
| TCGA-Z7-A8R5 | 61 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | locoregional recurrence | recur>bone | alive | 9.0 | European | TCGA.Z7.A8R5.01A.42R.A41B.07 | TCGA-Z7-A8R5-01 |
| TCGA-AR-A1AI | 47 | female | White | Primary solid Tumor | postmenopausal | medullary carcinoma | negative | negative | equivocal | NA | NA | alive | 9.02 | European | TCGA.AR.A1AI.01A.11R.A12P.07 | TCGA-AR-A1AI-01 |
| TCGA-AO-A126 | 39 | female | Asian | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | locoregional recurrence | NA | alive | 9.05 | East Asian | TCGA.AO.A126.01A.11R.A10J.07 | TCGA-AO-A126-01 |
| TCGA-AR-A0TT | 53 | female | Black or African American | Primary solid Tumor | premenopausal | IDC | positive | negative | negative | NA | NA | alive | 9.08 | African_admix | TCGA.AR.A0TT.01A.31R.A084.07 | TCGA-AR-A0TT-01 |
| TCGA-GM-A3NW | 63 | female | White | Primary solid Tumor | postmenopausal | ILC | negative | positive | equivocal | NA | NA | alive | 9.2 | European | TCGA.GM.A3NW.01A.21R.A22K.07 | TCGA-GM-A3NW-01 |
| TCGA-BH-A42U | 80 | female | Black or African American | Primary solid Tumor | postmenopausal | ILC | negative | negative | negative | NA | NA | alive | 9.21 | African | TCGA.BH.A42U.01A.12R.A24H.07 | TCGA-BH-A42U-01 |
| TCGA-AR-A24R | 45 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 9.39 | European | TCGA.AR.A24R.01A.11R.A169.07 | TCGA-AR-A24R-01 |
| TCGA-AO-A125 | 72 | female | Black or African American | Primary solid Tumor | postmenopausal | papillary carcinoma | positive | positive | negative | NA | NA | alive | 9.46 | African | TCGA.AO.A125.01A.11R.A10J.07 | TCGA-AO-A125-01 |
| TCGA-AO-A124 | 38 | female | White | Primary solid Tumor | premenopausal | mucinous/ductal | negative | negative | negative | NA | NA | alive | 9.6 | European | TCGA.AO.A124.01A.11R.A10J.07 | TCGA-AO-A124-01 |
| TCGA-GM-A2DL | 50 | female | White | Primary solid Tumor | perimenopausal | IDC | positive | positive | negative | NA | NA | alive | 9.63 | European | TCGA.GM.A2DL.01A.11R.A18M.07 | TCGA-GM-A2DL-01 |
| TCGA-A2-A0EP | 56 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | negative | negative | NA | NA | alive | 9.86 | European | TCGA.A2.A0EP.01A.52R.A22U.07 | TCGA-A2-A0EP-01 |
| TCGA-AR-A24O | 43 | female | White | Primary solid Tumor | premenopausal | ILC with ductal features | positive | positive | negative | not available | not available | alive | 9.88 | European | TCGA.AR.A24O.01A.11R.A169.07 | TCGA-AR-A24O-01 |
| TCGA-AR-A24M | 38 | female | White | Primary solid Tumor | premenopausal | IDC/ILC | positive | positive | negative | NA | NA | alive | 10.02 | European | TCGA.AR.A24M.01A.11R.A169.07 | TCGA-AR-A24M-01 |
| TCGA-A2-A04R | 36 | female | Black or African American | Primary solid Tumor | premenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 10.15 | African_admix | TCGA.A2.A04R.01A.41R.A109.07 | TCGA-A2-A04R-01 |
| TCGA-AR-A1AH | 51 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | negative | negative | NA | NA | alive | 10.42 | European | TCGA.AR.A1AH.01A.11R.A12D.07 | TCGA-AR-A1AH-01 |
| TCGA-AQ-A04L | 48 | female | White | Primary solid Tumor | perimenopausal | IDC | positive | negative | positive | NA | NA | alive | 10.83 | European | TCGA.AQ.A04L.01B.21R.A10J.07 | TCGA-AQ-A04L-01 |
| TCGA-3C-AALI | 50 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 10.97 | African | TCGA.3C.AALI.01A.11R.A41B.07 | TCGA-3C-AALI-01 |
| TCGA-3C-AAAU | 55 | female | White | Primary solid Tumor | premenopausal | ILC | positive | positive | negative | metastasis | lung | alive | 11.08 | European | TCGA.3C.AAAU.01A.11R.A41B.07 | TCGA-3C-AAAU-01 |
| TCGA-AR-A0U3 | 59 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 11.17 | European | TCGA.AR.A0U3.01A.11R.A109.07 | TCGA-AR-A0U3-01 |
| TCGA-A2-A0EN | 70 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | equivocal | NA | NA | alive | 11.19 | European | TCGA.A2.A0EN.01A.13R.A084.07 | TCGA-A2-A0EN-01 |
| TCGA-A2-A0CK | 60 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | new primary | contralateral | alive | 11.39 | European | TCGA.A2.A0CK.01A.11R.A22K.07 | TCGA-A2-A0CK-01 |
| TCGA-B6-A1KN | 57 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | not evaluated | NA | NA | alive | 11.59 | European | TCGA.B6.A1KN.01A.11R.A13Q.07 | TCGA-B6-A1KN-01 |
| TCGA-AR-A0TP | 43 | female | White | Primary solid Tumor | premenopausal | IDC | positive | negative | negative | NA | NA | alive | 11.7 | European | TCGA.AR.A0TP.01A.11R.A084.07 | TCGA-AR-A0TP-01 |
| TCGA-B6-A0IQ | 40 | female | White | Primary solid Tumor | indeterminate | IDC | negative | negative | not evaluated | NA | NA | alive | 11.73 | European | TCGA.B6.A0IQ.01A.11R.A034.07 | TCGA-B6-A0IQ-01 |
| TCGA-A2-A04N | 66 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | not evaluated | NA | NA | alive | 11.92 | European | TCGA.A2.A04N.01A.11R.A115.07 | TCGA-A2-A04N-01 |
| TCGA-B6-A0I2 | 45 | female | White | Primary solid Tumor | indeterminate | IDC | not evaluated | not evaluated | not evaluated | NA | NA | alive | 11.94 | European | TCGA.B6.A0I2.01A.11R.A034.07 | TCGA-B6-A0I2-01 |
| TCGA-AR-A24H | 65 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 13.4 | European | TCGA.AR.A24H.01A.11R.A169.07 | TCGA-AR-A24H-01 |
| TCGA-B6-A0RO | 71 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | not evaluated | NA | NA | alive | 13.49 | European | TCGA.B6.A0RO.01A.22R.A084.07 | TCGA-B6-A0RO-01 |
| TCGA-B6-A0IO | 66 | female | White | Primary solid Tumor | indeterminate | IDC | positive | Indeterminate | not evaluated | NA | NA | alive | 13.8 | European | TCGA.B6.A0IO.01A.11R.A034.07 | TCGA-B6-A0IO-01 |
| TCGA-AR-A2LE | 69 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | negative | not evaluated | new primary | endoometrium | alive | 13.86 | European | TCGA.AR.A2LE.01A.11R.A180.07 | TCGA-AR-A2LE-01 |
| TCGA-B6-A0RV | 42 | female | White | Primary solid Tumor | indeterminate | IDC/ILC | positive | positive | not evaluated | NA | NA | alive | 14.12 | European | TCGA.B6.A0RV.01A.11R.A084.07 | TCGA-B6-A0RV-01 |
| TCGA-B6-A0WT | 61 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | not evaluated | new primary | contralateral | alive | 15.71 | European | TCGA.B6.A0WT.01A.11R.A109.07 | TCGA-B6-A0WT-01 |
| TCGA-B6-A0IJ | 42 | female | Black or African American | Primary solid Tumor | indeterminate | IDC | positive | positive | not evaluated | NA | NA | alive | 19.46 | African | TCGA.B6.A0IJ.01A.11R.A034.07 | TCGA-B6-A0IJ-01 |
| TCGA-B6-A0RI | 44 | female | White | Primary solid Tumor | indeterminate | IDC | positive | positive | not evaluated | locoregional disease | chest wall | alive | 19.51 | European | TCGA.B6.A0RI.01A.11R.A056.07 | TCGA-B6-A0RI-01 |
| TCGA-B6-A0RE | 61 | female | Black or African American | Primary solid Tumor | indeterminate | IDC | negative | negative | not evaluated | NA | NA | alive | 21.29 | African_admix | TCGA.B6.A0RE.01A.11R.A056.07 | TCGA-B6-A0RE-01 |
| TCGA-B6-A0RN | 60 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | not evaluated | NA | NA | alive | 21.92 | European | TCGA.B6.A0RN.01A.12R.A084.07 | TCGA-B6-A0RN-01 |
| TCGA-B6-A0IA | 51 | female | White | Primary solid Tumor | indeterminate | ductal/cribiform | positive | positive | not evaluated | NA | NA | alive | 22.97 | European | TCGA.B6.A0IA.01A.11R.A034.07 | TCGA-B6-A0IA-01 |
| TCGA-B6-A0I5 | 49 | female | White | Primary solid Tumor | indeterminate | IDC | positive | positive | not evaluated | NA | NA | alive | 23.43 | European | TCGA.B6.A0I5.01A.11R.A034.07 | TCGA-B6-A0I5-01 |
| TCGA-B6-A0RU | 40 | female | White | Primary solid Tumor | indeterminate | ductal/metaplastic | negative | negative | not evaluated | NA | NA | alive | 23.56 | European | TCGA.B6.A0RU.01A.11R.A084.07 | TCGA-B6-A0RU-01 |
| TCGA-AC-A23H | 90 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | negative | positive | NA | NA | dead | NA | European | TCGA.AC.A23H.01A.11R.A157.07 | TCGA-AC-A23H-01 |
| TCGA-AC-A23H | 90 | female | White | Solid Tissue Normal | postmenopausal | IDC | positive | negative | positive | NA | NA | dead | NA | European | TCGA.AC.A23H.11A.12R.A157.07 | TCGA-AC-A23H-11 |
| TCGA-E9-A1N6 | 52 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | metastasis | bone>recur>liver | dead | NA | European | TCGA.E9.A1N6.01A.11R.A144.07 | TCGA-E9-A1N6-01 |
| TCGA-E9-A1N6 | 52 | female | White | Solid Tissue Normal | postmenopausal | IDC | positive | positive | positive | metastasis | bone>recur>liver | dead | NA | European | TCGA.E9.A1N6.11A.32R.A144.07 | TCGA-E9-A1N6-11 |
| TCGA-E9-A1NG | 62 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | dead | NA | European | TCGA.E9.A1NG.01A.21R.A14M.07 | TCGA-E9-A1NG-01 |
| TCGA-E9-A1NG | 62 | female | White | Solid Tissue Normal | postmenopausal | IDC | positive | positive | negative | NA | NA | dead | NA | European | TCGA.E9.A1NG.11A.52R.A14M.07 | TCGA-E9-A1NG-11 |
| TCGA-E9-A1NF | 60 | female | White | Primary solid Tumor | postmenopausal | IDC/ILC | positive | positive | negative | NA | NA | dead | NA | European | TCGA.E9.A1NF.01A.11R.A14D.07 | TCGA-E9-A1NF-01 |
| TCGA-E9-A1NF | 60 | female | White | Solid Tissue Normal | postmenopausal | IDC/ILC | positive | positive | negative | NA | NA | dead | NA | European | TCGA.E9.A1NF.11A.73R.A14D.07 | TCGA-E9-A1NF-11 |
| TCGA-C8-A3M7 | 60 | female | Asian | Primary solid Tumor | postmenopausal | ILC | negative | negative | negative | locoregional recurrence | NA | dead | 0.0 | East Asian | TCGA.C8.A3M7.01A.12R.A21T.07 | TCGA-C8-A3M7-01 |
| TCGA-AC-A62V | 58 | male | Black or African American | Primary solid Tumor | not applicable | IDC | positive | positive | not evaluated | metastasis | bone | dead | 0.01 | African | TCGA.AC.A62V.01A.11R.A31O.07 | TCGA-AC-A62V-01 |
| TCGA-C8-A12Q | 78 | female | Asian | Primary solid Tumor | postmenopausal | IDC | negative | negative | positive | metastasis | liver | dead | 0.01 | East Asian | TCGA.C8.A12Q.01A.11R.A115.07 | TCGA-C8-A12Q-01 |
| TCGA-E9-A2JS | 72 | female | White | Primary solid Tumor | postmenopausal | ILC | not evaluated | not evaluated | not evaluated | metastasis | bone|liver | dead | 0.04 | European | TCGA.E9.A2JS.01A.11R.A180.07 | TCGA-E9-A2JS-01 |
| TCGA-E9-A226 | 45 | female | White | Primary solid Tumor | premenopausal | IDC | not evaluated | not evaluated | not evaluated | metastasis | bone|liver | dead | 0.04 | European | TCGA.E9.A226.01A.21R.A157.07 | TCGA-E9-A226-01 |
| TCGA-AC-A3EH | 79 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | negative | negative | NA | NA | dead | 0.05 | European | TCGA.AC.A3EH.01A.22R.A22K.07 | TCGA-AC-A3EH-01 |
| TCGA-E9-A1RB | 40 | female | White | Primary solid Tumor | premenopausal | IDC | not evaluated | not evaluated | not evaluated | NA | NA | dead | 0.06 | European | TCGA.E9.A1RB.01A.11R.A157.07 | TCGA-E9-A1RB-01 |
| TCGA-E9-A1RB | 40 | female | White | Solid Tissue Normal | premenopausal | IDC | not evaluated | not evaluated | not evaluated | NA | NA | dead | 0.06 | European | TCGA.E9.A1RB.11A.33R.A157.07 | TCGA-E9-A1RB-11 |
| TCGA-E9-A245 | 47 | female | White | Primary solid Tumor | premenopausal | IDC | not evaluated | not evaluated | not evaluated | NA | NA | dead | 0.07 | European | TCGA.E9.A245.01A.22R.A16F.07 | TCGA-E9-A245-01 |
| TCGA-A8-A08L | 89 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | negative | negative | NA | NA | dead | 0.08 | European | TCGA.A8.A08L.01A.11R.A00Z.07 | TCGA-A8-A08L-01 |
| TCGA-BH-A42T | 75 | female | Black or African American | Primary solid Tumor | postmenopausal | ILC | positive | positive | positive | NA | NA | dead | 0.88 | African_admix | TCGA.BH.A42T.01A.11R.A24H.07 | TCGA-BH-A42T-01 |
| TCGA-AC-A2QJ | 48 | female | White | Primary solid Tumor | perimenopausal | metaplastic carcinoma | negative | negative | negative | metastasis | bone | dead | 1.22 | American | TCGA.AC.A2QJ.01A.12R.A19W.07 | TCGA-AC-A2QJ-01 |
| TCGA-D8-A1XC | 85 | female | White | Primary solid Tumor | postmenopausal | mucinous carcinoma | positive | positive | negative | metastasis | bone | dead | 1.03 | European | TCGA.D8.A1XC.01A.11R.A14D.07 | TCGA-D8-A1XC-01 |
| TCGA-D8-A1Y1 | 80 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | dead | 0.83 | European | TCGA.D8.A1Y1.01A.21R.A14M.07 | TCGA-D8-A1Y1-01 |
| TCGA-LL-A73Z | 55 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | positive | positive | equivocal | metastasis | skin | dead | 0.62 | African | TCGA.LL.A73Z.01A.11R.A32P.07 | TCGA-LL-A73Z-01 |
| TCGA-A2-A0CU | 73 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | equivocal | NA | NA | dead | 0.43 | European | TCGA.A2.A0CU.01A.12R.A034.07 | TCGA-A2-A0CU-01 |
| TCGA-E2-A15M | 66 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | dead | 0.92 | European | TCGA.E2.A15M.01A.11R.A12D.07 | TCGA-E2-A15M-01 |
| TCGA-E2-A15M | 66 | female | White | Solid Tissue Normal | postmenopausal | ILC | positive | positive | negative | NA | NA | dead | 0.92 | European | TCGA.E2.A15M.11A.22R.A12D.07 | TCGA-E2-A15M-11 |
| TCGA-D8-A73W | 79 | female | White | Primary solid Tumor | postmenopausal | mucinous carcinoma | positive | negative | negative | metastasis | lung|bone | dead | 1.05 | European | TCGA.D8.A73W.01A.22R.A352.07 | TCGA-D8-A73W-01 |
| TCGA-A2-A0T2 | 66 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | metastasis | liver|abdomen | dead | 0.7 | European | TCGA.A2.A0T2.01A.11R.A084.07 | TCGA-A2-A0T2-01 |
| TCGA-AQ-A7U7 | 55 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | dead | 1.6 | European | TCGA.AQ.A7U7.01A.22R.A352.07 | TCGA-AQ-A7U7-01 |
| TCGA-E2-A2P5 | 78 | female | Black or African American | Primary solid Tumor | postmenopausal | ILC | positive | positive | not evaluated | metastasis | bone | dead | 2.25 | admix | TCGA.E2.A2P5.01A.11R.A19W.07 | TCGA-E2-A2P5-01 |
| TCGA-OL-A5D6 | 71 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | negative | negative | not evaluated | NA | NA | dead | 3.02 | African_admix | TCGA.OL.A5D6.01A.21R.A27Q.07 | TCGA-OL-A5D6-01 |
| TCGA-E2-A14Z | 64 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | metastasis | bone | dead | 1.54 | European | TCGA.E2.A14Z.01A.11R.A115.07 | TCGA-E2-A14Z-01 |
| TCGA-A2-A04P | 36 | female | Black or African American | Primary solid Tumor | premenopausal | IDC | negative | negative | not evaluated | metastasis | bone>axilla recur|lung>liver | dead | 1.5 | African | TCGA.A2.A04P.01A.31R.A034.07 | TCGA-A2-A04P-01 |
| TCGA-A7-A13E | 62 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | negative | equivocal | metastasis | lung|bone|liver|brain|skin | dead | 1.68 | European | TCGA.A7.A13E.01A.11R.A12P.07 | TCGA-A7-A13E-01 |
| TCGA-A7-A13E | 62 | female | White | Solid Tissue Normal | postmenopausal | IDC | positive | negative | equivocal | metastasis | lung|bone|liver|brain|skin | dead | 1.68 | European | TCGA.A7.A13E.11A.61R.A12P.07 | TCGA-A7-A13E-11 |
| TCGA-A2-A0YT | 56 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | negative | not evaluated | NA | NA | dead | 1.98 | European | TCGA.A2.A0YT.01A.11R.A109.07 | TCGA-A2-A0YT-01 |
| TCGA-AO-A0J5 | 48 | female | White | Primary solid Tumor | premenopausal | ductal/micropapillary | positive | negative | equivocal | metastasis | lung|bone|liver | dead | 2.17 | European | TCGA.AO.A0J5.01A.11R.A034.07 | TCGA-AO-A0J5-01 |
| TCGA-A2-A0CM | 40 | female | Black or African American | Primary solid Tumor | premenopausal | IDC | negative | negative | negative | NA | NA | dead | 2.06 | African_admix | TCGA.A2.A0CM.01A.31R.A034.07 | TCGA-A2-A0CM-01 |
| TCGA-A2-A0EW | 53 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | metastasis | bone | dead | 5.16 | European | TCGA.A2.A0EW.01A.21R.A115.07 | TCGA-A2-A0EW-01 |
| TCGA-BH-A0BF | 56 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | dead | 3.62 | European | TCGA.BH.A0BF.01A.21R.A12P.07 | TCGA-BH-A0BF-01 |
| TCGA-A2-A3XY | 49 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | metastasis | lung>lymph nodes>brain | dead | 2.99 | African | TCGA.A2.A3XY.01A.11R.A239.07 | TCGA-A2-A3XY-01 |
| TCGA-AC-A2FE | 62 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | not evaluated | NA | bone>liver | dead | 7.22 | European | TCGA.AC.A2FE.01A.11R.A19W.07 | TCGA-AC-A2FE-01 |
| TCGA-A2-A0SV | 63 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | equivocal | metastasis | bone | dead | 2.26 | European | TCGA.A2.A0SV.01A.11R.A084.07 | TCGA-A2-A0SV-01 |
| TCGA-A8-A06U | 80 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | dead | 2.42 | European | TCGA.A8.A06U.01A.11R.A00Z.07 | TCGA-A8-A06U-01 |
| TCGA-E2-A1B4 | 74 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | dead | 2.75 | European | TCGA.E2.A1B4.01A.11R.A12P.07 | TCGA-E2-A1B4-01 |
| TCGA-A2-A3XU | 35 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | negative | negative | not evaluated | metastasis | bone>breast recur|chest wall | dead | 2.5 | African_admix | TCGA.A2.A3XU.01A.12R.A22U.07 | TCGA-A2-A3XU-01 |
| TCGA-A8-A06X | 77 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | negative | positive | NA | NA | dead | 2.58 | European | TCGA.A8.A06X.01A.21R.A00Z.07 | TCGA-A8-A06X-01 |
| TCGA-A1-A0SK | 54 | female | Asian | Primary solid Tumor | indeterminate | \neuroendocrine carcinoma, large-cell type, high-grade\"" | negative | negative | negative | NA | NA | dead | 2.65 | East Asian | TCGA.A1.A0SK.01A.12R.A084.07 | TCGA-A1-A0SK-01 |
| TCGA-OL-A66K | 72 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | equivocal | NA | NA | dead | 3.49 | European | TCGA.OL.A66K.01A.11R.A29R.07 | TCGA-OL-A66K-01 |
| TCGA-A2-A3XS | 62 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | negative | negative | not evaluated | metastasis | lung | dead | 2.83 | African_admix | TCGA.A2.A3XS.01A.11R.A22U.07 | TCGA-A2-A3XS-01 |
| TCGA-A8-A08J | 52 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | negative | negative | NA | NA | dead | 3.09 | European | TCGA.A8.A08J.01A.11R.A00Z.07 | TCGA-A8-A08J-01 |
| TCGA-B6-A3ZX | 50 | female | Black or African American | Primary solid Tumor | unknown | IDC/ILC | negative | negative | negative | metastasis | bone | dead | 3.15 | African | TCGA.B6.A3ZX.01A.11R.A239.07 | TCGA-B6-A3ZX-01 |
| TCGA-A2-A3XX | 49 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | dead | 3.94 | African | TCGA.A2.A3XX.01A.21R.A239.07 | TCGA-A2-A3XX-01 |
| TCGA-AR-A2LK | 62 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | equivocal | metastasis | bone | dead | 4.51 | European | TCGA.AR.A2LK.01A.11R.A180.07 | TCGA-AR-A2LK-01 |
| TCGA-BH-A0C1 | 61 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | metastasis | bone | dead | 3.86 | European | TCGA.BH.A0C1.01B.11R.A12D.07 | TCGA-BH-A0C1-01 |
| TCGA-A2-A0SW | 82 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | negative | not evaluated | metastasis | liver | dead | 3.74 | European | TCGA.A2.A0SW.01A.11R.A084.07 | TCGA-A2-A0SW-01 |
| TCGA-A2-A0CO | 85 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | dead | 4.02 | European | TCGA.A2.A0CO.01A.13R.A22K.07 | TCGA-A2-A0CO-01 |
| TCGA-BH-A0BP | 76 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | dead | 6.29 | European | TCGA.BH.A0BP.01A.11R.A115.07 | TCGA-BH-A0BP-01 |
| TCGA-HN-A2OB | 45 | female | not available | Primary solid Tumor | premenopausal | ILC | positive | positive | negative | metastasis | bone|omentum | dead | 5.2 | European | TCGA.HN.A2OB.01A.21R.A27Q.07 | TCGA-HN-A2OB-01 |
| TCGA-A2-A04V | 39 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | equivocal | NA | NA | dead | 5.26 | European | TCGA.A2.A04V.01A.21R.A034.07 | TCGA-A2-A04V-01 |
| TCGA-AR-A24L | 26 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | equivocal | NA | NA | dead | 7.85 | European | TCGA.AR.A24L.01A.11R.A169.07 | TCGA-AR-A24L-01 |
| TCGA-AR-A0TZ | 43 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | equivocal | metastasis | bone | dead | 8.93 | European | TCGA.AR.A0TZ.01A.12R.A084.07 | TCGA-AR-A0TZ-01 |
| TCGA-A2-A0CS | 73 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | equivocal | metastasis | ovary | dead | 6.43 | European | TCGA.A2.A0CS.01A.11R.A115.07 | TCGA-A2-A0CS-01 |
| TCGA-AO-A03P | 54 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | metastasis | liver | dead | 7.97 | African | TCGA.AO.A03P.01A.11R.A00Z.07 | TCGA-AO-A03P-01 |
| TCGA-B6-A0IP | 74 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | not evaluated | NA | NA | dead | 10.75 | European | TCGA.B6.A0IP.01A.11R.A034.07 | TCGA-B6-A0IP-01 |
| TCGA-A8-A08T | 64 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | not available | not available | dead | 9.33 | European | TCGA.A8.A08T.01A.21R.A00Z.07 | TCGA-A8-A08T-01 |
| TCGA-B6-A0IM | 75 | female | Black or African American | Primary solid Tumor | postmenopausal | ductal/cribiform | positive | positive | not evaluated | NA | NA | dead | 10.6 | African | TCGA.B6.A0IM.01A.11R.A034.07 | TCGA-B6-A0IM-01 |
| TCGA-B6-A0X1 | 48 | female | White | Primary solid Tumor | indeterminate | IDC | negative | negative | not evaluated | NA | NA | dead | 20.41 | European | TCGA.B6.A0X1.01A.11R.A109.07 | TCGA-B6-A0X1-01 |
| TCGA-B6-A0RH | 51 | female | Black or African American | Primary solid Tumor | indeterminate | IDC | positive | positive | not evaluated | NA | NA | dead | 17.68 | African | TCGA.B6.A0RH.01A.21R.A115.07 | TCGA-B6-A0RH-01 |
| TCGA-GM-A2DA | 46 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | equivocal | metastasis | bone>liver>lymph node>brain | dead | 18.05 | European | TCGA.GM.A2DA.01A.11R.A18M.07 | TCGA-GM-A2DA-01 |
| TCGA-B6-A0IC | 90 | female | White | Primary solid Tumor | postmenopausal | invasive papillary | positive | positive | not evaluated | NA | NA | dead | NA | European | TCGA.B6.A0IC.01A.11R.A034.07 | TCGA-B6-A0IC-01 |
| TCGA-BH-A1F8 | 90 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | dead | NA | European | TCGA.BH.A1F8.01A.11R.A13Q.07 | TCGA-BH-A1F8-01 |
| TCGA-BH-A1F8 | 90 | female | White | Solid Tissue Normal | postmenopausal | IDC | positive | positive | positive | NA | NA | dead | NA | European | TCGA.BH.A1F8.11B.21R.A13Q.07 | TCGA-BH-A1F8-11 |
| TCGA-UU-A93S | 63 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | negative | negative | positive | metastasis | bone|liver | dead | 0.32 | African_admix | TCGA.UU.A93S.01A.21R.A41B.07 | TCGA-UU-A93S-01 |
| TCGA-AR-A0TR | 68 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | equivocal | NA | NA | dead | 0.44 | European | TCGA.AR.A0TR.01A.11R.A084.07 | TCGA-AR-A0TR-01 |
| TCGA-AQ-A0Y5 | 70 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | dead | 0.47 | European | TCGA.AQ.A0Y5.01A.11R.A14M.07 | TCGA-AQ-A0Y5-01 |
| TCGA-BH-A18T | 70 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | positive | NA | NA | dead | 0.61 | European | TCGA.BH.A18T.01A.11R.A12D.07 | TCGA-BH-A18T-01 |
| TCGA-EW-A1P8 | 58 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | metastasis | lung|bone|liver|skin | dead | 0.65 | European | TCGA.EW.A1P8.01A.11R.A144.07 | TCGA-EW-A1P8-01 |
| TCGA-E2-A1LK | 84 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | negative | negative | equivocal | locoregional recurrence | axilla | dead | 0.73 | African_admix | TCGA.E2.A1LK.01A.21R.A14D.07 | TCGA-E2-A1LK-01 |
| TCGA-BH-A8FY | 87 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | dead | 0.81 | European | TCGA.BH.A8FY.01A.11R.A36F.07 | TCGA-BH-A8FY-01 |
| TCGA-AR-A5QQ | 68 | female | White | Primary solid Tumor | postmenopausal | squamous (metaplastic) carcinoma | negative | negative | negative | locoregional recurrence | chest wall|lung|liver|bone|adrenal glands | dead | 0.88 | European | TCGA.AR.A5QQ.01A.11R.A28M.07 | TCGA-AR-A5QQ-01 |
| TCGA-B6-A0I9 | 62 | female | White | Primary solid Tumor | indeterminate | IDC | Indeterminate | positive | not evaluated | metastasis | bone | dead | 0.99 | European | TCGA.B6.A0I9.01A.11R.A034.07 | TCGA-B6-A0I9-01 |
| TCGA-BH-A1EV | 45 | female | White | Primary solid Tumor | not available | IDC | positive | positive | positive | NA | NA | dead | 1.0 | European | TCGA.BH.A1EV.01A.11R.A137.07 | TCGA-BH-A1EV-01 |
| TCGA-BH-A1EV | 45 | female | White | Solid Tissue Normal | not available | IDC | positive | positive | positive | NA | NA | dead | 1.0 | European | TCGA.BH.A1EV.11A.24R.A137.07 | TCGA-BH-A1EV-11 |
| TCGA-A8-A09X | 62 | female | not available | Primary solid Tumor | postmenopausal | ILC | negative | negative | negative | NA | NA | dead | 1.17 | European | TCGA.A8.A09X.01A.11R.A00Z.07 | TCGA-A8-A09X-01 |
| TCGA-BH-A18N | 88 | female | White | Primary solid Tumor | not available | IDC | positive | positive | negative | NA | NA | dead | 1.28 | European | TCGA.BH.A18N.01A.11R.A12D.07 | TCGA-BH-A18N-01 |
| TCGA-BH-A18N | 88 | female | White | Solid Tissue Normal | not available | IDC | positive | positive | negative | NA | NA | dead | 1.28 | European | TCGA.BH.A18N.11A.43R.A12D.07 | TCGA-BH-A18N-11 |
| TCGA-AR-A1AR | 50 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | new primary | contralateral | dead | 1.43 | European | TCGA.AR.A1AR.01A.31R.A137.07 | TCGA-AR-A1AR-01 |
| TCGA-BH-A1EY | 79 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | metastasis | lung|liver | dead | 1.47 | European | TCGA.BH.A1EY.01A.11R.A13Q.07 | TCGA-BH-A1EY-01 |
| TCGA-B6-A0WW | 58 | female | Black or African American | Primary solid Tumor | indeterminate | IDC | positive | positive | not evaluated | metastasis | brain | dead | 1.53 | African | TCGA.B6.A0WW.01A.11R.A109.07 | TCGA-B6-A0WW-01 |
| TCGA-B6-A0IK | 63 | female | White | Primary solid Tumor | indeterminate | IDC | negative | negative | not evaluated | metastasis | lung | dead | 1.56 | European | TCGA.B6.A0IK.01A.12R.A056.07 | TCGA-B6-A0IK-01 |
| TCGA-B6-A409 | 44 | female | Black or African American | Primary solid Tumor | premenopausal | IDC | negative | negative | equivocal | metastasis | lung | dead | 1.57 | African | TCGA.B6.A409.01A.11R.A24H.07 | TCGA-B6-A409-01 |
| TCGA-BH-A1FG | 88 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | dead | 1.58 | European | TCGA.BH.A1FG.01A.11R.A13Q.07 | TCGA-BH-A1FG-01 |
| TCGA-BH-A1FG | 88 | female | White | Solid Tissue Normal | postmenopausal | IDC | positive | positive | negative | NA | NA | dead | 1.58 | European | TCGA.BH.A1FG.11B.12R.A13Q.07 | TCGA-BH-A1FG-11 |
| TCGA-BH-A18J | 56 | female | White | Primary solid Tumor | not available | IDC | positive | positive | negative | metastasis | bone | dead | 1.68 | European | TCGA.BH.A18J.01A.11R.A12D.07 | TCGA-BH-A18J-01 |
| TCGA-BH-A18J | 56 | female | White | Solid Tissue Normal | not available | IDC | positive | positive | negative | metastasis | bone | dead | 1.68 | European | TCGA.BH.A18J.11A.31R.A12D.07 | TCGA-BH-A18J-11 |
| TCGA-AR-A2LH | 55 | female | White | Primary solid Tumor | postmenopausal | ILC | negative | negative | equivocal | metastasis | bone|liver | dead | 1.69 | European | TCGA.AR.A2LH.01A.31R.A18M.07 | TCGA-AR-A2LH-01 |
| TCGA-B6-A0WX | 40 | female | Black or African American | Primary solid Tumor | premenopausal | pleomorphic/lobular | negative | negative | not evaluated | metastasis | bone | dead | 1.75 | African | TCGA.B6.A0WX.01A.11R.A109.07 | TCGA-B6-A0WX-01 |
| TCGA-B6-A0I8 | 46 | female | White | Primary solid Tumor | indeterminate | IDC | not evaluated | not evaluated | not evaluated | locoregional disease | pectoral muscle | dead | 2.05 | European | TCGA.B6.A0I8.01A.11R.A034.07 | TCGA-B6-A0I8-01 |
| TCGA-BH-A1F0 | 80 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | Indeterminate | negative | NA | NA | dead | 2.15 | European | TCGA.BH.A1F0.01A.11R.A137.07 | TCGA-BH-A1F0-01 |
| TCGA-BH-A1F0 | 80 | female | White | Solid Tissue Normal | postmenopausal | IDC | negative | Indeterminate | negative | NA | NA | dead | 2.15 | European | TCGA.BH.A1F0.11B.23R.A137.07 | TCGA-BH-A1F0-11 |
| TCGA-AC-A2FM | 87 | female | White | Primary solid Tumor | postmenopausal | ILC | not evaluated | not evaluated | not evaluated | metastasis | bone marrow | dead | 2.17 | European | TCGA.AC.A2FM.01A.11R.A19W.07 | TCGA-AC-A2FM-01 |
| TCGA-AC-A2FM | 87 | female | White | Solid Tissue Normal | postmenopausal | ILC | not evaluated | not evaluated | not evaluated | metastasis | bone marrow | dead | 2.17 | European | TCGA.AC.A2FM.11B.32R.A19W.07 | TCGA-AC-A2FM-11 |
| TCGA-BH-A18L | 50 | female | White | Primary solid Tumor | not available | IDC | positive | positive | negative | NA | NA | dead | 2.22 | European | TCGA.BH.A18L.01A.32R.A12D.07 | TCGA-BH-A18L-01 |
| TCGA-BH-A18L | 50 | female | White | Solid Tissue Normal | not available | IDC | positive | positive | negative | NA | NA | dead | 2.22 | European | TCGA.BH.A18L.11A.42R.A12D.07 | TCGA-BH-A18L-11 |
| TCGA-B6-A0X4 | 62 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | not evaluated | metastasis | bone | dead | 2.35 | European | TCGA.B6.A0X4.01A.11R.A109.07 | TCGA-B6-A0X4-01 |
| TCGA-E2-A1LE | 71 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | positive | metastasis | lung | dead | 2.41 | European | TCGA.E2.A1LE.01A.12R.A19W.07 | TCGA-E2-A1LE-01 |
| TCGA-BH-A18P | 60 | female | White | Primary solid Tumor | not available | IDC | positive | negative | positive | NA | NA | dead | 2.52 | European | TCGA.BH.A18P.01A.11R.A12D.07 | TCGA-BH-A18P-01 |
| TCGA-BH-A18P | 60 | female | White | Solid Tissue Normal | not available | IDC | positive | negative | positive | NA | NA | dead | 2.52 | European | TCGA.BH.A18P.11A.43R.A12D.07 | TCGA-BH-A18P-11 |
| TCGA-BH-A1F2 | 53 | female | White | Primary solid Tumor | not available | IDC | positive | positive | positive | NA | NA | dead | 2.63 | European | TCGA.BH.A1F2.01A.31R.A13Q.07 | TCGA-BH-A1F2-01 |
| TCGA-BH-A1F2 | 53 | female | White | Solid Tissue Normal | not available | IDC | positive | positive | positive | NA | NA | dead | 2.63 | European | TCGA.BH.A1F2.11A.32R.A13Q.07 | TCGA-BH-A1F2-11 |
| TCGA-B6-A0I6 | 49 | female | Black or African American | Primary solid Tumor | indeterminate | IDC | negative | negative | not evaluated | metastasis | bone|skin | dead | 2.71 | African | TCGA.B6.A0I6.01A.11R.A034.07 | TCGA-B6-A0I6-01 |
| TCGA-BH-A0EA | 72 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | dead | 2.71 | European | TCGA.BH.A0EA.01A.11R.A115.07 | TCGA-BH-A0EA-01 |
| TCGA-BH-A1FD | 68 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | dead | 2.76 | European | TCGA.BH.A1FD.01A.11R.A13Q.07 | TCGA-BH-A1FD-01 |
| TCGA-BH-A1FD | 68 | female | White | Solid Tissue Normal | postmenopausal | IDC | positive | positive | negative | NA | NA | dead | 2.76 | European | TCGA.BH.A1FD.11B.21R.A13Q.07 | TCGA-BH-A1FD-11 |
| TCGA-BH-A1FH | 47 | female | White | Primary solid Tumor | not available | IDC | positive | negative | not evaluated | metastasis | bone | dead | 2.83 | European | TCGA.BH.A1FH.01A.12R.A13Q.07 | TCGA-BH-A1FH-01 |
| TCGA-BH-A1FH | 47 | female | White | Solid Tissue Normal | not available | IDC | positive | negative | not evaluated | metastasis | bone | dead | 2.83 | European | TCGA.BH.A1FH.11B.42R.A13Q.07 | TCGA-BH-A1FH-11 |
| TCGA-BH-A18R | 50 | female | White | Primary solid Tumor | not available | IDC | Indeterminate | negative | positive | NA | NA | dead | 3.13 | European | TCGA.BH.A18R.01A.11R.A12D.07 | TCGA-BH-A18R-01 |
| TCGA-BH-A18R | 50 | female | White | Solid Tissue Normal | not available | IDC | Indeterminate | negative | positive | NA | NA | dead | 3.13 | European | TCGA.BH.A18R.11A.42R.A12D.07 | TCGA-BH-A18R-11 |
| TCGA-BH-A203 | 78 | female | White | Primary solid Tumor | postmenopausal | IDC | not evaluated | not evaluated | not evaluated | NA | NA | dead | 3.21 | European | TCGA.BH.A203.01A.12R.A169.07 | TCGA-BH-A203-01 |
| TCGA-BH-A203 | 78 | female | White | Solid Tissue Normal | postmenopausal | IDC | not evaluated | not evaluated | not evaluated | NA | NA | dead | 3.21 | European | TCGA.BH.A203.11A.42R.A169.07 | TCGA-BH-A203-11 |
| TCGA-AR-A1AT | 62 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | positive | NA | NA | dead | 3.48 | European | TCGA.AR.A1AT.01A.11R.A12P.07 | TCGA-AR-A1AT-01 |
| TCGA-BH-A1EU | 83 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | dead | 3.52 | European | TCGA.BH.A1EU.01A.11R.A137.07 | TCGA-BH-A1EU-01 |
| TCGA-BH-A1EU | 83 | female | White | Solid Tissue Normal | postmenopausal | IDC | positive | positive | negative | NA | NA | dead | 3.52 | European | TCGA.BH.A1EU.11A.23R.A137.07 | TCGA-BH-A1EU-11 |
| TCGA-BH-A1FM | 44 | female | White | Primary solid Tumor | not available | IDC | positive | negative | not evaluated | NA | NA | dead | 3.8 | European | TCGA.BH.A1FM.01A.11R.A13Q.07 | TCGA-BH-A1FM-01 |
| TCGA-BH-A1FM | 44 | female | White | Solid Tissue Normal | not available | IDC | positive | negative | not evaluated | NA | NA | dead | 3.8 | European | TCGA.BH.A1FM.11B.23R.A13Q.07 | TCGA-BH-A1FM-11 |
| TCGA-PE-A5DC | 72 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | positive | NA | NA | dead | 3.92 | European | TCGA.PE.A5DC.01A.12R.A27Q.07 | TCGA-PE-A5DC-01 |
| TCGA-BH-A1EX | 67 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | dead | 4.13 | East Asian | TCGA.BH.A1EX.01A.11R.A13Q.07 | TCGA-BH-A1EX-01 |
| TCGA-BH-A18U | 72 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | dead | 4.28 | European | TCGA.BH.A18U.01A.21R.A12D.07 | TCGA-BH-A18U-01 |
| TCGA-BH-A18U | 72 | female | White | Solid Tissue Normal | postmenopausal | IDC | positive | positive | positive | NA | NA | dead | 4.28 | European | TCGA.BH.A18U.11A.23R.A12D.07 | TCGA-BH-A18U-11 |
| TCGA-BH-A1FR | 73 | female | White | Primary solid Tumor | not available | IDC/mucinous | positive | positive | not evaluated | NA | NA | dead | 4.5 | European | TCGA.BH.A1FR.01A.11R.A13Q.07 | TCGA-BH-A1FR-01 |
| TCGA-BH-A1FR | 73 | female | White | Solid Tissue Normal | not available | IDC/mucinous | positive | positive | not evaluated | NA | NA | dead | 4.5 | European | TCGA.BH.A1FR.11B.42R.A13Q.07 | TCGA-BH-A1FR-11 |
| TCGA-BH-A1FL | 69 | female | White | Primary solid Tumor | not available | IDC | positive | positive | not evaluated | NA | NA | dead | 4.58 | European | TCGA.BH.A1FL.01A.11R.A13Q.07 | TCGA-BH-A1FL-01 |
| TCGA-BH-A1FU | 44 | female | White | Primary solid Tumor | not available | IDC | negative | negative | not evaluated | NA | NA | dead | 4.62 | European | TCGA.BH.A1FU.01A.11R.A14D.07 | TCGA-BH-A1FU-01 |
| TCGA-BH-A1FU | 44 | female | White | Solid Tissue Normal | not available | IDC | negative | negative | not evaluated | NA | NA | dead | 4.62 | European | TCGA.BH.A1FU.11A.23R.A14D.07 | TCGA-BH-A1FU-11 |
| TCGA-BH-A18Q | 56 | female | White | Primary solid Tumor | not available | IDC | negative | negative | positive | NA | NA | dead | 4.63 | European | TCGA.BH.A18Q.01A.12R.A12D.07 | TCGA-BH-A18Q-01 |
| TCGA-BH-A18Q | 56 | female | White | Solid Tissue Normal | not available | IDC | negative | negative | positive | NA | NA | dead | 4.63 | European | TCGA.BH.A18Q.11A.34R.A12D.07 | TCGA-BH-A18Q-11 |
| TCGA-BH-A1EW | 38 | female | White | Primary solid Tumor | premenopausal | IDC | negative | negative | negative | NA | NA | dead | 4.64 | European | TCGA.BH.A1EW.01A.11R.A137.07 | TCGA-BH-A1EW-01 |
| TCGA-BH-A1EW | 38 | female | White | Solid Tissue Normal | premenopausal | IDC | negative | negative | negative | NA | NA | dead | 4.64 | European | TCGA.BH.A1EW.11B.33R.A137.07 | TCGA-BH-A1EW-11 |
| TCGA-AR-A0TY | 54 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | negative | negative | metastasis | bone | dead | 4.65 | European | TCGA.AR.A0TY.01A.12R.A115.07 | TCGA-AR-A0TY-01 |
| TCGA-BH-A208 | 48 | female | White | Primary solid Tumor | not available | IDC | not evaluated | not evaluated | not evaluated | NA | NA | dead | 4.82 | European | TCGA.BH.A208.01A.11R.A157.07 | TCGA-BH-A208-01 |
| TCGA-BH-A208 | 48 | female | White | Solid Tissue Normal | not available | IDC | not evaluated | not evaluated | not evaluated | NA | NA | dead | 4.82 | European | TCGA.BH.A208.11A.51R.A157.07 | TCGA-BH-A208-11 |
| TCGA-B6-A0X7 | 62 | female | White | Primary solid Tumor | postmenopausal | IDC/ILC | positive | positive | not evaluated | new primary | colon | dead | 4.88 | European | TCGA.B6.A0X7.01A.11R.A10J.07 | TCGA-B6-A0X7-01 |
| TCGA-AO-A03U | 31 | female | White | Primary solid Tumor | premenopausal | secretory | negative | negative | negative | NA | NA | dead | 4.91 | European | TCGA.AO.A03U.01B.21R.A10J.07 | TCGA-AO-A03U-01 |
| TCGA-GM-A2D9 | 69 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | not evaluated | metastasis | bone>lymph node|lung | dead | 4.96 | European | TCGA.GM.A2D9.01A.11R.A18M.07 | TCGA-GM-A2D9-01 |
| TCGA-BH-A1FJ | 66 | female | White | Primary solid Tumor | not available | IDC | negative | positive | not evaluated | NA | NA | dead | 5.28 | European | TCGA.BH.A1FJ.01A.11R.A13Q.07 | TCGA-BH-A1FJ-01 |
| TCGA-BH-A1FJ | 66 | female | White | Solid Tissue Normal | not available | IDC | negative | positive | not evaluated | NA | NA | dead | 5.28 | European | TCGA.BH.A1FJ.11B.42R.A13Q.07 | TCGA-BH-A1FJ-11 |
| TCGA-B6-A0IE | 38 | female | Black or African American | Primary solid Tumor | premenopausal | IDC/ILC | negative | negative | not evaluated | metastasis | bone | dead | 5.46 | African_admix | TCGA.B6.A0IE.01A.11R.A034.07 | TCGA-B6-A0IE-01 |
| TCGA-BH-A18S | 79 | female | White | Primary solid Tumor | postmenopausal | mucinous carcinoma | positive | positive | negative | NA | NA | dead | 5.5 | European | TCGA.BH.A18S.01A.11R.A12D.07 | TCGA-BH-A18S-01 |
| TCGA-BH-A18S | 79 | female | White | Solid Tissue Normal | postmenopausal | mucinous carcinoma | positive | positive | negative | NA | NA | dead | 5.5 | European | TCGA.BH.A18S.11A.43R.A12D.07 | TCGA-BH-A18S-11 |
| TCGA-B6-A0X5 | 61 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | positive | positive | not evaluated | metastasis | bone|liver|pleura | dead | 5.74 | African_admix | TCGA.B6.A0X5.01A.21R.A109.07 | TCGA-B6-A0X5-01 |
| TCGA-BH-A1EN | 78 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | positive | NA | NA | dead | 5.82 | European | TCGA.BH.A1EN.01A.11R.A13Q.07 | TCGA-BH-A1EN-01 |
| TCGA-BH-A1EN | 78 | female | White | Solid Tissue Normal | postmenopausal | IDC | negative | negative | positive | NA | NA | dead | 5.82 | European | TCGA.BH.A1EN.11A.23R.A13Q.07 | TCGA-BH-A1EN-11 |
| TCGA-BH-A1FN | 34 | female | White | Primary solid Tumor | not available | IDC | positive | positive | not evaluated | NA | NA | dead | 6.0 | European | TCGA.BH.A1FN.01A.11R.A13Q.07 | TCGA-BH-A1FN-01 |
| TCGA-BH-A1FN | 34 | female | White | Solid Tissue Normal | not available | IDC | positive | positive | not evaluated | NA | NA | dead | 6.0 | European | TCGA.BH.A1FN.11A.34R.A13Q.07 | TCGA-BH-A1FN-11 |
| TCGA-BH-A18M | 39 | female | White | Primary solid Tumor | not available | IDC | positive | positive | positive | NA | NA | dead | 6.04 | European | TCGA.BH.A18M.01A.11R.A12D.07 | TCGA-BH-A18M-01 |
| TCGA-BH-A18M | 39 | female | White | Solid Tissue Normal | not available | IDC | positive | positive | positive | NA | NA | dead | 6.04 | European | TCGA.BH.A18M.11A.33R.A12D.07 | TCGA-BH-A18M-11 |
| TCGA-BH-A1FE | 31 | female | White | Primary solid Tumor | not available | IDC | positive | positive | not evaluated | NA | NA | dead | 6.22 | European | TCGA.BH.A1FE.01A.11R.A13Q.07 | TCGA-BH-A1FE-01 |
| TCGA-BH-A1FE | 31 | female | White | Solid Tissue Normal | not available | IDC | positive | positive | not evaluated | NA | NA | dead | 6.22 | European | TCGA.BH.A1FE.11B.14R.A13Q.07 | TCGA-BH-A1FE-11 |
| TCGA-B6-A0I1 | 73 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | negative | negative | not evaluated | metastasis | lung | dead | 6.46 | African_admix | TCGA.B6.A0I1.01A.11R.A21T.07 | TCGA-B6-A0I1-01 |
| TCGA-B6-A0RM | 57 | female | Black or African American | Primary solid Tumor | indeterminate | IDC | positive | positive | not evaluated | NA | NA | dead | 6.5 | African_admix | TCGA.B6.A0RM.01A.11R.A084.07 | TCGA-B6-A0RM-01 |
| TCGA-B6-A0WV | 67 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | not evaluated | NA | NA | dead | 6.62 | European | TCGA.B6.A0WV.01A.11R.A109.07 | TCGA-B6-A0WV-01 |
| TCGA-B6-A0RL | 60 | female | Black or African American | Primary solid Tumor | not available | IDC | positive | positive | not evaluated | NA | NA | dead | 6.76 | African | TCGA.B6.A0RL.01A.11R.A084.07 | TCGA-B6-A0RL-01 |
| TCGA-AO-A03O | 69 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | dead | 6.8 | African_admix | TCGA.AO.A03O.01A.11R.A00Z.07 | TCGA-AO-A03O-01 |
| TCGA-BH-A1ET | 55 | female | White | Primary solid Tumor | not available | IDC | positive | positive | negative | NA | NA | dead | 6.9 | European | TCGA.BH.A1ET.01A.11R.A137.07 | TCGA-BH-A1ET-01 |
| TCGA-BH-A1ET | 55 | female | White | Solid Tissue Normal | not available | IDC | positive | positive | negative | NA | NA | dead | 6.9 | European | TCGA.BH.A1ET.11B.23R.A137.07 | TCGA-BH-A1ET-11 |
| TCGA-BH-A204 | 80 | female | White | Primary solid Tumor | postmenopausal | IDC | not evaluated | not evaluated | not evaluated | NA | NA | dead | 6.94 | European | TCGA.BH.A204.01A.11R.A157.07 | TCGA-BH-A204-01 |
| TCGA-BH-A204 | 80 | female | White | Solid Tissue Normal | postmenopausal | IDC | not evaluated | not evaluated | not evaluated | NA | NA | dead | 6.94 | European | TCGA.BH.A204.11A.53R.A157.07 | TCGA-BH-A204-11 |
| TCGA-AR-A0U2 | 47 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | metastasis | bone|liver | dead | 6.98 | European | TCGA.AR.A0U2.01A.11R.A109.07 | TCGA-AR-A0U2-01 |
| TCGA-B6-A0IN | 45 | female | White | Primary solid Tumor | indeterminate | IDC with mucinous features | positive | negative | not evaluated | metastasis | bone|brain | dead | 7.04 | European | TCGA.B6.A0IN.01A.11R.A034.07 | TCGA-B6-A0IN-01 |
| TCGA-BH-A1F5 | 62 | female | White | Primary solid Tumor | not available | IDC | positive | positive | negative | NA | NA | dead | 7.43 | European | TCGA.BH.A1F5.01A.12R.A13Q.07 | TCGA-BH-A1F5-01 |
| TCGA-BH-A18K | 46 | female | White | Primary solid Tumor | not available | IDC | positive | positive | negative | NA | NA | dead | 7.56 | European | TCGA.BH.A18K.01A.11R.A12D.07 | TCGA-BH-A18K-01 |
| TCGA-BH-A18K | 46 | female | White | Solid Tissue Normal | not available | IDC | positive | positive | negative | NA | NA | dead | 7.56 | European | TCGA.BH.A18K.11A.13R.A12D.07 | TCGA-BH-A18K-11 |
| TCGA-BH-A1EO | 68 | female | White | Primary solid Tumor | postmenopausal | IDC/ILC features | positive | positive | negative | NA | NA | dead | 7.66 | European | TCGA.BH.A1EO.01A.11R.A137.07 | TCGA-BH-A1EO-01 |
| TCGA-BH-A1EO | 68 | female | White | Solid Tissue Normal | postmenopausal | IDC/ILC features | positive | positive | negative | NA | NA | dead | 7.66 | European | TCGA.BH.A1EO.11A.31R.A137.07 | TCGA-BH-A1EO-11 |
| TCGA-AR-A256 | 45 | female | White | Primary solid Tumor | premenopausal | IDC | negative | negative | negative | locoregional disease | NA | dead | 7.81 | European | TCGA.AR.A256.01A.11R.A169.07 | TCGA-AR-A256-01 |
| TCGA-B6-A0IH | 81 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | not evaluated | NA | NA | dead | 8.12 | European | TCGA.B6.A0IH.01A.11R.A115.07 | TCGA-B6-A0IH-01 |
| TCGA-B6-A0WS | 58 | female | Black or African American | Primary solid Tumor | indeterminate | IDC | positive | positive | not evaluated | NA | NA | dead | 8.12 | African_admix | TCGA.B6.A0WS.01A.11R.A115.07 | TCGA-B6-A0WS-01 |
| TCGA-BH-A1F6 | 51 | female | White | Primary solid Tumor | not available | IDC | negative | negative | negative | NA | NA | dead | 8.12 | European | TCGA.BH.A1F6.01A.11R.A13Q.07 | TCGA-BH-A1F6-01 |
| TCGA-BH-A1F6 | 51 | female | White | Solid Tissue Normal | not available | IDC | negative | negative | negative | NA | NA | dead | 8.12 | European | TCGA.BH.A1F6.11B.94R.A13Q.07 | TCGA-BH-A1F6-11 |
| TCGA-B6-A0RS | 38 | female | White | Primary solid Tumor | indeterminate | IDC | negative | negative | not evaluated | new primary | contralateral | dead | 8.39 | European | TCGA.B6.A0RS.01A.11R.A084.07 | TCGA-B6-A0RS-01 |
| TCGA-B6-A0RP | 73 | female | White | Primary solid Tumor | postmenopausal | IDC/ILC | positive | positive | not evaluated | metastasis | bone | dead | 8.56 | European | TCGA.B6.A0RP.01A.21R.A084.07 | TCGA-B6-A0RP-01 |
| TCGA-B6-A0WY | 40 | female | White | Primary solid Tumor | premenopausal | IDC | positive | negative | not evaluated | metastasis | bone | dead | 9.48 | European | TCGA.B6.A0WY.01A.11R.A109.07 | TCGA-B6-A0WY-01 |
| TCGA-BH-A1ES | 35 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | dead | 9.48 | European | TCGA.BH.A1ES.01A.11R.A137.07 | TCGA-BH-A1ES-01 |
| TCGA-BH-A1FC | 78 | female | Black or African American | Primary solid Tumor | postmenopausal | medullary carcinoma | negative | negative | negative | NA | NA | dead | 9.51 | African | TCGA.BH.A1FC.01A.11R.A13Q.07 | TCGA-BH-A1FC-01 |
| TCGA-BH-A1FC | 78 | female | Black or African American | Solid Tissue Normal | postmenopausal | medullary carcinoma | negative | negative | negative | NA | NA | dead | 9.51 | African | TCGA.BH.A1FC.11A.32R.A13Q.07 | TCGA-BH-A1FC-11 |
| TCGA-BH-A1FB | 60 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | dead | 10.05 | European | TCGA.BH.A1FB.01A.11R.A13Q.07 | TCGA-BH-A1FB-01 |
| TCGA-BH-A1FB | 60 | female | White | Solid Tissue Normal | postmenopausal | IDC | positive | positive | negative | NA | NA | dead | 10.05 | European | TCGA.BH.A1FB.11A.33R.A13Q.07 | TCGA-BH-A1FB-11 |
| TCGA-B6-A0IB | 64 | female | White | Primary solid Tumor | indeterminate | IDC | positive | positive | not evaluated | metastasis | skin>lung|bone|liver | dead | 10.79 | European | TCGA.B6.A0IB.01A.11R.A034.07 | TCGA-B6-A0IB-01 |
| TCGA-B6-A0X0 | 54 | female | White | Primary solid Tumor | indeterminate | cribiform | positive | positive | not evaluated | NA | NA | dead | 10.8 | European | TCGA.B6.A0X0.01A.21R.A115.07 | TCGA-B6-A0X0-01 |
| TCGA-BH-A209 | 77 | female | Black or African American | Primary solid Tumor | postmenopausal | medullary carcinoma | positive | positive | not evaluated | NA | NA | dead | 10.84 | African | TCGA.BH.A209.01A.11R.A157.07 | TCGA-BH-A209-01 |
| TCGA-BH-A209 | 77 | female | Black or African American | Solid Tissue Normal | postmenopausal | medullary carcinoma | positive | positive | not evaluated | NA | NA | dead | 10.84 | African | TCGA.BH.A209.11A.42R.A157.07 | TCGA-BH-A209-11 |
| TCGA-B6-A0RQ | 68 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | not evaluated | NA | NA | dead | 11.68 | European | TCGA.B6.A0RQ.01A.11R.A115.07 | TCGA-B6-A0RQ-01 |
| TCGA-B6-A0IG | 50 | female | White | Primary solid Tumor | indeterminate | IDC | positive | positive | not evaluated | NA | NA | dead | 12.2 | European | TCGA.B6.A0IG.01A.11R.A034.07 | TCGA-B6-A0IG-01 |
| TCGA-E2-A15A | 45 | female | White | Metastatic | not available | NA | NA | NA | NA | NA | NA | alive | 1.94 | European | TCGA.E2.A15A.06A.11R.A12D.07 | TCGA-E2-A15A-06 |
| TCGA-BH-A18V | 48 | female | White | Metastatic | not available | NA | NA | NA | NA | NA | NA | dead | 4.26 | European | TCGA.BH.A18V.06A.11R.A213.07 | TCGA-BH-A18V-06 |
| TCGA-E2-A15K | 58 | female | White | Metastatic | not available | NA | NA | NA | NA | NA | NA | alive | 0.09 | European | TCGA.E2.A15K.06A.11R.A12P.07 | TCGA-E2-A15K-06 |
| TCGA-AC-A6IX | 49 | female | White | Metastatic | not available | NA | NA | NA | NA | NA | NA | alive | 1.02 | European | TCGA.AC.A6IX.06A.11R.A32P.07 | TCGA-AC-A6IX-06 |
| TCGA-E2-A15E | 40 | female | White | Metastatic | not available | NA | NA | NA | NA | NA | NA | alive | 1.72 | European | TCGA.E2.A15E.06A.11R.A12D.07 | TCGA-E2-A15E-06 |
| TCGA-BH-A1ES | 35 | female | White | Metastatic | not available | NA | NA | NA | NA | NA | NA | dead | 9.48 | European | TCGA.BH.A1ES.06A.12R.A24H.07 | TCGA-BH-A1ES-06 |
| TCGA-BH-A1FE | 31 | female | White | Metastatic | not available | NA | NA | NA | NA | NA | NA | dead | 6.22 | European | TCGA.BH.A1FE.06A.11R.A213.07 | TCGA-BH-A1FE-06 |
| TCGA-EW-A1PF | 50 | female | NA | Primary solid Tumor | not available | IDC | NA | NA | NA | NA | NA | alive | 1.2 | NA | TCGA.EW.A1PF.01 | TCGA-EW-A1PF-01 |
| TCGA-EW-A1P7 | 59 | female | NA | Primary solid Tumor | not available | IDC | NA | NA | NA | NA | NA | alive | 2.51 | NA | TCGA.EW.A1P7.01 | TCGA-EW-A1P7-01 |
| TCGA-EW-A1J6 | 70 | female | NA | Primary solid Tumor | not available | IDC | positive | positive | negative | NA | NA | alive | 2.4 | NA | TCGA.EW.A1J6.01 | TCGA-EW-A1J6-01 |
| TCGA-E2-A159 | 50 | female | White | Primary solid Tumor | not available | IDC | NA | NA | NA | NA | NA | alive | 2.09 | NA | TCGA.E2.A159.01 | TCGA-E2-A159-01 |
| TCGA-AO-A0JM | 40 | female | NA | Primary solid Tumor | not available | IDC | NA | NA | NA | NA | NA | alive | 5.98 | NA | TCGA.AO.A0JM.01 | TCGA-AO-A0JM-01 |
| TCGA-E2-A1LA | 59 | female | NA | Primary solid Tumor | not available | IDC | NA | NA | NA | NA | NA | alive | 2.05 | NA | TCGA.E2.A1LA.01 | TCGA-E2-A1LA-01 |
| TCGA-EW-A2FW | 52 | female | White | Primary solid Tumor | not available | Intraductal papillary adenocarcinoma with invasion | NA | NA | NA | NA | NA | alive | 1.84 | NA | TCGA.EW.A2FW.01 | TCGA-EW-A2FW-01 |
| TCGA-EW-A1J1 | 38 | female | White | Primary solid Tumor | not available | IDC | NA | NA | NA | NA | NA | alive | 1.58 | NA | TCGA-EW-A1J1-01 | TCGA-EW-A1J1-01 |
| TCGA-EW-A1P4 | 43 | female | White | Primary solid Tumor | premenopausal | Medullary carcinoma | NA | NA | NA | NA | NA | alive | 2.48 | NA | TCGA-EW-A1P4-01 | TCGA-EW-A1P4-01 |
| TCGA-EW-A1PE | 56 | female | White | Primary solid Tumor | not available | IDC | NA | NA | NA | NA | NA | alive | 0.88 | NA | TCGA-EW-A1PE-01 | TCGA-EW-A1PE-01 |
| TCGA-EW-A423 | 75 | female | White | Primary solid Tumor | not available | Lobular carcinoma | NA | NA | NA | NA | NA | alive | 1.46 | NA | TCGA-EW-A423-01 | TCGA-EW-A423-01 |
| TCGA-EW-A1IZ | 53 | female | White | Primary solid Tumor | not available | IDC | NA | NA | NA | NA | NA | alive | 1.52 | NA | TCGA-EW-A1IZ-01 | TCGA-EW-A1IZ-01 |
| TCGA-A2-A0T1 | 55 | female | American Indian or Alaska Native | Primary solid Tumor | not available | IDC | NA | NA | NA | NA | NA | alive | 1.43 | NA | TCGA-A2-A0T1-01 | TCGA-A2-A0T1-01 |
| TCGA-AO-A12B | 63 | female | White | Primary solid Tumor | not available | IDC | NA | NA | NA | NA | NA | alive | 8.19 | NA | TCGA-AO-A12B-01 | TCGA-AO-A12B-01 |
| TCGA-E2-A10A | 41 | female | White | Primary solid Tumor | not available | IDC | NA | NA | NA | metastasis | brain | alive | 3.37 | NA | TCGA-E2-A10A-01 | TCGA-E2-A10A-01 |
| TCGA-E2-A9RU | 90 | female | Black or African American | Primary solid Tumor | not available | IDC | NA | NA | NA | NA | NA | alive | 0.0 | NA | TCGA-E2-A9RU-01 | TCGA-E2-A9RU-01 |
| TCGA-OL-A6VQ | 49 | female | White | Primary solid Tumor | not available | Lobular carcinoma | NA | NA | NA | NA | NA | alive | 1.64 | NA | TCGA-OL-A6VQ-01 | TCGA-OL-A6VQ-01 |
| TCGA-EW-A424 | 51 | female | White | Primary solid Tumor | not available | Lobular carcinoma | NA | NA | NA | NA | NA | alive | 1.96 | NA | TCGA-EW-A424-01 | TCGA-EW-A424-01 |
| TCGA-5L-AAT0 | 42 | female | White | Primary solid Tumor | not available | Adenocarcinoma | NA | NA | NA | NA | NA | alive | 4.04 | NA | TCGA-5L-AAT0-01 | TCGA-5L-AAT0-01 |
| TCGA-A8-A08R | 52 | female | NA | Primary solid Tumor | postmenopausal | IDC | NA | NA | NA | NA | NA | alive | 0.08 | NA | TCGA-A8-A08R-01 | TCGA-A8-A08R-01 |
| TCGA-A8-A07S | 73 | female | NA | Primary solid Tumor | postmenopausal | IDC/ILC | NA | NA | NA | NA | NA | alive | 0.67 | NA | TCGA-A8-A07S-01 | TCGA-A8-A07S-01 |